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Abstract
The effects of yV-methyl-D-aspartate (NMDA) receptor antagonists on learning
behaviour have been studied extensively as they block long-term potentiation (LTP),
the suspected neural substrate for memory storage mechanisms. However, NMDA
receptor antagonists also induce prominent changes in motor behaviour and so it is
ambiguous whether the learning impairment induced by these drugs are due to a block
of LTP or a behavioural abnormality.
Competitive NMDA receptor antagonists are not fully satisfactory
pharmacological tools in examining the above question because the dose response of
both effects are too close to distinguish. On the other hand, the non-competitive
NMDA receptor antagonists like MK-801 (dizocilpine) exhibit distinguishing
behavioural effects but they cause ataxia that is so severe that they can hardly be used
in behavioural experiments.
In an attempt to resolve this issue, the drug chosen in this thesis was a novel
non-competitive NMDA receptor antagonist, FR 115427 ((+)-1 -methyl- 1-phenyl-
1,2,3,4-tetrahydroisoquinoline hydrochloride). Although its binding affinity to the
NMDA receptors is about 10 times weaker than that ofMK-801, it induces relatively
mild ataxia and shows a faster time course of kinetics. This allows testing in a wider
range of doses; it also exhibits clear-cut time effects.
Three types of procedure are used in this thesis: open field activity tests, in vivo
LTP examinations and water maze experiments. The open field activity tests showed
that FR115427 induced a characteristic motor syndrome: ataxia, head weaving, body
rolling and hyperlocomotion. These effects occurred with a potency of approximately
30 ~ 100 times weaker than those produced by MK-801. With FR115427, indices for
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ataxia and head weaving reached a peak within 30 min post injection and began to
decline after 40, whereas the peak indices with MK-801 was less well defined and lay
between 40 and 60 min.
LTP examinations in anaesthetised rats showed that a 10 mg/kg dose of
FR115427 completely blocked LTP which was induced 90 min post injection but not
if it was induced 30 min post injection. This suggests a late onset effect on LTP by the
drug. MK-801 was too toxic at doses required to show a significant effect in
anaesthetised animals.
The water maze experiments showed that FR115427 impaired the spatial
learning at a lower dose (3.2 mg/kg) than that was required to block LTP. A
comparison of the learning effect between a short interval (20 min) experiment and a
long interval (90 min) experiment revealed that the learning effect of the drug had an
early onset. MK-801 did not show any clear-cut time dependent effects at the doses
tested.
In conclusion, the action of FR115427 on LTP was temporally and dose
dependently differentiated from that on spontaneous behaviour and learning. It is
suggested that non-competitive NMDA receptor antagonists impair spatial learning by
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The novel isoquinoline derivative (+)-l-methyl-1 -phenyl-1, 2, 3, 4-
tetrahydroisoquinoline hydrochloride (FR115427, Fig. 1-1), synthesized by Fujisawa
Pharmaceutical Co., Ltd., has been characterized as a specific non-competitive
NMDA receptor antagonist (Hodgkiss et al., 1993; Sherriffs et al., 1993). It has
been found to prevent neuronal death following ischaemic insult in gerbils
(Nakanishi et al., 1994) and in rats (Katsuta et al., 1995). The pharmacological
analysis of this compound is expected to give us useful informations about the
physiological role ofNMDA receptors and the clinical side effects in the therapeutic
use of this compound for stroke. From this point of view, this thesis investigated,
the effect of FR115427 on synaptic transmission and synaptic plasticity in vivo,
spontaneous behaviour and a type of learning thought to depend on NMDA
receptors.
1.1 NMDA receptor
Excitatory action of glutamate in the brain of rats, dogs and human(s) was
originally reported by Hayashi in 1954. Nowadays, glutamate and related excitatory
amino acid receptors are accepted as the main transmitter receptors mediating
synaptic excitation in the mammalian central nervous system (Watkins and Evans,
1981; Collingridge et al., 1983; Monaghan et al., 1989). Four classes excitatory
amino acid receptors are recognized to date, and all of which bind glutamate with
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Fig. 1 -1 Chemical structues of (+) MK-801maleate (dizocilpine)
and (+) FR115427 HC1
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high affinity (Monaghanet al., 1989; Iversen, 1995). Three of them are ionotropic
glutamate receptors functioning as ligand-gated cation channels and are traditionally
defined by their selective agonists: N-methyl-D-aspartate (NMDA) receptors, kainate
receptors, and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)
receptors. The forth class of receptors is a family of G protein coupled metabotropic
glutamate receptors. Recent advances, achieved using molecular cloning and
mutagenesis coupled with functional analysis have revealed a high degree of
molecular diversity in the subunits of the ionotropic receptors and metabotropic
glutamate receptors, (Seeburg, 1993; Hollmann and Heinemann, 1994; Nakanishi
and Masu, 1994; Pin and Duvoisin, 1995).
Among a variety of glutamate receptors, considerable attention has been
focused on the NMDA receptors because it has been found to be implicated in
neuropathological cell death (Meldrum and Garthwaite 1990; Olney 1990) and
synaptic plasticity and learning (Morris et al., 1986a).
1.1.1 Competitive antagonists for NMDA receptors
The key step in the analysis of NMDA receptors has been the development of
specific antagonists. D(-) isomers of 2-amino 5-phosphonopentanoate (AP5)
(Davies and Watkins, 1982; Evans et al., 1982) and 2-amino-7-phosphonoheptanoate
(AP7) (Perkins et al., 1982) were developed as specific competitive NMDA
antagonists and are useful as the pharmacological tool for investigating and
identifying the role of NMDA receptors in the CNS. These compounds are also the
bases for development of more potent antagonists. An AP7 analogue with a
conformationally restricted structure, 3-((±)2-carboxypiperazin-4-yl) propyl-1-
phosphonate (DL-CPP) was developed to show higher affinity for NMDA receptor
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than AP5 (D-isomer of CPP was found to have higher affinity than L-isomer later).
A cyclic analogue of AP5, cis-4-phosphonomethyl-2-piperidine carboxylate
(CGS19755) is about equipotent with DL-CPP. [3H] D-AP5 and [3H] CPP label a
single population of sites with Kp values of 0.5 |lM and 0.3 |lM respectively and
Bmax values of around 4 pmol/mg protein in tests using synaptosomal (P2) fraction
of rat cerebral cortex. Kq values of glutamate and NMDA for inhibition of [3H] D-
AP5 binding are 0.9 jlM and 11 (iM respectively (Olverman and Watkins 1989).
1.1.2 Recognition sites for modulators of NMDA receptors
In addition to the agonist recognition site, the NMDA receptor/channel
complex has several regulatory sites. Lodge et al.( 1989), Wong and Kemp (1991)
enumerate the proposed regulatory sites as follows.
(i) Magnesium site: At the resting potential, Mg2+ blocks the NMDA ion
channel by binding to a site deep within the ionophore at a concentration well below
that normally present in extracellular fluid. This confers a unique voltage
dependency on the NMDA receptor-mediated response, which is evoked very little
at low frequency synaptic activation, but becomes apparent when the membrane is
depolarised (above -50 ~ -30 mV) for more prolonged periods (e.g. during repetitive
high-frequency synaptic activation).
(ii) Phencyclidine (PCP) site: The dissociative anaesthetics (e.g. PCP,
ketamine) and MK-801 (see below) have high affinity in a stereoselective manner
for a single population of sites whose affinity correlates well with their potency as
blockers of NMDA-induced depolarization in rat brain. The selective binding of
[3H]-MK-801 is markedly enhanced by NMDA receptor agonists and inhibited by
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competitive NMDA receptor antagonists. The non-additive nature of combinations
of ketamine with both competitive antagonists and Mg2+ suggests that ketamine acts
at a site distinct from the NMDA recognition site and from the magnesium site. The
requirement of repeated application of NMDA to fully develop the block of the
NMDA response by MK-801, a phenomenon called use-dependency, suggests this
group of compounds antagonize NMDA by entering and blocking the open channel.
(iii) Glycine site: Glycine potentiates the NMDA response by increasing
channel-opening probability in a voltage independent manner. Only very low
concentrations of glycine are required for this effect (EC50: 100-300 nM) about ten
fold lower than those required to activate the inhibitory, strychnine sensitive
receptor. Glycine has been suggested to bind to an allosteric site within the NMDA
receptor and act as a co-agonist, i.e. agonist binding at both the glutamate
recognition site and glycine site is required for channel activation. (R)-a-amino
acids, such as D-alanine and D-serine, are found to be potent agonists. Kynurenic
acid analogues, such as 5,7-dichlorokynurenic acid or L-689,560, are developed as
specific antagonists for this sites (Leeson and Iversen 1994).
(iv) Zinc site: Zn2+ produces selective and non-competitive antagonism of
NMDA receptors in cultured neurons. Its action is distinct from that ofMg2+ in that
the reduction of NMDA currents is relatively less voltage-dependent, but is still due
to reduced channel open time. Zn2+ also reduces binding at the PCP site in a manner
different from all other classes ofNMDA antagonist. This action is mimicked by
high doses of some tricyclic structures such as desipramine and promethazine
although, electrophysiologically, the tricyclics show some voltage dependence.
(v) Polyamine site: Polyamines, such as spermidine potentiate MK-801/PCP
binding. This may be part of a positive feed back system as NMDA also stimulates
the activity of ornitine decarboxylase, the enzyme responsible for the synthesis of
such polyamines. The neuroprotective agent ifenprodil may act at this site.
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1.1.3 Calcium permeability
The important role ofNMDA receptors in central nervous system is mediated
by Ca2+ entering through its associated channel. The Ca2+ permeability of NMDA
receptor channels is shown by voltage-clamp studies of cultured neurons injected
with a Ca2+-sensitive dye, which directly indicates Ca2+ influx after NMDA
applications in a manner independent of the voltage-dependent Ca2+ channels
(MacDermott et al., 1986; Mayer et al., 1987). Furthermore, the reversal potentials
of NMDA-induced currents are appropriately altered by changes in the extracellular
concentration of calcium (Mayer and Westbrook, 1987; Jahr and Stevens, 1987;
Ascher and Nowak, 1988 ).
The increase in intracellular ions is thought to initiate the biochemical process
responsible for NMDA receptor-induced plasticity (long-term potentiation) (it is
further discussed in section 1.3) and NMDA receptor mediated excitotoxic cell death
(Rothman and Olney, 1987).
1.1.4 NMDA receptor heterogeneity
The development ofmolecular biological techniques achieved cloning of
complementary DNA encoding a vast variety of subunits of AMPA, Kainate,
NMDA and metabotropic glutamate receptors of rats (Nakanishi, 1992; Seeburg,
1993). A numbers of mouse glutamate receptor subunits have also been cloned and
characterised by Mishina's group (Kutsuwada et ah, 1992). It is now known that the
ionotropic glutamate receptors form a distinct ligand-gated ion channel family and
the size of their subunits is about twice of that of nicotinic acetylcholine receptor
subunit. Each subunit of glutamate receptor probably three or five transmembrane
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domaines, whereas nicotinic receptor subunit has four (Hollmann et al., 1994; Galen
Wo and Oswald, 1995; Bennett and Dingledine 1995).
According to the reviews by Seeburg (1993) and Nakanish and Masu (1995),
NMDA receptors of rats can be reconstituted as heteromeric structures from two
subunit types, the NMDAR1 (NR1) subunit and one of four NMDAR2 subunit
(NR2A, NR2B, NR2C and NR2D). Expression of NR1 alone, or combined
expression of NR1 with one of NR2 subtypes forms an active receptor complex in
Xenopus oocytes. The resulting complexes display characteristic NMDA channel
properties, including Ca2+ permeability, the requirement of both glycine and
glutamate (or both glycine and NMDA) to activate the channel, sensitivity to Mg2+
in a voltage-dependent manner and sensitivity to the channel blocker MK-801. The
different combinations of the various subtypes show different affinity for various
agonists and antagonists, and varying kinetics of responses and stimulatory effects of
glycine. In situ hybridization analysis revealed that NR1 mRNA is found at a high
level in most areas of rat brain while the mRNA of NR2A, B, C and D shows
distinct spatial patterns of expression (Monyer et al., 1992; Ishii et al., 1993). These
expression patterns coupled with a functional difference in subtypes of subunits
could provide the molecular basis for the generation of the heterogeneity in the
physiological and pharmacological properties of NMDA receptors proposed to occur
in different neuronal cells and brain regions (Monaghan et al., 1988; Monaghan,
1991; Gonzales, 1992). A further variation ofNMDA receptors due to alternative
splice forms of the NMDAR1 subunits mRNA is also reported by several groups
including Hollmann et al. (1993) and Laurie et al. (1995). They reported that splice
variants of NMDAR1 show heterogeneity in functional properties and regional
distribution in the brain. This multiple alternative splicing may be an alternative
basis for the known heterogeneity of endogenous NMDA receptors.
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1.2 MK-801 and FR115427 : PCP like NMDA receptor antagonists
1.2.1 MK-801
MK-801 or Dizocilpine ((+)-5-methyl-10, 1 l-dihydro-5H-dibenzo [a, d]
cyclohepten-5, 10-imine maleate) (Fig. 1-1) is a potent NMDA antagonist which has
the therapeutic advantage of good CNS penetration across the blood-brain barrier.
This compound was discovered originally by Clineschmidt et al. (1982a, b and
c) as a potent anticonvulsant agent with anxiolytic and sympathomimetic properties.
Subsequently, Wong et al.(1986, 1988) found that radiolabeled [3H]-MK-801 bound
to a specific population of receptor sites in rat brain membranes, and these appeared
to be associated with a glutamate receptor of the NMDA type. [3H]-MK-801
binding was displaced by structural analogues ofMK-801, phencyclidine(PCP),
ketamine, and (+)SKF-10,047. Foster and Wong (1987) reported that high-affinity
[3H]-MK-801 binding requires the presence of micromolar concentrations of L-
glutamate or other NMDA agonists, suggesting a functional link between the MK-
801 binding site and the agonist binding site. Later, [3H]-MK-801 binding was also
found to be enhanced by glycine and other compounds that act at the strychnine-
insensitive glycine modulatory site on NMDA receptors (Reynolds et al., 1987;
Wong et al., 1987).
Electrophysiological studies using slices of rat cerebral cortex showed that
MK-801 antagonized the depolarizing actions of NMDA, leaving response to
quisqualate or kainate unchanged (Kemp et al. 1986). Moreover, a near perfect
correlation was found between the ability of MK-801, PCP, ketamine and
SKF10,047 to block NMDA responses and to displace [3H]-MK-801 binding (Wong
et al., 1986). The blockade of NMDA responses in rat cortical slices by MK-801
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was found to be accelerated by repeated agonist administration illustrating the use-
dependent nature of antagonism by MK-801. (Kemp et al., 1986; Woodruff et al.,
1987)
Therefore, the antagonist effects of MK-801 are regarded as non-competitive
and agonist-dependent.
1.2.2 FR115427
(+)-l-methyl-1-phenyl-1, 2, 3, 4-tetrahydroisoquinoline hydrochloride
(FR115427, Fig. 1-1) is a novel MK-801 analogue synthesized in the New Drug
Research Laboratories of Fujisawa Pharmaceutical Co., Ltd. Osaka Japan.
The pharmacological profile of FR115427 has been examined in vitro by
Hodgkiss et al. (1993) and Sherriffs et al. (1993).
Ligand binding studies by Hodgkiss et al. (1993) and Sherriffs et al. (1993)
using rat cortical membrane have revealed that:
(a) [3H] MK-801 binding was inhibited by MK-801 and FR115427 with Ki
values of 3.14 and 43.3 nM respectively in Hodgkiss's data and, 3.57 nM and 35.4
nM respectively in Sherriffs's data in the presence of L-glutamate (10 |lM). Those
data show FR115427 has about a 10-fold lower affinity than MK-801.
(b) The Ki values for non-competitive NMDA receptor antagonists (PCP,
ketamine, N-allylnormetazocine) in the [3H] FR115427 and [3H] MK-801 binding
assay exhibit a close correlation (r = 0.964) (Sherriffs et al. 1993).
(c) The affinity of FR115427 for [3H] MK-801 was enhanced by addition of L-
glutamate and/or glycine however the extent of enhancement was less than that for
MK-801 (Sherriffs et al. 1993).
The electrophysiological study (Hodgkiss et al. 1993) has revealed that:
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(d) The depolarization induced by NMDA was inhibited by FR115427(1 |iM)
in cortical wedge preparations.
(e) The Schild plot showed a slope of 1.21-1.6 (greater than 1) and a pA2
value of 6.45-6.6.
(f) The electrophysiological responses to the non-NMDA agonist AMPA were
unaffected by FR115427.
(g) FR115427 showed use-dependent blockade of NMDA induced
depolarization and antagonism could not be overcome by increasing the dose of
NMDA.
(h) Intracellular recording in hippocampal pyramidal cells has revealed that
FR115427 blocks a second slow component but not the first fast component of
excitatory postsynaptic potentials (EPSPs) elicited by synaptic stimulation.
The above binding studies show that FR115427 competitively interacts with
MK-801 binding sites and electrophysiological experiments confirm that FR115427
functionally acts as a non-competitive NMDA receptor antagonist.
In vivo study revealed that:
(i) FR115427 completely suppresses NMDA-induced convulsions in mice at
doses 0.32 pg/mouse i.e.v., 32 mg/kg i.p. or 100 mg/kg p.o. (ED50 values reveal a
10 times weaker potency of FR115427 than MK-801 in all administration routes) but
not quisqualate or kainate induced convulsions (Nakanishi et al., 1995).
(ii) Pretreatment with 10 mg/kg FR115427(i.v.) or 1 mg/kg of MK-801(i.v.)
protects neuronal damage in the hippocampal CA1 region of gerbils following 5 min
bilateral carotid artery occlusion (Nakanishi et al 1994).
(iii) 10 mg/kg FR115427 (i.p.) significantly reduced the brain damage while 1
mg/kg (i.p.) ofMK-801 was effective in rat MCA occlusion model (Katsuta et al.,
1995)
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These evidences prove that FR115427 is active as an NMDA receptor
antagonist in vivo as well as in vitro and its potency is about 10 times less than that
ofMK-801.
Although the fundamental features of FR115427 as an non-competitive
NMDA receptor antagonist are similar to that of MK-801, FR115427 may not be
just a weaker analogue of MK-801. For example:
The EC50 values for stimulation of [3H] FR115427 binding by L-glutamate and
glycine were 2-4 times lower than that for [3H] MK-801 binding (Sherriffs et al.,
1993)
FR115427 exhibits higher stereoselectivity than MK-801 in the affinity for
NMDA receptors (Sherriffs et al., 1993; Nakanishi et al., 1995).
The ratio of the dose that induces locomotor activity to the anti convulsant
dose for FR115427 is higher than the ratio for MK-801 (Nakanishi et al., 1995).
Thus, FR115427 induces less intense behavioural side effects than MK-801
relatively to their anticonvulsant potencies.
Although it is not clear whether all these differences between FR115427 and
MK-801 are related to each other, the less behavioural side effects may be an
advantage of FR115427 in utilising it in the study of learning and memory. As is
discussed later, the behavioural side effects of MK-801 limits the use of this drug in
the study of animal learning models.
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1.3 Long-term potentiation
The recent attention to the involvement ofNMDA receptors in learning is
greatly due to its capacity to their role in inducing hippocampal long-term
potentiation (LTP) (Collingridge et al., 1983).
LTP is a relatively long lasting increase in synaptic efficacy at monosynaptic
junctions, occurring as the result of an afferent fibre tetanisation. LTP was first
described by Bliss and Lpmo (1973) who demonstrated that repetitive high
frequency stimulation of medial perforant pathways of the hippocampus, in the
anaesthetized rabbit, induced a potentiation of synaptic transmission lasting up to 10
hr. Subsequent experiments with chronically implanted electrodes showed that LTP
could last for days and weeks at a time (Bliss and Gordner-Medwin, 1973; Douglas
and Goddard, 1975).
1.3.1 NMDA receptors and LTP
The role of NMDA receptor in the induction of LTP was first demonstrated in
the CA1 region of hippocampal slices of rat. It was found that the competitive
NMDA receptor antagonist AP5 (2-amino-5-phosphonopentanoate) reversibly
prevented induction of LTP of the population spike in the Schaffer/commissural
pathway, without affecting the low frequency response either before or after LTP
was induced (Collingridge et al., 1983). Subsequently, AP5 was found to prevent
induction of LTP of dendritic EPSPs in CA1 (Collingridge et al., 1987) and has been
found to prevent induction of LTP in the rat dentate gyrus in vivo whilst having little
or no effect on the normal low frequency response (Morris et al., 1986a; Errington
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et al., 1987). The non-competitive NMDA antagonist, MK-801, has also been found
to block the induction of LTP in vitro (Coan et al., 1987) and in vivo under certain
conditions (Abraham and Mason, 1988; Morimoto et al., 1991).
The reason that tetanic stimulation is required to induce LTP under standard
experimental conditions may be solely to keep the cell at a depolarised level to
relieve the voltage dependent Mg2+ block of NMDA receptors. Treatments that
allow NMDA receptor activation, such as a Mg2+ -free medium, depolarization of
cell membranes and high intensity stimulation, also induce LTP in an AP5-sensitive
manner. Even if AMPA receptors are blocked by CNQX (6-cyano-7-
nitroquinoxaline-2, 3-dione), LTP can be induced by the tetanus stimulation.
Therefore, NMDA receptor activation is critical for the induction of LTP in CA1
(Collingridge and Davies 1989).
For the most part, perforant path and Schaffer collateral LTP appear to be quite
similar, whereas mossy fibre to CA3 synapses exhibit a substantially different,
NMDA receptor-independent form of LTP (Harris and Cotman, 1986; Zalutsky and
Nicoll, 1990; Staubli et al., 1990). In the following part of this thesis, NMDA
receptor dependent LTP will be mainly discussed.
1.3.2 Mechanism of LTP
The high permeability of the activated NMDA receptor-gated ion channel to
Ca2+ ions results in a large increase of intracellular Ca2+ levels in dendritic spines
which can then trigger long lasting molecular events. The critical role of Ca2+ is
supported by the observation of the calcium dependency of LTP (Wigstrom et al.
1979), the blockade of LTP by intracellular injection of calcium-chelating EGTA
(Lynch et al. 1983), the increase of calcium deposits in dendrites after induction of
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LTP (Kuhnt et al. 1985) and induction of LTP-like synaptic enhancement by
increasing intracellular Ca2+.(Turner et al. 1982, Reyman et al., 1986). LTP is also
found to be associated with increased phosphoinositide turnover (Lynch et al. 1988)
and arachidonic acid metabolites (Williams and Bliss 1988). These system may
interact in the activation of Ca2+ dependent enzymes such as protein kinase C, Ca2+-
calmoduline-dependent kinase II and Ca2+ dependent protease that may lead to
genomic events such as induction of c-fos, jun-B and zif/268 expression (Madison et
al. 1991).
At least some of the critical events responsible for triggering LTP occur in the
postsynaptic cell but the locus for the persistent synaptic modulation has been
controversial especially since the proposal of a pre-synaptic component of LTP
(Malinow and Tsien, 1990; Bekkers and Stevens, 1990). Recently, the analysis of
the trial to trial amplitude fluctuation of synaptic signals in CA1 hippocampus has
reconciled the different views (Kullman and Nicoll, 1992; Liao et al., 1992). These
new analyses show an increase both in the number of quanta released and in quantal
amplitude consistent with combined pre- and post-synaptic modification (increase in
neurotransmitter release and augmentation of postsynaptic response) after induction
of LTP.
If part of the mechanism for the expression of LTP resides within the
presynaptic cell, the postsynaptic cell must communicate with the presynaptic
terminal, perhaps by releasing some factor. The prominent candidates for such
messengers are arachidonic acid (Williams et al. 1989), nitric oxide (Bohme et al.,
1991; O'Dell et al., 1991; Schuman and Madison, 1991; Haley et al., 1992) and
carbon monoxide (Zhuo et al., 1993; Stevens and Wang, 1993).
Although the detailed mechanisms of LTP are still far from fully understood
and are based, in many respects, on still unsettled experimental results, two
properties ofNMDA receptors (voltage dependent Mg2+ blockade and association
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with Ca2+ channels) seem to represent the key aspects of LTP operation which
underlie associativity and trigger long-lasting change. NMDA antagonists are,
therefore, useful tools to investigate the mechanism and the physiological role of
LTP.
1.3.3 LTP and memory
(a) Physiological properties of LTP relevant to a possible role in learning and
memory
Several characteristics of LTP as follows suggest that it is an attractive
candidate for an information storage system in the brain (Teyler and Discenna, 1984;
McNaughton and Morris, 1987a ; Morris et al., 1989).
(1) Rapid onset: LTP can be induced by brief (tens of milliseconds order)
stimulation of an afferent input (usually at 100 to 400 Hz) and develops over a time-
course of about a minute. This observation accords with the fact that memories are
rapdly formed by an event takes place only once.
(2) Long duration: A decay time-course of hours in acute in vitro preparations,
and, in chronic in vivo LTP experiments, of greater than a day or a month, has been
reported. This longer decay time course of LTP is reported to correlate with the rate
of forgetting of spatial information in an animal learning task.
(3) Input specificity: When a single group of presynaptic fibres is conditioned,
LTP is generated only in the tetanized fibres and not in untetanized fibres, even
though they terminate on the same postsynaptic neurons. This property could be
significant to increase the information storage capacity of the brain and to permit a
parallel distributed processing style of computation. Although the suggested
existence of a diffuse retrograde messenger like NO or CO during the early phase of
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LTP induction casts doubt on this 'input specificity' principle, Zuho et al. (1993) put
forward a possible solution to this problem in their experiment on hippocampal
slices . They found that only the pathway which received weak tetanic stimulation
paired with NO or CO exhibited enhanced and long lasting (at least 1 hr) EPSP but
not the pathway which received weak tetanus stimulation 5 min before application of
NO or CO. Hence, long-term enhancement mediated by NO or CO may still be
spatially restricted to the synapses which also receive an active signal.
(4)Associativity: So called associative LTP is observed if a weak tetanus is
delivered with a strong input. LTP will then be seen on the synapses that receive
both inputs. This property of LTP is highly suggestive of conditioning paradigms,
such as Pavlovian conditioning, in which a neutral (i.e. weak) stimulus paired with a
reinforcing (i.e. strong) stimulus evokes a response corresponding to a 'memory' of
the strong stimulus.
(b) Evidence that LTP represents the physiological synaptic enhancement
Barnes (1979) has found that memory deficit in aged rats is correlated with a
faster decay of LTP. This evidence suggests that changes in the ability to maintain
LTP underlie a substantial fraction of age related impairment of memory function.
It is demonstrated that artificial saturation of inducible LTP (= saturation of the
capacity for synaptic weight change) in the dentate gyrus caused learning deficit in
the circular platform maze (McNaughton et. al. 1986) and in the water maze *(Castro
et al.1989). The synaptic weight change associated with experimentally induced
*
The reliability of the results reported by Castro et al., (1989) is now equivocal.
Five individual groups have failed to replicate the spatial learning deficit following
LTP saturation in the water maze task (Cain et al., 1993; Jeffery and Morris, 1993;
Korol et al. 1993; McNamara et al., 1993; Sutherland et al., 1993; introductory
commentary is given by Bliss and Richter-Levin in the same issue 1993). According
to their comments, one possible explanation for this inconsistency is that it is not
practically possible to saturate all synapses in the dentate gyrus and the original
study may detect false positive learning deficit.
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LTP is suggested to be equivalent to the natural change postulated to occur during
memory formation.
(c) Experimental implications of LTP in learning and memory
Important behavioural evidence linking hippocampal LTP to learning and
memory was provided by a series of experiments using the water maze paradigm
(Morris et al., 1986a; Morris, 1989; Davis et al., 1992). It was shown that
intraventricular infusion of AP5 (Mixture of D and L isomers was used for the
experiments reported in 1986. Pure D-isomer was used in the later experiments.)
caused an impairment of spatial learning in the water maze which is known to be
highly sensitive to hippocampal damage (Morris et al., 1982), leaving no effect on
visual discrimination learning which is not. The same AP5 treatment also
suppressed LTP in vivo. The L-isomer of AP5 did not produce any behavioural
effects or LTP suppression. These results suggested that AP5 impaired learning by
disrupting hippocampal LTP.
The striking point of the above experiments was that they correlated two
different levels of concept - a neurobiological concept (synaptic plasticity) and
psychological concepts (learning and memory). In another words, this difficult work
was only achieved by the combination of rigorous neurophysiological analysis and
behavioural analysis.
This achievement has encouraged many researchers to investigate disruptive
effect of NMDA antagonists on animal learning. Competitive and non-competitive
NMDA receptor antagonists have also been reported to disrupt learning in radial arm
mazes (Danysz et al. 1988; Ward et al. 1990), passive avoidance tests (Danysz et al.
1988; Parada-Turska and Turkui 1990), aversively motivated Y-maze tests (Tang
and Ho 1988) and T-mazes (Flood et al 1990) and delayed conditional
discrimination task (Tan et al., 1989) as well as other studies using the water maze
tasks (see Table 1-1). Although many studies have discussed the relationship
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between the effect of an NMDA antagonist on LTP and on learning and memory,
very few presented substantial evidence to suggest an involvement of LTP in each
learning model. These kinds of investigations should provide the evidence
suggesting not only that the NMDA receptor antagonist blocks the change of
synaptic efficacy (neurophysiological evidence) but also that the drug actually
blocks the fundamental learning process (psychological evidence). As we do not
have the method to measure either concept directly, we should carefully analyse the
alternative indirect evidence concerning the above two points. Therefore, it should
first be checked if the drug impairs the artificial induction of synaptic enhancement
(LTP) in the equivalent condition to that in which animals have the learning task.
This point is so far straightforward. The second point is not very easy. It should be
checked if the drug actually impairs learning by blocking memory acquisition but
not by some other 'side effect'. The 'side effect' means disrupting a prerequisite for
learning performance; for example, causing a sensory motor disturbance or a
disturbance in motivation or attention which is essential to perform the maze task.
As escape performance in the water maze is motivated by aversion to the water, the
experiment is sensitive to the psychological modulation of aversion. Ways to check
the second point are discussed in the next section.
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1.4 The Water Maze
1.4.1 'Place navigation'
The open field water maze task developed by Morris (Morris 1981, 1984) has
been proven very useful for investigating spatial learning and memory in rodents.
It consist of a large circular pool filled with cool water made opaque with milk
powder. Submerged just below the water surface somewhere in the pool is a
platform onto which the rat can climb to emerge from cool water and escape from
the necessity of swimming.
In the standard use of the Water Maze (WM), a submerged platform (= hidden
or invisible platform) is maintained in a fixed position and a rat is placed into the
pool then allowed to swim until it escapes to the platform. This trial is repeated
from variety of starting positions near the pool wall (the angular relationship
between the platform and the starting position is randomly changed). The efficiency
of escape, which is represented by the decrease of latency or path length taken to
find escape, improves across training and reaches an asymptotic level suggesting a
limit of the animal's ability. Because there are no cues within the pool to guide the
rat to the platform, most rats solve this maze by learning the spatial position of the
platform relative to distal (i.e. extramaze) cues (Morris, 1984). At the same time, the
rats also learn some skills in searching for the platform (e.g. acquiring a specific
sequence of movements). However, these non-spatial strategies are less effective in
the WM and are generally not considered to represent true spatial learning. The
acquisition of knowledge of the submerged platform's location based on extramaze
cues is called 'place (space) navigation' or 'place (spatial) learning' (Morris et al.,
1982; McNamara and Skelton, 1993). The asymptote of escape performance
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exhibited by the animals after considerable training is close to the average of the
shortest possible escape (the average of escape latency or escape path taken by the
straight line escape from various starting positions to the platform), while the
asymptote of escape performance of rats which fail to acquire spatial memory is a
much longer escape latency or escape path.
A typical example of specific impairment of place navigation is observed in
the performance of hippocampal lesioned animals (Morris et al., 1982). Morris et al.
(1982) showed that although the escape latency of hippocampal lesioned animals
was decreased with the repetition of training trials, it was significantly longer than
that of control rats and reached a poorer asymptote. This asymptote level seemed to
be comparable to the performance of normal rats trained with a submerged platform
whose position was changed randomly on every trial. In such training, normal rats
have no chance to memorise the position of the platform and move around randomly
to search for it. Therefore the poor asymptote of escape performance of the
hippocampal lesion rats suggested that they cannot acquire knowledge about the
position of the submerged platform. This dissociation between the acquisition of
spatial memory and the acquisition of non-spatial strategy is based on the principle
of this task: the 'place navigation' is the best strategy to find the hidden platform.
The above advantage ruled by the principle of the task is one of the great
strength of this learning model since many other learning tasks have trouble in
distingishing between spatial and non-spatial components of learning. For example,
in the radial arm maze task, not only the acquisition of spatial memory but also
acquisition of non-spatial strategy (e.g. circuit strategy, particular angle movement
strategy) achieves best performance. Thus it is basically hard to distinguish the
improvement of performance due to the acquisition of spatial memory from that due
to non-spatial skill in that maze task.
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At the same time, the place navigation task in the WM has also practical
advantages as follows:
(1) Intramaze cues such as odour trails are easily obviated.
(2) No pretraining is required and acquisition is quite rapid, allowing for large
numbers of animals/treatments to be assessed in a short period of time.
(3) It has several measures of performance (e.g. escape latency, path length
and path directionality) that are quantitative descriptions rather than highly abstract
measures of observed behaviour.
In addition to the advantages of the place navigation task alone, the WM
system as a whole provides a variety of reference procedures which are useful to
examine side effects of experimental manipulations (drug administration, lesion
surgery) on the performance of animals in the place navigation task. Some
procedures are suitable to confirm whether the acquisition of place navigation is
intact or not. Some are introduced to monitor disturbances in sensory-motor ability
or motivation or attention. Because the reference procedures use the same animals
and apparatus, and can be carried out without significant modification to the
incentive or sensorimotor requirements of the task, they can be compared with the
place navigation procedure directly.
Among these reference procedures, the transfer test, visible platform training,
visual discrimination and place recall test are discussed in the following section.
1.4.2 Reference procedures
(a) Transfer Test
This is useful to detect the establishment of spatial memory in the animal and
dissociate spatial and non-spatial strategies (Morris, 1981; 1984). This test is usually
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carried out after the performance of rats in place navigation training reaches the
asymptotic level. In this test, the escape platform is removed and a rat permitted to
swim freely about the pool for a limited period (e.g. 60 sec). The use of a place
navigation strategy is inferred if the rat spends more time in the quadrant that
previously contained the platform or cross over its position more often than
equivalent positions in the other three quadrants. This bias is quantified by the time
spent or path length traversed in the target quadrant against the other quadrants
and/or the number of crossing over the exact surface area of the platform. If the rats
took non-spatial strategies, the swimming paths are not biased towards a particular
quadrant or platform location; for example it may involve large circles at the
appropriate distance from the pool wall, or be directed towards or away from a single
cue (such as the experimenter). Morris et al. (1982) confirmed that the hippocampal
lesion animals did not acquire any knowledge about the location of the platform
during place navigation training by this transfer test. As this procedure represents
the retrieval process ofmemory, it is also possible to test the drug's effect on the
retrieval process specifically if the drug is administered only before this transfer test.
(b) Cue navigation training (Visible Platform Training)
In this procedure, the visible platform which protrudes above the water surface
is utilised as the escape area in the pool in place of the hidden platform submerged
under water (Morris, 1981; 1984). The rat is only required to learn to swim towards
the visible object (cue) and escape onto it. The position of the visible platform and
the starting position are changed from trial to trial in order to prevent the use of a
spatial strategy. This reference procedure is useful to rule out the sensory motor
and/or motivational impairment of the drugs or brain lesion. Morris et al. (1982)
suggested the specificity of the effect of hippocampal lesion to the place navigation
by the effective performance of the lesioned animals in this cue navigation training.
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(c) Visual Discrimination Learning
In this task, two visible platforms which are painted in clearly different
patterns from each other are present in the pool (Morris, 1984; Morris et al., 1986b).
One of the platform is rigid and offers secure escape from the water. The other is
floating such that when a rat attempts to get onto the platform, it immediately falls
back into the water. Following repeated trials, a rat learns to swim straight to the
rigid platform. The start position and location of the two platforms are changed
from trial to trial. The pool is usually surrounded by curtains to minimise the
influence of extramaze cues and the improvement in performance is expressed by the
reduction of errors (i.e. occasions that the rat tries to climb onto the floating
platform). The main purpose of this task is to dissociate the effect on spatial
learning which is sensitive to the hippocampal damage from the effect on another
type of learning which is found to be unaffected by hippocampal lesions. This test is
also useful to check whether the effect of drug or surgery on learning is associated
with sensory motor ability, motivation or a reinforcement process.
(d) Place Recall Test
This is place navigation training and/or transfer test given to the drug treated or
lesioned rats that were already trained in the place navigation procedure prior to drug
treatment or lesioning (Morris, 1989; MacNamara and Skelton, 1993). It may reveal
impairment to almost all of the process required for proper performance of the task
(sensory, motor, motivation, memory retrieval, spatial information processing)
except for the process required for acquisition of spatial memory.
The above tests are only a few examples of control procedures which are
available in the WM experiments. As this system has great flexibility, further
modification and a variety of procedures is possible.
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1.4.3 Some problems in the water maze experiments
Although the WM learning task is a powerful system to investigate brain
function and drug effects on spatial learning, there are several points that we have to
be careful of in analysing the animal performance in this system.
(a) Transfer test
Although the swimming bias during the transfer test is a good index of spatial
memory of animals, it may not always precisely express their memory. Some of the
normal rats acquire the knowledge about the location of platform quickly and learn
to swim directly toward the platform in the early phase of place navigation training
(late trials on the first day or early trials of the 2nd day). However, even these 'quick
learners' show a significant swimming bias in the transfer test only after
considerable repetition of training trials. If these quick learners are given a transfer
test following good performances but insufficient training, they easily give up their
attempt to recall their memory after short time of appropriate search and start to look
round only for other places at which escape during the rest of the test period. This
suggests that the biased swimming behaviour of rats in the transfer test requires not
only the acquisition of spatial memory, but also the generation of confidence in, or
persistency of, memory. In another words, an animal has a conflict between two
types of strategy: the place navigation strategy and random search strategy, and the
choice can be shifted by situations (repeated failure to find the platform) or
psychological states during training or test trials. Therefore, if a drug just delays the
acquisition of persistency or confidence, or, if it reduces the level of persistency or
confidence, it may reduce the acquisition of swimming bias. The effect of anxiolytic
benzodiazepine, chlordiazepoxide on place navigation learning reported by
McNaughton and Morris (1987b) seems to show such an effect. In the transfer test,
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they observed that "the chlordiazepoxide rat swims, initially, towards the correct
annulus, but then he shows no tendency to stay in its immediate vicinity or to rotate
in the water at the correct location". As this place/random conflict during test trials
sometimes impedes an analysis of spatial memory of animals, some attempts to clear
this problem have been reported.
Spooner et al. (1994) designed an "Atlantis platform" system in which a
collapsible cantilevered platform is raised near to the water surface only if a rat
dwells within a defined area for a set period of time in order to exclude the chance
for a rat to find the platform by random search. As normal rats were forced to use
only a place navigation strategy during training in this system, they showed a
remarkably more focused search at the correct target location during the transfer test.
Another attempt to cope with place/random problems was reported by
Whishaw et al. (1995). They analysed the swim path just at the beginning of the
transfer test and rats were quickly removed from the water as soon as they swam out
of the correct quadrant. The digitized swim path from start position to the point at
which a rat came closest to the platform's position was interpolated by their own
way to accommodate the data to averaging and statistical analysis. They also
analysed locations at which rats changed their swimming direction after their
swimming course had been set toward the platform. The turning points were
characterized by a sharp deceleration in swim speed and an obvious body turn. This
turning behaviour has been regarded as an attempt for the rats to look for the
platform closely. In any case, the validity of their attempt may have to be examined
further.
(b) Cue navigation training
Normal performance in cue navigation training may not always guarantee a
normal level of escape motivation of test animals. There could be a difference in the
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extent in anxiety or motivation between a task requiring uncertain escape (place
navigation) and a task requiring swimming to a conspicuous secure object or,
respectively, a difference between escape to a submerged platform and escape onto a
platform which protrudes above the water and enable rats to get out of the water
completely.
(c) Conceptual problems
I would like to add a brief comment on the above discussion from another
point of view. As this thesis tries to discuss the LTP as a memory storage
mechanism, a "memory" in animals simply means a storage of sensory information.
However, I am not sure whether it is possible to distinguish a simple information
storage process from various processes accompanying memory utilisation or
mobilisation mechanisms clearly, because we can only detect an animal's memory
through their behaviour. We can take a standpoint that memory process includes
whole system to utilise or materiarise stored information. In this point of view, a
deficit in the transfer test directly means a deficit in memory system. On the other
hand, if we define 'memory' in narrow sense as a storage of sensory informations,
deficit in transfer test should be caused by not only defect in memory storage but
also any other kind of defects for example motivational problems or inhibition in
another processes of learning such as consolidation, retrieval or expression of stored
information. This standpoint requires the careful discussion whether the poor
learning performance is simply due to inability of memory acquisition.
The combination of reference tests and close observation of animal behaviour
may be helpful to investigate the actual mechanism of learning impairment induced
by experimental manipulations.
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1.4.4 Role of NMDA receptor activation in learning and memory in the water maze
Several groups have reported the effect of MK-801 on the learning
performance of rats in the water maze (Halliwell and Morris, 1987; Whishaw and
Auer, 1989; Robinson et al., 1989; McLamb et al., 1990; Heale and Harley, 1990).
Although MK-801 is expected to block physiological activation of the NMDA
receptor like AP5, the effect of MK-801 on learning seems to be different from that
of AP5. Table 1-1 (in page 17) summarised the experimental conditions and results
of these reports in comparison with the result of the AP5 experiment reported by
Morris (1989).
(a) The effect of AP5 on learning in the water maze
In the experiment of Morris (1989), the impairment of place navigation caused
by D, L-AP5 was demonstrated by two different measures of performance. The D,L-
AP5 group showed a significant longer escape latency than controls during place
navigation training (this is also expressed as a longer path length) and a poor
swimming bias to the training quadrant during the transfer test. The transfer test was
carried out after 5 days training (3 trials/day) because, by that stage, the performance
of both control and AP5 animals reached asymptote level. The specificity of the
drug's effect as an NMDA receptor antagonist was proved by the lack of
impairment by L-AP5. A visual discrimination test was carried out to check the
possibility that the impairment of spatial learning was caused by the impairment of
motivation or reinforcement to escape to the platform or by the sensory motor
disturbance. It was also checked whether non-spatial pretraining had an effect on
place navigation. The pretraining reduced sensory motor disturbance during place
navigation training, but had no effect on the drug-induced learning impairment. It
suggested that, although some aspects of a sensory motor disturbance is induced by
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AP5, it was probably not the main cause of spatial learning impairment. The lack of
effect of AP5 on place-recall test suggested that AP5 did not impair the retrieval
process of memory. It also reinforced the idea that the learning impairment caused
by AP5 had nothing to do with the effect on motivation, or sensory motor ability.
Finally, it was demonstrated that infusion of the same concentration of AP5 by the
same route (i.e.v.) as that used in the WM experiments caused a total blockade of
LTP in vivo but had no effect on normal fast synaptic transmission in the
hippocampus. It was proposed that AP5 impaired place navigation learning by
blocking synaptic plasticity in hippocampus. This proposal was reinforced by the
dose response study showing a highly significant correlation between AP5 content in
hippocampus and both percentage LTP and escape latency (Morris et al., 1990a;
Davis et al., 1992).
(b) The effect of MK-801 on learning in the water maze
In contrast to AP5, the behavioural specificity of the effect of MK-801 on
learning in the WM has been poorly characterised.
Among the WM studies examining the effect ofMK-801, the experiment
reported by Whishaw and Auer (1989) is hard to draw any conclusion because it was
carried out under exceptional conditions: i) The water temperature was much lower
than in other reports (18°C). ii) The rats received intensive pretraining (16 trials a
day for 10 days) before just one day training with drug administration, iii) there was
a 3 hr interval between drug administration and the commencement of training.
These conditions may decrease the sensitivity of learning task to detect any effect of
the drug.
Other experiments (Halliwell and Morris, 1987; Robinson et al., 1989;
McLamb et al., 1990; Heale and Harley, 1990) showed similar results in the place
navigation training. All four reported MK-801 (0.05 ~ 0.1 mg/kg) caused an
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impairment in the rate of acquisition which was demonstrated by an increase in
latency or path length taken to locate the platform during place navigation training.
The cue navigation training and place recall test reported by Robinson et al. (1989),
and the motor activity and startle response test reported by McLamb et al.(1990),
showed that MK-801 at the dose of 0.05 mg/kg had no effect on sensory motor
function or memory retrieval. Post training administration of MK-801 (Robinson et
al., 1989; McLamb et al., 1990) revealed that MK-801 had little effect on memory
consolidation. Therefore, the significantly poor performance during place navigation
training induced by the 0.05 mg/kg MK-801 is suggested to be due to disturbances in
the memory acquisition process.
The reports differed, however, with respect to the results of a transfer test.
While Robinson et al.( 1989) and Heale and Harley (1990) reported that MK-801
impaired the acquisition of spatial memory resulting in a poor performance in the
transfer test. Halliwell and Morris (1987), and McLamb et al. (1990) reported that
MK-801 had no effect on performance during transfer tests. This suggests that it is
not impossible for rats which received 0.1 mg/kg or lower dose of MK-801 to
memorise the location of the hidden platform. Halliwell and Morris also reported
that MK-801 did not block LTP at the same dose. Although the effect ofMK-801
on the performance during transfer test looks different from that of AP5, the result of
the experiment using MK-801 was consistent with the result of the experiment using
AP5 in showing that the drug does not block acquisition of spatial memory at a
concentration of drug that does not block LTP.
It should be noted that in the experiments which demonstrated poor
performance of the MK-801 group in the transfer test, animals were trained for short
periods (Robinsons: 3 days, Heale and Harley: 2 days) while the experiments which
demonstrated no inhibitory effect on memory, animals were trained for longer
periods (Halliwell and Morris: 5 days, McLamb: 8 days). The poor performance of
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MK-801 groups in the transfer test observed by Robinson et al and Heale and Harley
and during training observed by all four groups could be due to a delay of
acquisition rather than a complete block of acquisition of memory about the platform
location
The result of LTP experiments in urethane anaesthetised rats by Halliwell and
Morris (1987) (in which i.p. injection of 1 mg/kg MK-801 20 min prior to the
tetanus stimulation did not block LTP) seems to be consistent with the results
reported by Abraham and Mason (1988). They showed that 0.1 mg/kg or 0.5 mg/kg
ofMK-801 did not block the induction of LTP of dentate EPSPs in urethane
anaesthetised rat if the tetanus stimulation was applied 30 min or 150 min after i.p.
injection. In addition, 1 mg/kg of MK-801 given 30 min prior to the tetanus
stimulation still did not block LTP induction, but when given 150 min prior to the
tetanus stimulation, it did block LTP. Morimoto et al. (1991) have shown that LTP
of EPSPs induced in the dentate gyrus of anaesthetised rat was blocked by the i.p.
injection of 1 or 2 mg /kg MK-801 given 120 min prior to the tetanus stimulation.
These results suggest that all four WM experiments in Table 1-1 were carried out
under conditions in which MK-801 does not block LTP in the dentate gyrus.
A report by Gilbert and Mack (1990) claimed that 0.1 and 1.0 mg/ kg ofMK-
801 suppresses the LTP if the animal is not anaesthetized. However, what they
called LTP was the LTP of population spike which is not a real LTP in the strict
sense (* see further explanation below). Therefore their result may not be strong
counter evidence to the claim made above. As they failed to induce LTP of the
EPSP (because of an unstable EPSP in unanaesthetised animals) it is difficult to
accept that their experiment is reliable.
Since APS impaired learning at the same dose range as it blocked LTP in
anaesthetised rat, at least in neurophysiological terms, the above water maze
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experiments using MK-801 were not carried out under the comparable conditions to
those in which AP5 induced learning impairment.
To sum up, the effect of MK-801 on the learning performance of rat in the
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synaptic efficacy (Teyler and DiScenna, 1987), and the slope of the
population EPSP (see Fig.4-1 in Chapter 4) is the authorized parameter for
monitoring synaptic efficacy (Lomo, 1971). Sometimes LTP is demonstrated
by the increase of population spike amplitude because potentiation of EPSP
increases the probability of cell firing. However, the potent* Strictly
speaking, LTP is the long lasting enhancement of iation of population spike
is disproportionally greater than potentiation of the EPSP because the
relation between EPSP and population spike (input-output curve) is shifted
after the induction of LTP (Bliss and Lomo, 1973; Abraham et al., 1985).
Therefore the potentiation of population spike involves some mechanisms
independent of enhancement of synaptic efficacy and has not been
systematically investigated at the intracellular level. If MK-801 suppressed
the potentiation of population spike, this effect would not necessarily be
mediated by the suppression of LTP. Abraham and Mason (1988) reported a
significant decrease in amplitude of the population spike after injection of
0.5 mg/kg MK-801 at which no significant effect on basal EPSP or LTP was
observed. They suggested that the effect on LTP and effect on population
spike of MK-801 were unrelated.
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1.4.5 Hippocampus and spatial learning
As is discussed so far, the hippocampus is an important site at which NMDA
receptor antagonists exhibit their effects and at which the induction of LTP and some
processes of spatial learning take place. However, I have avoided discussing how
the hippocampus is involved in learning and memory. This is too great a subject for
this thesis, to go into too much detaile of each incompatible theories (e.g. spatial
map theory and working memory theory) However, the LTP hypothsis is
compatible with either theory about hippocampus function. I will mainly discuss
one of the theories of hippocampal function, the spatial map theory which is useful
to explain that hippocampus dependent processes are specifically involved in the
place navigation learning in the water maze.
First of all, it is important to point out that the term "hippocampus" is used to
refer to "the pyramidal cell fields of the hippocampus proper (CA1-CA3) together
with the hilar and granule cells in the dentate gyrus" (Jarrard, 1993) throughout this
thesis. The word "hippocampal system" is used to refer to hippocampus with the
major afferent and efferent projections.
Among the vast variety of theories about hippocampal function, "spatial map"(
or "cognitive map") theory postulated by O'Keefe and Nadel (1978; 1979) is the
most prominent and the best basis for the discussion about the place navigation in
the water maze. According to this theory, rats in the water maze learn the spatial
map of environment representing the goal object and their own location relative to
the extramaze cue. This hypothesis well explains the following features of place
navigation learning in the water maze:
(1) Rats can rapidly learn to find an object (platform) that they cannot see,
hear, or smell.
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(2) Rats show good directionality in the path (straight escape path) taken from
any start position.
(3) The place navigation is a learning dependent on the distal cues and is
dissociated from the learning dependent on proximal cues (cue navigation) by the
sensitivity to hippocampal damage.
(4) When rats are required to approach from a novel starting location, they can
adapt to find the platform with no measurable increase in latency (Morris, 1981).
(5) Rats can rapidly adapt to a new escape location when the fixed position of
the platform is changed (Morris, 1981).
Point (3) represents and justifies discrimination of two classes of learning:
'locale' and 'taxon', assumed in the "spatial map" theory. In the 'taxon' system, rats
guide themselves by approaching or leaving a particular object (proximal cue) or by
taking a specific sequence of movements. This system is suggested to be located
outside the hippocampus. In the 'locale' system, rats identify a place using spatial
configuration of sets of stimuli (extramaze cues). This understanding of a place is a
spatial map and is supposed to be organized in the hippocampus.
The difference between taxon and locale system is not just a difference of the
utilised cue (intramaze versus extramaze cue) but a difference in the place
representation with the cues. The performances of rats with damage to the
hippocampal system reported by Eichenbaum et al. (1990) is a good example which
emphasises this difference. They trained the animals to escape to the platform from
the same starting location to encourage rats to associate the extramaze cues with a
particular swim trajectory and with the place of escape. The escape platform located
in the fixed position was initially visible but the visibility was gradually faded out.
Both normal rats and rats with Fimbria-Fornix lesion (FX rats) acquired this task
rapidly and eventually both groups could locate the submerged platform (the
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accurate navigation of both groups was confirmed by the proper swimming bias in
the transfer test). However, the FX rats, unlike normal rats, could not escape
properly when the cues just behind the goal were moved or starting position was
changed. In short, both normal and FX rats eventually learned to locate the hidden
platform relying solely on extramaze cues but their understanding about the place
showed an apparent difference in the flexibility when a minor spatial modification
was introduced. These results suggests that the two groups used completely
different strategies. As is discussed further in the following section, the flexible
adaptation of the normal rats to the spatial modification in the task suggests that they
employ the extramaze cues as locale cues (references for the map) while the poor
flexibility of FX rats to a novel situation suggests that they employ the extramaze
cues as taxon cues. (However, Eichenbaum et al. did not discuss this point clearly.)
The behavioural flexibility, demonstrated by experiments (4) or (5), is a
particular feature of spatial learning predicted by the spatial map theory. In the case
(4), changing the starting position does not modify the spatial relationship in the map
and in the case (5), moving platform location only requires a change to the map entry
denoting the position of the platform. Therefore, rats can flexibly apply their spatial
memory (map) to locate a goal in novel situations, provided the environment
remains constant.
Whishaw et al. (1995) recently reported a study which is similar to that of
Eichenbaum et al. (1990) and challenged the dependence of spatial map on
hippocampal function. The main difference in experimental procedure is that they
trained rats to swim from each of the four starting positions instead of a single fixed
position during training with a visible platform and following training with a hidden
platform located in the same place. The performance of FX rats was basically as
accurate as that of control rats on the trials of visible platform training, hidden
platform training and transfer test. They assumed that the impairment of FX rats is
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not in learning the location of the platform in relation to extramaze cues ("knowing
where") but in some process of motoric control ("getting there"). As FX rat
eventually locate platform without intramaze cue, they explained that the damage in
the hippocampal system did not impair acquisition of spatial map. Because the poor
performance of FX rats was improved by the experience to swim directly to the goal,
they suggested that the process of the acquisition of motoric refinement was
damaged in the FX rats. However, utilising extramaze cue to locate a particular
place is not necessarily a spatial map learning as is discussed above. It may be
possible for rats to achieve the accurate performance by the establishment of
independent approaching process to the target from the four starting points with the
aid of extra maze cues (utilisation of extramaze cue as 'taxon cue'). Of course, it
may be much easier for normal rats to utilise extramaze cues as 'locale cue' than
'taxon cue'. Only the combination of the inability to acquire the 'locale' navigation
with the special training (training from the same start position or training with fading
out platform) is supposed to enable rats to utilise the extramaze cues as the 'taxon
cue' to guide themselves to the platform. What Whishaw et al. called motoric
refinement process could be this particular process. Therefore, the results of this
experiment cannot deny the dependence of the acquisition of spatial map on the
normal hioppocamal function.
Another example of speculative commentary on the spatial map theory is
recently made by Amsel (1993). He claims that the spatial learning is a simple
discrimination learning. The escape behaviour is an accumulating go/no-go decision
and the position of the platform should be the focal point of the weight of go
decision. The hippocampus is a centre for conflict between approaching and
avoiding some distal (extramaze) cues. Therefore the association between escape
behaviour and extramaze cue depends on the hippocampal function. This
hippocampal dependent conflicting (namely, vicarious trial and error) theory seems
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to explain the hippocampal function in both spatial and nonspatial learning
uniformly. However, it is not clear the difference between a navigation with an
accumulating go/no-go decision and snap shot like monitoring of position with
extramaze cue in the Eichenbaum's FX rats. Further experimental evidences may be
necessary to show that the vicarious trial and error process specificcaly take place in
the hippocampus.
While the spatial map theory discusses a specific type of information that is
processed by the hippocampus, a number of alternative hypotheses were proposed
aiming at more abstract characterisation of hippocampal functions. Among them,
working memory theory (Olton et al., 1979) is a well-known opponent in debates.
They proposed that the hippocampus is selectively involved in behaviours that
require working memory irrespective of the type of information (spatial or
nonspatial) which is processed. The working memory holds information pertinent
to only a single-trial of an experimental procedure. The reference memory holds
information pertinent to several trials. Their radial arm maze studies revealed that
damage to the hippocampal system produced a similar deficit in both spatial and
nonspatial test procedure. In contrast, the lesions exclusively impaired the
performance requiring working memory but no effect was observed on the bases of
the reference memory.
In opposition to this claim, many studies have been reported to show that
damage to the hippocampal system impairs spatial reference memory but not
nonspatial reference memory (for example, Morris et al., 1986b; Jarrard, 1993). I do
not intend discussing this controversy further. In my opinion, the structure of animal
memory is task dependent. The identical classification of memory cannot be
applyed to the different learning tasks. It may not be possible to discuss 'reference
memory' in radial arm maze and that in water maze uniformly. The 'working
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memory' system utilised in radial arm maze may not be utilised in water maze. The
important point seems to be that spatial map system or spatial navigation is a
characteristic and interesting system in the animals to process and memorise
sensory information.
In this thesis, the drug's effect is tested on the place navigation task. The
dependence of learning on hippocampal function will be confirmed by hippocampal
lesion experiments.
1.5 Other behavioural effects of NMDA antagonists
1.5.1 NMDA receptor and conventional synaptic transmission in the brain
It is generally accepted that NMDA receptors have a special role in plasticity
but contribute very little to normal synaptic transmission on pyramidal cells in
hippocampus (Collingridge et al., 1983). However in other part of brain, there is
some evidence for the involvement ofNMDA receptor mediated synaptic
transmission in the normal physiological state. For example, AP5 has been reported
to block low-frequency transmission in slices of rat somatosensory cortex (Thomson
et al. 1985). Sensory input in the thalamus and thalamocortical, cortico-rubral and
thalamo-midbrain pathways in rats have also been found to be mediated by NMDA
receptors (Headley and Grillner 1990). Esguerra et al. (1992) suggested NMDA
receptors participate in fast synaptic events (less than 10 msec) underlying
conventional retinogeniculate transmission in the ferret brain.
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Therefore, administration of NMDA antagonists may produce some effects in
animals due to change in spontaneous neural activity outside the hippocampus. In
fact NMDA receptor antagonists have been reported to evoke behavioural responses,
discriminative stimulus effect, decreased response to auditory stimulus, EEG
desynchronization indicating enhanced arousal and weak anxiolytic effects
(Wroblewski and Danysz, 1989).
1.5.2 Ataxia and stimulant effects on behaviour
PCP like non-competitive NMDA antagonists (e.g. MK-801, PCP, ketamine),
as well as competitive antagonists (e.g. AP5, AP7, CPP, CGS19755) produce a
complex behaviour syndrome, including increased locomotion, sniffing, head
weaving, body rolls and falling, which progresses to ataxia with increasing dose in
mice (Tricklebank et al., 1989; Koek and Colpaert, 1990; Liljequest et al., 1991). In
rats, PCP and MK-801 were reported to produce similar hyper activity, stereotyped
behaviour and ataxia (Koek et al. 1989, Hiramats et al. 1989, Tiedtke et al. 1990,
Kretschmer et al. 1992). The following evidence suggests that the inhibitory effect
on NMDA receptor mediated neurotransmission may be directly involved in the
behavioural effects of NMDA antagonists:
1) Competitive and non-competitive NMDA antagonists induce qualitatively
similar behavioural effects in spite of the lack of similarity in their chemical
structure (Schmidt, 1986; Tricklebank et al., 1898; Koek and Colpaert, 1990)
2) The potencies for competitive and non-competitive NMDA antagonists to
produce locomotion and falling correlate (r = 0.92 p < 0.01) with their relative
potencies to antagonize NMDA-induced convulsions (Koek and Colpaert, 1990).
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3) PCP-type non-competitive NMDA antagonists, PCP, ketamine and MK-
801, induced hyperlocomotion and falling in mice with a potency order (MK-801 >
PCP > ketamine) similar to their relative affinities for the PCP receptor (Koek and
Colpeart, 1990). Danysz et al. (1994) reported MK-801, PCP and ketamine induced
hyperlocomotion, ataxia and stereotypy (head waving) in rats and correlated their
potency of their capacity to inhibit [3H]-MK-801 binding. This order has no relation
with their affinity to the sigma binding site (Wong et al., 1988), or to the dopamine
uptake site (Vignon et al., 1988).
4) D-serine, a selective agonist at the strychnine-insensitive glycine binding
site of the NMDA receptor complex, antagonized PCP and MK-801 induced
stereotyped behaviour and ataxia (0.5 ~ 1.0 |lmol i.c.v./rat) (Contreras, 1990).
5) D-alanine, but not L-alanine (10 - 100 pg/side i.e.v.) attenuated hyper
locomotion induced by PCP (100 mg/kg) in the rat. This stereo selectivity agrees
with the potency of these agents as agonists for the strychnine-insensitive glycine
site (Tanii et al., 1991).
In the following section, recent more detailed neurochemical and behavioural
research ofNMDA receptor antagonists are discussed to get a clearer idea about
whether the behavioural effects of MK-801 and another PCP-type antagonists are
really exhibited though their inhibitory activity against NMDA receptor mediated
neurotransmission and what kind of mechanisms are involved.
Though we have abundant information about the behavioural effects of PCP,
the following discussion will be made mainly about MK-801 since PCP has high
affinity for the sigma binding site (Ki = 0.5-3 |lM) which could explain part of the
behavioural effect of PCP (Largent et al., 1988; Contreras et al., 1986). MK-801 is a
highly selective ligand for the PCP site of the NMDA receptor complex with little
effect on the sigma recognition site or dopamine uptake site at a pharmacologically
relevant concentration (Lodge and Johnson, 1990)
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1.5.3 Involvement of catecholaminergic system
One of the earliest pharmacological reports ofMK-801, that by Clineshmidt et
al (1982b), suggested the participation of receptors for catecholamines in the
stimulus effect of MK-801. (1) The behavioural syndrome caused by MK-801 was
similar to the behaviour observed after administration of classic psychostimulants
like amphetamine. (2) MK-801 (0.05 mg/kg p.o.) induced ipsilateral turning in rats
with a unilateral nigrostriatal lesion produced by 6-hydroxydopamine. MK-801
induced turning is reduced by haloperidol or alpha-methyl-p-tyrosine and blocked by
reserpine. (3) Stimulation of locomotor activity in mice produced by MK-801 (0.3
mg/kg p.o.) was abolished by reserpine and significantly antagonized by haloperidol.
Following this study, investigations about the involvement of dopaminergic
and other catecholaninergic system in the behavioural effect of MK-801 have
accumulated. As shown in Table 1-2, MK-801-induced hyper activity and
stereotypy is reported to be inhibited by selective Dj and D2 dopamine receptor
antagonists or D1/D2 mixed antagonist (Dall'Olio et al., 1992; Hoffman, 1992;
Loscher and Honack, 1992; Verma and Kulkani, 1992; Ouagazzal et al., 1993).
These studies suggest that both Dj and D2 dopaminergic receptors may be involved
in the behavioural effects ofMK-801.
This suggestion seems to be supported by some biochemical data showing an
increase of dopamine metabolites (DOPAC or HVA) in various brain regions
following MK-801 administration. In these reports, MK-801 was demonstrated to
increase dopamine turnover in striatum and some parts of cortex (Hiramats et al.
1989, 0.5 mg/kg i.p. ; Rao et al. 1990, 0.3-1 mg/kg i.p. ; Losher etal. 1991,0.3
mg/kg i.p.), in the nucleus accumbens (Losher et al. 1991, 0.3 mg/kg i.p.) and in
other parts of brain (Rao et al. 1990, 0.3-1 mg/kg i.p. ; Losher et al. 1991, 0.3mg/kg
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the rate of dopamine metabolism in the striatum and limbic forebrain of mice.
However, in some experiments, MK-801 did not increase DOPAC or HVA in the
striatum (Gandolfi et ai., 1990; Bubser et al., 1992) or in the nucleus accumbens
(Rao et al., 1990) of rats. The inconsistencies of results between experiments could
be explained by the variety in strain, sex and age of experimental animals and
difference in the dosages of drugs, extraction timing and procedure for measuring
metabolites of dopamine. Losher et al. (1993) compared the behavioural and
neurochemical effects of MK-801 and CGP37849 (competitive NMDA receptor
antagonist) in the unified condition. MK-801 and CGP37849 increased dopamine
turnover in selective brain regions at equipotent doses for inducing stimulus effects
on behaviour. It is strongly suggested that blockade ofNMDA receptors induces
alterations in dopaminergic activity and amphetamine-like adverse effects.
Microdialysis experiments directly demonstrated an increase of extracellular
concentration of dopamine in the nucleus accumbens and caudate after local
application of MK-801 (10-6 and 10~5 M) to respective region of rat brain (Imperato,
1990) and in the prefrontal cortex after systemic application of MK-801 (0.4 mg/kg)
to rats (Wedzony et al., 1993). NMDA receptor antagonists may reduce the activity
of an inhibitory input to dopaminergic neurons and stimulate dopamine release
which, in turn, is possibly responsible for the hyper locomotion and stereotypies.
However, other evidence suggests that the underlying mechanism of the
behavioural effect of MK-801 may be more complicated than that of dopaminergic
agents like amphetamine. Although MK-801 induced locomotor activity is
attenuated by either Dj or D2 dopamine receptor antagonists, this sensitivity is less
than that of d-amphetamine -induced locomotor stimulation (Ouagazzal et al., 1993).
Consistent with this result, the increase in locomotor activity produced by MK-801
(2.5 ~ 5 fig) infused into nucleus accumbens is not blocked by intra-accumbens
infusion of haloperidol at a dose (2.5 |ig, 15 min prior to MK-801) sufficient to
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block amphetamine-induced locomotor activity. In addition, Wedzony et al. (1993)
found that the locomotor hyper activity induced by MK-801 (0.4 mg/kg) was not
correlated with an alteration in the extracellular concentration of dopamine in the
prefrontal cortex of rats. These authors suggest that the complexity of the
behavioural effects of MK-801 may be partly explained by the involvement of a
novel category of dopamine receptor subtypes and/or other monoaminergic
transmitter systems in the brain.
Recent molecular-genetic studies have revealed the existence of additional
members of the Dopamine receptor family in humans and rodents. The cDNA for
receptor subtypes of Dj, D2, D3, D4 and D5 has been cloned from the human gene
(Seeman and Van Tol, 1994). The D4 receptor draws pharmacological attention as a
possible target of clozapine which is an 'atypical' neuroleptic with less
extrapyramidal motor side effects.
Tieditke et al. (1990) reported clozapine (5 mg/kg s.c.) potently antagonize
MK-801-induced stereotypy in rat. Hoffman (1992) demonstrated that clozapine
reduced MK-801-induced locomotor activity at the dose of 1.0 ~ 10.0 mg/kg (s.c.)
and sniffing at the dose of 10.0 mg/kg (s.c.). There is a possibility that MK-801
activated neurotransmission is mediated by a D4 like receptor subtype in rats.
The aj-adrenenoceptor antagonist prazocine has been shown to attenuate MK-
801 induced hyperlocomotion and head weaving in rats (Losher and Honack, 1992)
and hyperlocomotion in mice (Clineschmidt, 1982b) while cl\- and 0C2-adrenoceptor
agonists were found to potentiate motor activity induced by MK-801 (Carlsson and
Carlsson, 1990).
In addition to the effect of adrenergic agents, there is also evidence to suggest
that serotonin receptors are involved in the behavioural alterations produced by MK-
801. Losher and Honack (1992) reported that the 5-HTia receptor ligands, ipsapiron
and NAN-190 (which are known to display antagonist-like properties in in vivo
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models) inhibited hyperlocomotion and head weaving induced by MK-801 (0.1
mg/kg i.p.). This result was consistent with the neurochemical observation that MK-
801 (0.3 mg/kg i.p.) increased 5-HT turnover in several brain regions (e.g. frontal
cortex, amygdala, striatum, nucleus accumbens) (Losher et ah, 1991). Following
these investigations, Losher et al. (1993) confirmed that an increase in 5-HT
turnover and behavioural effect (ataxia, hyperlocomotion, head weaving) were
induced after administration of MK-801 (0.3 mg/kg i.p.) under identical
experimental conditions.
Microdialysis experiments showed that MK-801 increases not only serotonin
metabolism but also its release in some brain regions including striatum (Whitton et
al., 1992).
1.5.4 Involvement of catecholamine independent systems
The involvement of catecholamine independent mechanisms in the behavioural
effects of MK-801 was also suggested by the work of Carlsson and Carlsson (1989)
which revealed that MK-801 (1-4 mg/kg i.p.) caused a pronounced and dose
dependent increase in locomotion in catecholamine depleted mice (using reserpine
and a-methyl-para-tyrosine) and that this hyperlocomotion was not attenuated by
haloperidol (1 mg/kg) pretreatment. However, it should be noted that the dose of
MK-801 in this experiment was about 10 times higher than the dose in the above
mentioned experiments revealing catecholamine dependent effects ofMK-801.
Probably both mechanisms (catecholaminergic and non-catecholaminergic) may be
involved in the behavioural effects of MK-801 and non-catecholaminergic
mechanisms might become emphasized after administration of a higher dose of MK-
801.
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1.5.5 Differential effect between competitive and non-competitive NMDA
antagonists
The behavioural studies which compare the effect of competitive and non¬
competitive NMDA receptor antagonists showed that the potency of the competitive
antagonists to produce stimulatory effects was relatively weak (Tricklebank et al.,
1989; Liljequist et al., 1991; Svensson et al., 1991; Kretschmer et al., 1992; Losher
et al., 1993). For example, Losher et al. (1993) reported the dose ofMK-801 (0.3
mg/kg i.p.) required to induce behavioural change was about 4 times higher than its
anticonvulsant ED50 in rats, while the dose of CGP37849 a competitive NMDA
antagonist (30 mg/kg i.p.) was about 15 times its anticonvulsant ED50. Another
competitive NMDA antagonist, CGP39551, exhibits much less hyperlocomotion and
stereotyped behaviour than CGP37849, although both drugs have a similar potency
in the anticonvulsant action in rodents. Willetts et al. (1990) calculated the ratio of
ED50 for motor impairment to ED50 for NMDA-induced seizure or lethality of
various NMDA antagonists. The index for PCP like antagonists was in the range of
0.1 ~ 1.3 while the index for competitive antagonists was in the range of 1.0 ~ 11.9.
In the induction of behavioural effects of competitive antagonists as well as
PCP-type antagonists, the involvement of the dopaminergic and serotonergic
mechanisms is suggested. In the above report of Loscher et al. (1993), it was
demonstrated that MK-801 and CGP37849 increased dopamine and serotonin
turnover in selective brain regions at behaviourally equipotent doses whereas
CGP39551 was almost devoid of such effects. Consistently, the behavioural effects
induced by competitive NMDA antagonists have been reported to be blocked by
dopamine and serotonin antagonists (Imperato et al., 1990; Loscher and Honack,
1991). Although some reports found CPP-ene and AP5 to enhance significant
dopamine release in nucleus accumbens and striatum (Gruen et al., 1990; Imperato,
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1990), some reports demonstrated that systemic or central administration of AP5,
AP7, CPP, CPP-ene, CGP39551 and CGS19755 were without effect on dopamine or
serotonin turnover (Kabuto et al., 1987; Rao et al., 1990; 1991; Svensson et al.,
1991; Bubster et al., 1992). However, it seems likely that if competitive NMDA
antagonists are administered at doses which induce comparable behavioural
activities, they could induce a similar alteration in dopamine or serotonin turnover in
specific brain regions to those of PCP type antagonists.
The reason for the lesser potencies of competitive NMDA antagonists in
producing stimulant effects on behaviour and alteration in dopaminergic and
serotonergic activity are not clear at present. Rao et al. (1990; 1991) have explained
the marked difference between competitive and non-competitive NMDA receptor
antagonists by the existence of binding sites for non-competitive NMDA receptor
antagonist that are not coupled to the NMDA binding site. According to this
hypothesis, NMDA receptor-uncoupled binding sites would be responsible for those
effect of non-competitive NMDA receptor antagonists that cannot be reproduced by
competitive NMDA receptor antagonists. The existence of several subtypes of
NMDA receptor suggested by the molecular pharmacological study (discussed in the
first section) might be a possible explanation for the existence of those different
binding sites.
Apart from a difference in the receptor itself, an interaction with the factors
surrounding the NMDA receptor (e.g. glutamate) may also explain the difference.
Extracellular glutamate is known to be actively modulated by a glutamate uptake
carrier (transporter), which exist in both neurons and glia and usually keeps
glutamate below toxic levels. However, it sometimes operates backwards to increase
glutamate levels in pathological conditions (e.g. ischaemia) (Nicholls and Attwell,
1990). Recently three high affinity, sodium dependent glutamate transporters of rats
were cloned: GLT-1 (Pines et al., 1992), EAAC1 (Kanai and Hediger, 1992) and
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GLAST (Storck et al., 1992). Immunohistochemical evidence showing a selective
localization of each transporter subtype suggests that glutamate levels are modulated
in a site specific manner in the rat CNS (Rothstein et al., 1994).
Speliotes et al., (1994) found an example which suggests that glutamate uptake
can modulate the potency of an NMDA receptor antagonist. In an astrocyte-rich rat
cortical culture, AP5 was more potent against NMDA-mediated toxicity than
glutamate-mediated toxicity because glutamate is taken up on its transporter thus
very high concentrations of glutamate are necessary to induce toxicity. AP5 is,
however, equipotent against the two in astrocyte-poor cultures in which transporter
is absent. In contrast, MK-801 was similar in potency against glutamate and NMDA
in both astrocyte-rich and astrocyte-poor cultures. If there is a brain region at which
the extracellular glutamate level is high, the potency of AP5 can be relatively weaker
than that of MK-801 at that region. Wallace et al., (1992) suggested physiological
changes in extracellular glutamate level modulate the binding of MK-801 in the
brain. They demonstrated that the binding of i.v. administrated [3H] MK-801 to
ischaemic cortex and striatum is significantly enhanced relative to normal brain.
In addition to the glutamate trapping/releasing system, brain tissue also seems
to have a system to trap drugs. Morris et al. (1990a) and Davis et al. (1992) reported
that the whole- tissue level of AP5 is about 30-fold higher than the extracellular level
(based on the microdialysis data) in hippocampus after chronic infusion of AP5.
Perfusion of 20 mM ethylene-bis(oxyethylenenitrate)tetra-acetic acid (EGTA) in
Ca2+ free artificial cerebrospinal fluid (aCSF) instead of normal aCSF caused
masssive release of AP5 in the dialisate. These data suggest that a significant
proportion of whole-tissue AP5 is trapped to the cellular membrane by a Ca2+-
dependent mechanism. Supposition of different trapping systems or different




The behaviourally stimulant effects of non-competitive NMDA receptor
antagonists are suggested to be mediated by the blockade of NMDA receptor
mediated neurotransmission outside the hippocampus. These effects of non¬
competitive NMDA receptor antagonists are exhibited at a relatively lower dose than
that at which they exhibit an inhibitory effect on epilepsy or LTP in the
hippocampus, while competitive antagonists exhibit the behavioural effect at the
same or a higher dose than that at which they block LTP or epilepsy. Therefore, the
effect of MK-801 or FR115427 on learning is possibly dominated by "side effects".
The dose response and the time course of the drug's effect on behaviour and LTP
need to be carefully analysed to check if it is possible to distinguish these effects.
This insight is a relevant aspect of the design of the experiments to be reported in
this thesis.
1.6 Aims of the thesis
This thesis examines whether the effect of non-competitive NMDA receptor
antagonists: MK-801 and FR115427 on spatial learning is predominately related to
their stimulatory effect on behaviour or related to their inhibitory effect on LTP.
It is expected that this comparative analysis gives us some clue about how





Male Lister-hooded rats (199 ~ 466g) from the breeding stock of the Department
of Pharmacology University of Edinburgh, were used. The rats were maintained in
the University's animal house which provides the environment with constant room
temperature (about 25°C) and a light/dark cycle of 14:10 hours (lights on at 0800hr).
The rats were housed in group of 4 or 5 with sawdust and filter paper for bedding. In
the water maze experiments only, the rats were transferred to individual cages after the
habituation trials as described below. Free access to food and water was allowed
throughout. The animals was brought out from the animal house to the laboratory at
the beginning of each day's experiment and they were brought back to the animal
house or sacrificed at the end of the day's experiment. All experiments were carried
out in the light phase (8 am - 10 pm).
2.2 Drugs
(a) FR115427 ((+)-l-methyl-1 -phenyl-1, 2, 3, 4-tetrahydroisoquinoline
hydrochloride)
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FR115427 was synthesised in the New Drug Research Laboratories, Fujisawa
Pharmaceutical Co. Ltd., Osaka Japan.
(b) MK-801 or Dizocilpine ((+)-5-methyl-10, 1 l-dihydro-5H-dibenzo [a, d]
cyclohepten-5, 10-imine maleate)
MK-801 was obtained from Research Biochemicals Inc., U.S.A.
Other drugs were obtained from Sigma and were of the highest available purity.
(c) Urethane Carbamate
Urethane Carbamate was used as a non-recoverable anaesthetic during
electrophysiological phase of experiments. Urethane carbamate was dissolved in
saline at 500 mg/ml and given by single i.p. injection (1.5 g/kg) at the start of the
surgery prior to electrophysiology.
(d) Tribromoethanol (Avertin)
Tribromoethanol was used as a recoverable anaesthetic during surgery for
making hippocampal lesions. A stock concentration (2,2,2,-tribromoethanol 1.6 g/ml
in absolute ethanol) was kept at 4°C, in a dark container to avoid light degradation. A
dilution of 1 in 55 was made in saline, 12 hours prior to surgery. The initial injection
(i.p.) dose was 10 ml/kg body weight (tribromoethanol 0.29 g/kg), supplemented by a
0.5 ml injection as required throughout the surgery.
(e) Ibotenic acid (a-amino-3-hydroxy-5-isoxazoleacetic acid)
Ibotenic acid was used as neurotoxin to remove the cells in the hippocampus.
The stock solution was made by dissolving ibotenic acid in phosphate-buffered saline
at a concentration of 10 pg/pl and a pH of 7.4. Aliquots of approximately 50 pi of
solution were stored in a freezer and thawed at room temperature for use.
2.3 Water Maze Experiments
2.3.1 Equipment
The spatial learning experiments were carried out in an open field water maze,
developed by Morris (1981,1984). The maze consisted of a large circular tank of
opaque water and a small escape platform.
(a) Environment
A cue environment was created in the rectangular (4.2m x4.6m) room (Fig. 2-
1A). The wall were painted white. A black curtain was hung from the ceiling on the
arbitrarily designated West wall. Two metal frame stands (190 cm height, 55 cm
width) were placed in the vicinity of the North East and West sides of the pool as
conspicuous cues. The top of the frame on the West side was covered with a black
plastic bag. Small posters were put on the East side and South side walls. A cabinet
was placed near the south west corner. The South side wall was a partition between
the pool room and the computer operating room with a window and a door way which
may have also functioned as cues.
(b) The pool
The pool was 2.0m in diameter and 0.6m off the floor. The structure was made
of glass fibre and coated with white gel coat. The pool was plumbed into the water
system and could be automatically filled and drained daily. Though the water level in
the tank (0.4 m high) and water temperature (25°C) was roughly set by an automatic
operating system, the exact water level (1.5 cm above the height of the hidden
platform or 1.5 cm below the top of the visible platform) and water temperature (25.0
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Fig. 2-1 Top view of the room for water maze experiments (A)
and Open Field Activity tests (B)
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opaque by adding fresh milk or milk powder. The water surface was divided into four
"quadrants" as shown in Fig. 2-1 (NW, SW, SE and NE) for the convenience of later
analysis.
The escape platforms were made from sections of Plexiglas tubing (10 cm in
diameter) filled with stones and sealed at the top to provide the platform for rats and
the bottom to form a base board. Two types of platform were used. One was the
submerged (hidden) platform whose height was arranged to be about 1 cm below the
water level and whose top was painted grayish green to match the water colour. The
other was the visible platform which was arranged to be about 2 cm taller than the
submerged platform to protrude just above the water surface and painted with black
and white stripes. The hidden or visible platform was usually placed in the centre of
one of the four quadrants during training.
(c) Tracking system
The swimming behaviour of the animals was monitored using a video tracking
system. A camera was fixed above the pool in a position where the entire water
surface area could be viewed (Fig. 2-2). Using 4 x 500 watt halogen flood lights
angled toward the corners of the ceiling created sufficient diffuse lighting to allow
image analyzer (HVS Ltd. model VP110) to detect the black head of a swimming rat
against the pale colour water of the pool. The image analyzer sampled the position of
the rat's head at the rate of 10 Hz and relayed the x and y coordinate to an Archimedes
microcomputer where the data coordinates were stored on diskettes and used to
















Fig.2-2 Cross section of the system to monitor and record the animal behaviour
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2.3.2 Training and testing procedures
The general procedures are shown in Fig. 2-3. The water maze training (place
navigation) and testing took 5 days (Day 1 ~ Day 5). In the previous week rats
received handling and habituation swimming trials. After the water maze procedure,
some rats were used in LTP experiments on Day 6.
(a) Handling
Handling was carried out in the animal house. One or two rats were taken from
the home cage and placed on the knees of the experimenter sitting on a stool. The
heads of the rats were covered by the experimenter's left hand and the backs of the rats
were gently rubbed by the right hand for 3 min. This handling was carried out once a
day and repeated 3 times for each rat. The last handling was given on the morning of
the day when the habituation trials were carried out.
(b) Habituation
Three days before the commencement of the main place navigation training, the
rats grouped in 4 or 5 were divided into individual cages with a paper towel laid on the
bottom and received habituation trials. In these trials, the escape platform was
removed from the pool. Each rat was placed into the pool and forced to swim for 60
sec without a chance to escape. The water temperature was kept at 25±0.5°C. After
the forced swimming, the rat was picked up from the water by hand and returned to
the cage with a paper towel, then blown gently with hair dryer to warm their body.
This forced swimming was repeated one more time after a 90 sec interval. The rats
did not receive any drug treatment in this habituation. After the 2 trials of habituation,
each rat was transferred to an individual cage with sawdust and brought back to the
animal house. In the following day, every time the swimming training was started,
56
MonTueWedhrFriSatun



























LTP experiment Visible Platform
Fig.2-3GeneralprotocolfoWa erM zeEx eriment
the animals were transferred to the cages with a paper towel.
(c) Hidden platform training (place navigation training)
The place navigation training with hidden escape platform was started 3 days
after the habituation trials and took 4 days (Fig.2-3 , Day 1 ~ Day 4 ). The position of
the hidden platform was fixed at one location (NE or SW) throughout the training with
half the animals in each group being trained to each position. The animals kept in
individual cages were brought out from the animal house to the semi-dark computer
operating room next to the pool to have training (Fig.2-1A). Each rat was given 6
trials per day for 4 days (total 24 trials). On each trial, a rat was taken out from the
home cage and placed into the water at one of four (N,E,S orW) starting points on the
perimeter of the pool. The randomised permutation of the four starting points (N,E,S
andW) was designated beforehand. The rat was allowed to swim until it found the
submerged escape platform. Once the rat climbed onto the platform, it was left on it
for 30 sec and returned to its home cage. If a rat failed to find the platform within 60
sec, the experimenter indicated the position of the platform by hand to assist escape.
If a rat showed no intention of escaping to the platform even after the experimenter's
instruction, it was picked up from the water and held by hand on the platform for 30
sec. A 60 sec interval (the inter trial interval) was taken at the home cage before the
next trial. During the intervals, the rats were occasionally blown with the hair dryer
fixed outside of the home cages to maintain their body temperature. The water level
was adjusted 1.5 cm above the surface of the hidden platform and the temperature of
the pool water was usually kept at 25.0 ± 0.5 °C.
If the animals received drug treatment in this experiment, the drug was dissolved
in saline and administered by i.p. 30 or 90 min before the first trial each day.
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(d) Transfer test
On Day 5, the platform was removed from the pool. Each rat was placed into
the pool at the most distant point (SW or NE) from the location where the platform
existed during the training period. The rats were allowed to swim freely for 60 sec to
search for the platform. The drug was administered 30 or 90 min before this test.
(e) Visible platform training (cue navigation training)
Immediately after the transfer test, each rat had 6 trials of training to escape to
the visible platform. The positions of the platform (NE, SE, SW or NW) and starting
points (N, E, S orW) were varied across trials. The randomised combination of
starting position and platform position was designated beforehand. Rats were given a
30 sec interval on the platform followed by a 2 min inter-trial interval in their home
cages (This inter-trial intervals was 1 min longer than that for hidden platform training
because changing the position of the platform after each trial took an extra 1 min.)
(g) LTP experiment
On Day 6, some of the rats which received 10 mg/kg of FR115427 during 5
days of training and testing were submitted to an LTP experiment. The surgical
procedure and electrophysiological method of stimulation and recording are described
in the following section 2.5. Each rat received a 6th i.p. injection of 10 mg/kg FR, 30




At the moment a rat was placed into the water and started to swim, the computer
analysis system was started manually by pressing a button set at each starting point of
the pool wall. This system was stopped manually by a button on the wall of the room
at the moment the rat reached the platform and commenced the motion of climbing
onto it, or it stopped automatically if 60 sec had passed before the rat found the
platform. The escape latency was defined as the time between the start switch being
turned on and the stop switch being turned off.
(b) Escape path length
The escape path length was defined as the length of the track that a rat traversed
from the start of swimming and the animal's escape onto the platform. This length
was calculated by the sampled x and y coordinate of the rat's position.
(c) Swimming speed
The swimming speed was defined as : Escape path length / escape latency .
(d) Swimming bias during transfer test
The track which a rat traversed during 60 sec transfer test was divided into four
parts corresponding to the four quadrants (NW,SW,SE and NE) of the pool (the
configuration of each quadrant is shown in Fig.2-1 A). These fragments of the
swimming path gave the time spent in each quadrant. The swimming pattern of a rat
during the transfer test was expressed as the bias of swimming to each quadrant which




The animal anaesthetised with Tribromoethanol was positioned in a Kopf
stereotaxic instrument. Anaesthetic was supplemented as required. After exposing the
skull surface by a midline incision, the position of the skull between bregma and
lambda was adjusted to be on the same horizontal plane. The skull area overlying the
region to be lesioned was dried, A-P and M-L limits are marked, and the bone within
this area was removed with a drill.
The stock solution of ibotenic acid was injected into the hippocampus using a 1
jllI Hamilton syringe mounted on a stereotaxic frame.
The stereotaxic coordinates for the lesion are given in Table 2-1 which shows 24
separate injection points (12 on each side). The amounts of ibotenic acid solution
injected was 0.05 or 0.10 pi. The injection was done by manually at a rate of
approximately 0.10 pl/min, and the needle left in place for 1 min following the
injection. If the injections were made at the same A-P and M-L location in the
different D-V extent, the injection at the most ventral site was made first, the needle
was raised after 5-10 sec, and the most dorsal injection was followed 1 min later in
order to prevent spread up the tract.
The scalp incision was closed with discontinuous suture and the animal placed in
a post operative recovery box overnight. It was then transferred to the individual's
normal cage to be given a recovery period of 14 days before commencing training.
(b) Histology
The rats were perfused transcardially with phosphate buffered saline followed
by 10% formalin. Horizontal sections of the brain (30 pm thick) were stained with
fast cresyl violet to assess cell loss.
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Table 2-1
Stereotaxic coordinates for hippocamous lesion
Bregma was used as the zero point for the A-P and M-L coordinates while
the D-V measure is taken from the surface of the cortex. Bregma and
lambda are on the same horizontal plane. The volume of ibotenic acid
injected was 0.05 pi at all sites except for those marked with an * where




-3.0 ±1.4 -2.6, -3.4
-3.0 ±3.0 -3.0*




-5.6 ±5.1 -4,0, -4.9, -5.8
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2.4 Open field activity Experiments
2.4.1 Environment and equipment
The system for the water maze experiment was modified for this open field
activity experiment. Although the room where this experiment was carried out was
not identical to the room used in the water maze experiments, the environment and
equipment were similar to that as shown in Fig. 2-IB.
A white painted inset was attached to the empty pool to make a horizontal
circular stage at the normal water surface level as shown in Fig.2-2. A rat can walk
freely across this circular stage (about 1.9 m in diameter) surrounded by the pool wall
(about 30 cm in height). The video camera mounted above the pool was utilized to
record the activity of the animal on the stage. As the stage was at the water surface
level and painted white, image analyser (HVS Ltd. model VP110) could monitor the
position of black head of the rat as in the water maze experiments, and the rat could
see similar cues as they saw in the water maze. The track which the animal walked




Handling was carried out before the activity test. The procedure of the handling
was the same as in water maze experiments. One or two rats were held on the knees
of the experimenter and their backs were rubbed gently for 3 min. This handling was
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carried out once a day and repeated 3 times for each rat. The last handling was given
on the morning of the day of the activity recording.
(b) Habituation and recording of activity
The experiment was run in replicates, consisting of habituation and activity
recording where 4 animals were used per replicate. The 4 animals were housed in the
same cage. Each animal had 30 min habituation and 10 trials of activity recording
along the time schedule shown in Fig. 2-4.
In habituation, all 4 animals were placed on the stage and allowed to explore the
testing environment for 30 min before being taken back to their home cage.
About 5 min later, the first animal was placed on the stage and left for 2 min to
record its behaviour in the "pre-drug state" on a videotape. Immediately after this
recording, the first rat received an i.p. injection of drug and was returned to its home
cage. Subsequently, the second rat was placed on the stage to have 2 min activity
recording followed by a drug treatment. The third and fourth rats also had the activity
recording and drug treatment. This activity recording and drug treatment of all 4
animals was completed within 10 min. Exactly 10 min after the drug treatment, the
first rat was brought back to the stage and again left for 2 min to record its behaviour.
This behaviour was analysed as "10 min post-drug state". The behaviour of the
second, third and fourth rat was also recorded 10 min after the drug treatment
respectively. The same procedure was repeated at 10 min intervals until the
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2.4.3 Analysis of behaviour
As measures of activity, 4 indices (ataxia, head weaving, body rolling and
locomotor activity) were adopted. Ataxia, head weaving and body rolling were scored
by observing the video monitor replaying each 2 min record of animal activity. The
scorer was blind to the drug treatment given to each animal. The reliability of the
scoring system was checked by comparison between the scoring of the experimenter
and an experienced specialist, Dr Allan Young in the Department of Pharmacology,
University of Edinburgh. The reproducibility of scoring was checked by repeated
scoring of the same videotape.
Locomotor activity was quantified by computer analysis of the track of animal
movements.
(a) Ataxia
Ataxia was rated on a 4 point scale from 0 to 3. A rating of 0 was given if ataxia
was absent, i.e. the animal showed normal walking activity. A rating of 1 was given
if ataxia was equivocal, i.e. the animal showed a slight awkwardness ofmovement
such as tottering or stumbling. A rating of 2 was given if ataxia was present, i.e. the
animal showed an apparent impairment of righting reflexes indicated by partial
abduction of hindlimbs resulting in frequent falling on one side but the animal could
still move forward. A rating of 3 was given if ataxia was intense, i.e. the animal
showed almost complete cessation of locomotion with abduction of fore- and
hindlimbs. The animal may change the direction of its body or occasionally roll onto
its side or raised its head.
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(b) Head weaving
Head weaving was scored by counting the total number of lateral head
movements during the 2 min recording period. Each count was given if the head of
the animal was shifted more than 45° from the midline of the body.
(c) Body rolling
This index was scored by counting the total number of side-to-side movements
of the hind quarters with the detachment of the sole of 4 limbs from the stage floor
during the 2 min recording period.
(d) Locomotor activity
Quantification of locomotor activity was done by calculating the total length of
the trace that the animals traversed during each 2 min recording period. Thus,
locomotor activity was expressed as meters per 2 min.
2.5 LTP Experiments
2.5.1 Surgery
Rats were anaesthetised with Urethane (1.5 g/kg i.p.) and placed in a Kopf
stereotaxic device. A midline incision along the scalp was made to expose the skull
surface. Holes were drilled in the skull for electrodes and a stainless steel screw
which was placed anterior to bregma and served as the earth.
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A stimulating electrode, consisting of two Teflon-coated stainless steel wires
(110 Jim diameter) twisted together and separated horizontally at the tip by
approximately 1.0 mm, was implanted in the perforant path. A recording electrode,
consisting of a single Teflon-coated stainless steel wire (110 |im diameter) was
implanted in the hilus of the dentate gyrus. The coordinates, relative to bregma were
3.5 mm posterior and 2.0 mm lateral for the recording electrode and 8.0 mm posterior
and 4.0 mm lateral for the stimulating electrode. The electrodes were lowered to
optimise the amplitude of evoked field responses of granule cells (the depth of
stimulating electrode and recording electrode were approximately 2.7 mm and 1 mm
respectively). The electrode placement and recording were sometimes made
bilaterally.
2.5.2 Electrophysiological procedure
A programmable stimulator (Neurolog NL-800, Digitimer) delivered constant
0.7 mA current monopolar stimuli (100 |isec biphasic, square wave pulses) at 20 sec
intervals throughout the experiment. The evoked field excitatory post synaptic
potential (EPSP) was amplified and filtered between 1 Hz and 10 kHz using a Grass
EEG amplifier. The signals were converted from analog to digital in a Minc-11/23
computer and the data stored on magnetic disks. The slope of the early-rising part of
the evoked field-potential was measured using linear regression (Fig. 4-1 page97).
After a stable response was observed for more than 15 min, a pre-drug baseline
response was recorded for 10 min and the drug was then administered i.p. The drugs
(MK-801 and FR115427) were made up in 0.9 % saline. A high frequency tetanus,
consisting of 5 trains of 400 Hz 50 msec stimulation spaced 10 sec apart, was given
after a 30 min or 90 min interval. The slope of the EPSP was analysed as the sole
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index of synaptic efficacy in the dentate gyrus. The body temperature of the
anaesthetised animals was kept within ± 0.1 °C from the initial body temperature (36.1
~ 36.8°C) using an electric blanket and a desk lamp throughout the recording period.
2.6 Data analysis
In the analysis of parametric data, ANOVA followed by Dunnett's multiple
comparison test was carried out to compare one control group and other drug groups.
Tukey's honestly significant difference test was carried out to compare two
arbitrary selected groups.
The results of the ANOVA is described in the following formula.
[F(a, b)=c p value]
a: degree of freedom in the experimental condition
b: degree of freedom in the residual error
c: F value
= mean of square of condition's effect / mean of square of residual error
p value is a probability of type 1 error (rejecting null hypothesis when it is
true)
In the analysis of non-parametric data, Kruskal-Wallis ANOVA followed by
Wilcoxon test was carried out.




Experiment 1: Open Field Activity Test
3.1 Introduction
The aim of this experiment was to examine whether systemic administration of
FR115427 produced MK-801-like motor effects in rats. The Open Field Activity
Test was designed to analyse behavioural changes by four indices, ataxia, locomotor
activity, head weaving and body rolling which had been described in other
investigations evaluating characteristic changes induced by NMDA receptor
antagonists (Tricklebank et al., 1988; Hiramatsu et ah, 1989; Loscher and Honack,
1992). As a wider range of drug doses were testable as well as the time course of the
drug's effect, compared to water maze or LTP experiments, this open field activity
test was carried out first. The objective was to find a suitable drug dose and timing
of administration for subsequent experiments.
In order not to give excessive stress to the animals in the behavioural test
compared with the animals in the water maze task, handling and habituation trial was
given to the animals as in the water maze experiments and the tests were carried out
on the specially designed stage set in the water pool under the same lighting
condition as in the maze training.
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3.2 Brief Procedure of Experiment
Details of the method were described in Chapter 2. In this section, the outline
of procedure is summarised.
In advance to the test trial, Lister hooded rats received handling and
habituation sessions in which animals were allowed to explore the experimental
environment (white circular stage set in the water maze pool) for 30 min (see Fig. 2-
2). The stage was illuminated by soft diffuse lights. Following the habituation, the
animals received repetitive 2 min behavioural test trials. In each test trial, the rat
was placed on the stage and its behaviour recorded on the video tape by a camera
mounted in the ceiling above the stage. At the end of the 2 min test period, the
animal was brought back to its home cage. The animals were allocated to one of the
9 groups (saline, MK 1 mg/kg, MK 0.32 mg/kg, MK 0.1 mg/kg, MK 0.032 mg/kg,
FR 32 mg/kg, FR 10 mg/kg, FR 3.2 mg/kg, and FR 1 mg/kg). Each group consisted
of 8 animals. Each animal received i.p. injections of drug only once. The
behavioural test trial was carried out just before the drug injection and repeated at 10
min intervals after drug injection until 90 min post drug period (see Fig. 2-4).
The recorded behaviour was analysed and quantified by the following indices,
ataxia, head weaving body rolling and locomotor activity. The score of ataxia, head
weaving and body rolling were rated manually by observing video monitor. Ataxia
was rated on a four point scale of 0 to 3. The score for head weaving is a direct
count of lateral head movement in 2 min. The score for body-rolling is a direct
count of side-to-side movements of the hind quarters in 2 min. Locomotor activity
was automatically measured by the image analyzing system which expresses the
activity by the distance that the animals traversed across the stage in 2 min period.
The scorer was blind to the drug treatment and the validity of scoring was
checked by Dr Allan Young in the Department of Pharmacology.
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3.3 Results
High doses of MK-801 (1 ~ 0.32 mg/kg) and FR115427 (32 ~ 10 mg/kg)
induced marked ataxia, head weaving immediately after i.p. administration.
Locomotor activity of rats receiving the highest dose of MK-801 or FR115427 was
initially inhibited by severe ataxia then gradually enhanced with the recovery from
the ataxic effect. Those rats showed body rolling as their locomotor activity
recovered.
As summarised in Table 3-1, overall one-way between- and within-subjects
ANOVAs of each behavioural score suggested that MK-801 and FR 115427 induced
significant changes in the scores for ataxia, head weaving, body rolling and
locomotor activity (a significant group effect at the level of p < 0.0001). These
changes were also suggested to be time dependent (the effect of * trial was significant
at p < 0.0001) (*: see Fig. 2-4). The significance (p < 0.0001) in interaction terms
(group x trial) suggests the adequacy of independent analysis at each trial. Kruskal-
Wallis Nonparametric one-way ANOVA followed by Wilcoxon test was applied to
analyse the scores for ataxia, head weaving and body rolling. A one-way between-
subjects parametric ANOVA followed by Dunnett's multiple comparison test was
carried out to compare the locomotor activity of the saline group and that of drug
groups, and a one-way within-subjects ANOVA followed by Dunnett's multiple
comparison test was performed to analyse the time dependent change in locomotor
activity.
As described below, all scores during the pre-drug period indicated no
significant difference between groups.
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Table 3-1
Over-all one-way between- and one-way within-subjects ANOVA
Ataxia
source of df sum of mean F P
variation squares square
Group 8 468.625 58.578 108.782 0.0000
Error 63 33.925 0.538
Trial 9 33.078 3.675 54.022 0.0000
Group X Trial 72 85.345 1.185 17.423 0.0000
Error 567 38.575 0.068
Head Weaving
source of df sum of mean F P
variation squares square
Group 8 26024.194 3253.024 20.402 0.0000
Error 63 1045.000 159.444
Trial 9 4204.644 467.183 8.067 0.0000
Group X Trial 72 18825.556 261.466 4.515 0.0000
Error 567 32837.000 57.914
Body Rolling
source of df sum of mean F p
variation squares square
Group 8 1218.519 152.315 15.552 0.0000
Error 63 617.013 9.794
Trial 9 104.446 11.605 3.380 0.0000
Group x Trial 72 905.842 12.581 3.665 0.0000
Error 567 1946.613 3.433
Locomotor activity
source of df sum of mean F p
variation squares square
Group 8 7940.400 992.550 7.918 0.0000
Error 63 7897.115 125.351
Trial 9 846.932 94.104 5.550 0.0000
Group x Trial 72 5857.126 81.349 4.789 0.0000
Error 567 9613.104 16.954
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3.3.1 Ataxia
The time course of the mean (± standard error of the mean: s.e.m.) ataxic sore
of each group is shown in Fig. 3-1. An overall one-way between- and within-
subjects ANOVA of ataxic scores revealed significant effects of group (p < 0.0001),
trial (p < 0.0001) and group x trial interaction (p < 0.0001) (Table 3-1). All animals
were scored 0 (= no sign of ataxia) at the pre-drug trial. Kruskal-Wallis ANOVA
performed at each post-drug trial shows significant group effects (p < 0.0001) at all
trials (between 10 min and 90 min post drug period) (Table 3-2). The scores of the
saline group were 0 throughout the experiment. The i.p. injection of 1 mg/kg of
MK-801 induced severe ataxia (Fig. 3-1). Comparison by Wilcoxon test between
the MK-801 1 mg/kg group and the saline group indicated a significant effect at all
post drug periods (p < 0.05 at 10 min. p< 0.01 between 20 and 90 min.) (Table 3-2).
The score of the 0.32 mg/kg group may not be the same as the saline group at the
level of p < 0.01 between the 20 min and 70 min post injection (at 30 min, p < 0.001)
using a Wilcoxon test. The repeated same tests showed that 0.1 or 0.032 mg/kg MK-
801 did not induce any significant ataxic effect at any period after injection.
I.p. administration of 32 mg/kg FR115427 induced rapid and strong ataxia.
Within 10 min, the ataxic index reached an almost maximal score (Fig. 3-1), with 7
out of 8 animals in the condition of rate 3 ataxia during the first 30 min. A recovery
from the severe ataxia of this group was faster than that of the 1 mg/kg MK-801
group. At 90 min, 7 out of 8 animals only rated a score of 1. The difference in the
ataxic score between this group and control group was found to be highly significant
(p < 0.001) in the multiply performed Wilcoxon test (Table 3-2) throughout the 90
min post injection periods. 10 mg/kg of FR115427 induced a weak ataxia (mean
score < 1) (Fig.3-1). Wilcoxon test suggested that the score of this group was not
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Fig. 3 -1 Comparison of ataxia induced by saline MK-801 and FR115427 in rats.
The rating scale was described in Materials and Methods in chapter 2. Values are the
means ± s.e.m. of eight animals
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Table 3-2
Kruskal-Wallis Nonparametric ANOVA of Ataxic scores and
One sample nonparametric test (Wilcoxon Test)
Ataxia
Trial (min) 10 20 30 40 50 60 70 80 90
Kruskal-Wallis (KW) 51.559 57.578 59.182 64.024 61.875 61.839 65.607 61.571 66.222
statistics
P value (KW) (p <) .0001*** .0001*** .0001*** .0001*** .0001*** .0001*** .0001*** .0001*** .0001***
saline median 0 0 0 0 0 0 0 0 0
MK 1.0 mg/kg median l 2.5 3 3 3 2.5 2 2 2
Sum of positive ranks 21 36 36 36 36 36 36 36 36
No. of pairs 6 8 8 8 8 8 8 8 8
One tailed P value .0156 * .0039** .0039** .0039** .0039** .0039** .0039** .0039** .0039**
MK 0.32 mg/kg median 0 1 1 1 1 1 1 0 0
Sum of positive ranks 3 15 28 21 21 15 21 3 1
No. of pairs 2 5 7 6 6 5 6 2 1
One tailed P value .25 .0312 * .0078** .0156 * .0156 * .0312 * .0156 * .25 .50
MK 0.1 mg/kg median 0 1 1 1 1 1 1 0 0
Sum of positive ranks - 1 1 1 1 1 - - -
No. of pairs - 1 1 1 1 1 - - -
One tailed P value - .50 .50 .50 .50 .50 - - -
MK0.032mg/kg median 0 0 0 0 0 0 0 0 0
Sum of positive ranks - - 1 - - - - - -
No. of pairs - - 1 - - - - - -
One tailed P value - - .50 - - - - - -
FR 32 mg/kg median 3 3 3 3 2.5 2 2 2 1
Sum of positive ranks 36 36 36 36 36 36 36 36 36
No. of pairs 8 8 8 8 8 8 8 8 8
One tailed P value .0039** .0039** .0039** .0039** .0039** .0039** .0039** .0039** .0039**
FR 10 mg/kg median 0.5 0 0 0 0 0 0 0 0
Sum of positive ranks 10 6 6 - 1 - - - -
No. of pairs 4 3 3 - 1 - - - -
One tailed P value .0625 .125 .125 - .50 - - - -
FR 3.2 mg/kg median 0 0 0 0 0 0 0 0 0
Sum of positive ranks - - - - - - - - -
No. of pairs - - - - - - - - -
One tailed P value - - - - - - - - -
FR 1.0 mg/kg median 0 0 0 0 0 0 0 0 0
Sum of positive ranks - - - - - - - - -
No. of pairs - - - - - - - - -
One tailed P value - - - - - - - - -
not possible to analyse because SD value is 0
No. of pairs: 0 values were excluded from calculations
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injection (p > 0.05). The animals which received 3.2 or 1 mg/kg FR115427 did not
show any sign of ataxia during the 90 min.
3.3.2 Head weaving
As shown in Fig.3-2, the saline group showed a stable and low level of head-
weave counts throughout the experimental period. An overall one-way between- and
within-subjects ANOVA of head weaving scores revealed significant effects of
group (p < 0.0001), trial (p < 0.0001) and group x trial interaction (p < 0.0001)
(Table 3-1). Kruskal-Wallis nonparametric ANOVA revealed significant group
effect at 10, 20, 30, 40, 50, 60 and 80 min post drug period (Table 3-3). At these
periods, Wilcoxon test was performed to compare the score of each group with the
saline group (Table 3-3).
In the MK-801 (1 mg/kg) group, the count of head weaving significantly
increased at 10 min (p < 0.01), 30, 40, 50 min (p < 0.05) and 60, 80 min (p < 0.01)
(Table 3-3, Fig. 3-2). The time course of the above score was complicated because
the ataxia reduced the head-weave score by inhibiting the lateral movement of the
animal's head. The count was especially suppressed at 20 and 30 min. During this
period, the animals still moved their head very rapidly but the lateral shift of the
head was restricted and too small to satisfy the counting criteria (the shift larger than
45°). The 0.32 mg/kg dose of MK-801 significantly ( p < 0.05) increased the count
of head weaving at all periods after injection except 70 and 90 min (Table 3-3, Fig 3-
2), while neither 0.1 nor 0.032 mg/kg ofMK-801 increased the frequency of head
weaving significantly.
The 32 mg/kg dose of FR induced significant increase in head weaving
between 30 min and 80 min except at 70 min after injection (p < 0.05 - 0.01
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Fig. 3-2 Comparison of head weaving induced by saline MK-801 and FR115427 in
rats. The rating scale was described in Materials and Methods in chapter 2. Values are









Kruskal-Wallis Nonparametric ANOVA of Head Weaving scores and
One sample nonparametric test (Wilcoxon Test)
Head Weaving
Trial (min) pre- 10 20 30 40 50 60 70 80 90
Kruskal-Wallis (KW)
statistics
7.630 23.217 15.982 31.397 37.132 35.132 32.136 15.387 17.350 10.999
P value (KVV) .470 .003** .0426* .0001*** .0001*** .0001*** .0001*** .052 .0267* .202
saline median 1.5 2.5 2.5 2.0 1.0 2.0 1.5 1.0 0.5 2.0
MK 1.0 mg/kg median 2.0 12.0 6.5 12.5 23 26.5 19.5 5.5 4.5 2.5
Sum of positive ranks 30.0 36 27.5 32.5 35 34.5 36 26.5 36 18
Sum of negative ranks -6.0 0 -8.5 -3.5 -1 -1.5 0 -1.5 0 -10
No. of pairs 8 8 8 8 8 8 8 7 8 7
Two tailed P value 0.109 .0078** 0.1953 .0391* .0156* .0156* .0078** 0.031 .0078** .578
MK 0.32 mg/kg median 2.0 4.5 8.0 5.0 5.5 5.0 5.5 3.0 4.0 2.5
Sum of positive ranks 25.5 34.5 34.0 21.0 28.0 33.5 34.0 26.5 34.5 1.0
Sum of negative ranks -10.5 -1.5 -2.0 0.0 0.0 -2.5 -2.0 -1.5 -1.5 17.5
No. of pairs 8 8 8 6 7 8 8 7 8 -10.5
Two tailed P value 0.313 .0156* .0234* .0312* .0156* .0234* .0234* 0.031 .0156* 0.578
MK 0.1 mg/kg median 3.0 3.0 2.5 2.0 2.0 2.0 2.5 1.5 1.0 2.0
Sum of positive ranks 32.5 20.5 15.5 23.0 22.0 11.5 27.0 19.0 33.0 10.5
Sum of negative ranks -3.5 -15.5 -20.5 -13.0 -6.0 -9.5 -9.0 -9.0 -3.0 -4.5
No. of pairs 8 8 8 8 7 6 8 7 8 5
Two tailed P value 0.039 .742 .742 .547 .219 .844 .250 .469 .0391 * .438
MK0.032mg/kg median 1.5 2.0 3.0 3.0 3.0 4.0 3.0 2.0 3.0 2.5
Sum of positive ranks 24.0 16.5 23.0 20.0 20.0 24.5 30.0 15.0 33.0 16.0
Sum of negative ranks -12.0 -19.5 -13.0 -8.0 -1.0 -3.5 -6.0 0.0 -3.0 -5.0
No. of pairs 8 8 8 7 6 7 8 5 8 6
Two tailed P value 0.461 .844 .547 .375 .063 .078 .109 .063 .0391* .313
FR 32 mg/kg median 2.0 0.0 23.0 41.0 34.0 22.0 3.5 14.5 6.5 4.0
Sum of positive ranks 29.0 15.0 31.0 36.0 36.0 36.0 34.0 15.0 33.0 25.0
Sum of negative ranks -7.0 -21.0 -5.0 0.0 0.0 0.0 -2.0 0.0 -3.0 -3.0
No. of pairs 8 8 8 8 8 8 8 5 8 7
Two tailed P value .148 .742 .078 .0078** .0078** .0078** .0234* .063 .0391* .078
FR 10 mg/kg median 2.5 2.0 3.5 2.5 4.0 2.5 1.5 1.5 2.5 3.0
Sum of positive ranks 26.5 18.5 27.5 19.5 27.0 16.0 24.0 17.0 34.0 2.5
Sum of negative ranks -9.5 -17.5 -8.5 -8.5 -1.0 -5.0 -12.0 -4.0 -2.0 -18.5
No. of pairs 8 8 8 7 7 6 8 6 8 6
Two tailed P value .250 .945 .195 .375 .0312* .313 .461 .219 .0234* .094
FR 3.2 mg/kg median 1.0 3.0 1.5 3.5 1.0 1.5 1.5 3.5 2.0 2.0
Sum of positive ranks 20.0 21.0 14.0 21.0 12.0 10.5 21.0 20.0 32.0 9.0
Sum of negative ranks -16.0 -15.0 -22.0 -7.0 -3.0 -10.5 -15.0 -1.0 -4.0 -12.0
No. of pairs 8 8 8 7 5 6 8 6 8 6
Two tailed P value .844 .742 .641 .297 .313 1.000 .742 .063 .055 .844
FR 1.0 mg/kg median 3.0 1.5 1.0 0.0 2.0 1.0 1.0 1.0 1.0 1.5
Sum of positive ranks 30.0 6.0 9.0 6.0 23.0 2.5 13.0 3.0 28.0 1.5
Sum of negative ranks -6.0 -30.0 -27.0 -15.0 -5.0 -18.5 -23.0 -3.0 -8.0 -13.5
No. of pairs 8 8 8 6 7 6 8 3 8 5
Two tailed P value .109 .109 .250 .438 .156 .094 .547 1.000 .195 .125
No. of pairs: 0 values were excluded from calculations
Kruskal-Wallis ANOVA indicated that group effect is not significant
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Table 3-3). At 10 and 20 min period the animals moved their head rapidly but the
ataxic effect prevented the lateral shift of the head from exceeding the counting
criteria. Although the Wilcoxon test detected a significant increase of score in the 10
mg/kg FR group at 40 and 80 min when the score of the saline group was unusually
low, 10 mg/kg or lower doses of FR did not significantly increase the count of head
weaving (Fig. 3-2, Table 3-3).
3.3.3 Body rolling
No body rolling was observed in the saline group throughout the experiment.
Before drug administration, no animals in any group showed any sign of body
rolling. An overall one-way between- and within-subjects ANOVA of body rolling
scores revealed significant effects of group (p < 0.0001), trial (p < 0.0001) and group
x trial interaction (p < 0.0001) (Table 3-1).
As shown in the Fig. 3-3, the significant group effect is due to an increase of
body rolling scores in MK 1 mg/kg and FR 32 mg/kg groups. Wilcoxon tests
following Kruskal-Wallis nonparametric ANOVAs confirmed a significant effect in
MK 1 mg/kg and FR 32 mg/kg groups (Table 3-4). In these groups, the increase of
body rolling scores were suppressed by ataxic effects during the early phase
following drug administration (Fig. 3-3). The severe ataxia abolished the chance of
body rolling as well as the locomotor activity of animals. As the animals recovered
from ataxia, their locomotor activity and body rolling scores increased (compare Fig.
3-1, 3-3 and 3-4).
At the second highest dose of these drugs, 0.32 mg/kg ofMK-801 and 10 mg
of FR 115427, a slight increase in the score was observed but the change was not
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: p < 0.01 compared to saline group (Wilcoxon Test)
*: p < 0.05 compared to saline group (Wilcoxon Test)
Fig. 3-3 Comparison of body rolling induced by saline MK-801 and FR115427 in
rats. The rating scale was described in Materials and Methods in chapter 2. Values are
the means ± s.e.m. of eight animals
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Table 3-4
Kruskal-Wallis Nonparametric ANOVA of Body Rolling scores and
One sample nonparametric test (Wilcoxon Test)
Body Rolling
Trial (min) 10 20 30 40 50 60 70 80 90
Kruskal-Wallis (KW) 22.545 19.071 19.330 34.148 26.882 39.170 65.607 58.794 64.256
statistics
P value (KW) (p <) .01** .05* .05*** .0001*** .001*** .0001*** .0001*** .0001*** .0001***
saline median 0 0 0 0 0 0 0 0 0
MK 1.0 mg/kg median 1 0 0 0 0 1 1 4.5 7
Sum of positive ranks 10 6 6 6 6 10 10 36 28
No. of pairs 4 3 3 3 3 4 4 8 7
One tailed P value .0625 .125 .125 .125 .125 .0625 .0625 .0039** .0078**
MK 0.32 mg/kg median 0 0.5 0.5 0 0 0 0 0 0
Sum of positive ranks 1 10 10 - 6 3 3 1 -
No. of pairs 1 4 4 - 3 2 2 1 -
One tailed P value .50 .0625 .0625 - .125 .25 .25 .50 -
MK 0.1 mg/kg median 0 0 0 0 0 0 0 0 0
Sum of positive ranks - - 1 - - - - 1 -
No. of pairs - - 1 - - - - 1 -
One tailed P value - - .50 - - - - .50 -
MK0.032mg/kg median 0 0 0 0 0 0 0 0 0
Sum of positive ranks - - - - - - - - -
No. of pairs - - - - - - - - -
One tailed P value - - - - - - - - -
FR 32 mg/kg median 0 0 1 3 6 8 6 3.5 3
Sum of positive ranks 6 6 10 15 15 28 36 28 36
No. of pairs 3 3 4 5 5 7 8 7 8
One tailed P value .125 .125 .0625 .0312 * .0312 * .0078** .0039** .0078** .0039**
FR 10 mg/kg median 0.5 0 0 0 0 0 0 0 0
Sum of positive ranks 10 3 3 - 1 - - - -
No. of pairs 4 2 2 - 1 - - - -
One tailed P value .0625 .25 .25 - .50 - - -
FR 3.2 mg/kg median 0 0 0 0 0 0 0 0 0
Sum of positive ranks - - - - - - - - -
No. of pairs - - - - - - - - -
One tailed P value - - - - - - - - -
FR 1.0 mg/kg median 0 0 0 0 0 0 0 0 0
Sum of positive ranks - - - - - - - - -
No. of pairs - - - - - - - - -
One tailed P value - - - - - - - -
not possible to analyse because SD value is 0
No. of pairs: 0 values were excluded from calculations
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and 3.2, 1 mg/kg FR), animals were scored 0 except one animals in the 0.1 mg/kg
MK group.
3.3.4 Locomotor activity
Fig. 3-4 shows the locomotor activity expressed by the mean (± s.e.m.)
distance which an animal traversed across the test stage during each two min trial.
As with other indices, an overall one-way between- and within-subjects ANOVA of
locomotor activity scores revealed significant effects of group (p < 0.0001), trial (p <
0.0001) and group x trial interaction (p < 0.0001) (Table 3-1).
The time course of locomotor activity of the saline group shows a typical
habituation pattern in which the activity decreased with the repetition of test trial and
reached a stable level. One-way within-subjects ANOVA across the trials in the
saline group detects this change as a significant effect of trial [F(9, 63)=5.434 p <
0.0001] (Table 3-5). Dunnett's pairwise comparison test indicates that the
locomotor activity at 20 min post-injection trial and the later trials (20 min ~ 90 min)
was significantly lower than at the initial pre-injection trial ( pre-injection vs. 20
min, p < 0.05; pre-injection vs. 30 min or later trials, p < 0.01) (Table 3-5).
One-way between-subjects ANOVA followed by Dunnett's multiple
comparison test was carried out to compare the locomotor activity of the saline
group and drug groups ( Table 3-6). The 1 mg/kg dose ofMK-801 significantly
increased locomotor activity at 10, 70, 80 and 90 min in comparison with saline (p <
0.01). Between 20 min and 60 min, the ataxic effect competed with the locomotor
stimulating effect. 0.32 mg/kg MK-801 significantly increased locomotor activity at
all post injection periods (p < 0.05 at 10 min , p < 0.01 between 20 and 90 min). The
mean scores of locomotor activity of 0.1 mg/kg MK-801 group are not significantly
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different from that of the saline group at any test trial. However, the 'habituation
pattern', which is the significant decrease of locomotor activity in one-way within
subjects ANOVA, was not detected in this group (table 3-5). This relatively higher
locomotor activity in the late phase trials suggests that some kind of change in
behaviour was induced after administration of 0.1 mg/kg ofMK-801. Locomotor
activity of 0.032 mg/kg MK group was not different from that of saline (Table 3-6).
One-way within subjects ANOVA followed by Dunnett's test (Table 3-5) revealed a
significant decrease of locomotor activity at 50, 60 and 90 min post drug periods in
comparison with locomotor activity at the pre-injection period.
In the 32 mg/kg FR115427 group, locomotor activity was strongly suppressed
between 10 and 30 min post drug periods by ataxia (Fig. 3-4). One-way within-
subjects ANOVA followed by Dunnett's comparison test suggests the significance
(p < 0.01) of this suppression (Table 3-5). At 60 min or later, a significant increase
(p < 0.01) of locomotor activity in this group in comparison with saline group is
revealed by one-way between-subjects ANOVA and post hoc Dunnett's comparison
test (Table 3-6, Fig. 3-4). The 10 mg/kg dose of FR significantly increased
locomotor activity between 10 min and 30 min (p < 0.05 at 10 min, p < 0.01 at 20
and 30 min Table 3-6). As for 3.2 mg/kg FR group, one-way between subjects
ANOVA (Table 3-6) did not detect any significant difference against saline group
throughout the experimental period. However, one-way within-subjects ANOVA in
3.2 mg/kg group (Table 3-5) revealed no significant decrease of locomotor activity
('habituation pattern') which suggests some kind of change in the animals'
behaviour. Locomotor activity of 1 mg/kg FR group was not significantly different
from that of the saline group. One-way within-subjects ANOVA (Table 3-5)
revealed a significant effect of trial (p < 0.01). Post hoc Dunnett's test showed the
scores at 70, 80 and 90 min are significantly lower than the score of pre-injection





































—m—- FR 32 mg/kg
—••— FR10 mg/kg
—±—- FR 3.2mg/kg \
" FR 1 mg/kg
90 min
post drug
** : p < 0.01 compared to saline group (Dunnett comparisonTest)
* : p < 0.05 compared to saline group (Dunnett comparisonTest)
Fig. 3-4 Comparison of locomotor activity induced by saline MK-801 and
FR115427 in rats. The rating scale was the distance that an animal traversed during the
2 min test trial. Values are the means ± s.e.m. of eight animals
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3.4 Discussion
The main findings of this experiment are:
(1) FR115427 as well as MK-801 induces stereotyped motor syndrome like
ataxia, head weaving, body rolling and hyper locomotion.
(2) The potency of FR115427 to induce the above motor syndrome is about 30
times, or more, weaker than that of MK-801.
(3) The animals receiving FR115427 show a quicker onset of motor syndrome
and quicker recovery from that effects than the animals receiving of MK-801. A
peak effect of the ataxia and head weaving is induced within 30 min after injection
of FR115427. The time course of locomotor activity and body rolling is complicated
because of the ataxia.
3.4.1 Dose response of MK-801 and FR115427
The minimum effective doses of both drugs that induced significant changes in









0.32 0.32 1.0 0.32
FR115427
(mg/kg)
32 10 32 10
approximate ratio 100 30 30 30
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The absolute figures for minimum effective dose is variable according to the
method of analysis. Some multiple comparison tests other than the Wilcoxon test
may show different minimum effective doses. If the analysis is carried out across
trials rather than across groups, different aspects of drugs effects are detected. In the
analysis of locomotor activity, the one-way within-subjects ANOVA across trials
revealed the disappearance of the saline group like habituation pattern in the
locomotor activity at the dose of 0.1 mg/kg of MK-801 and 3.2 mg/kg of FR115427
(Table 3-5) (the approximate ratio of the potency was 30 to 1).
The sensitivity of these behavioural indices to detect the drug's effect is also
different between experiments. Hiramats et al. (1989) observed ataxia with MK-801
at the dose of 0.25 mg/kg (i.p.), and increased head weaving and locomotor activity
at 0.125 mg/kg (i.p.). Loscher and Honack (1992) observed intense head weaving
and hyper locomotion and moderate to marked ataxia at the dose of 0.1 mg/kg MK-
801 (i.p.). Ouagazzal et al. reported the minimum effective dose ofMK-801 to
induce a significant increase in locomotor activity at 0.3 mg/kg (i.p.) in 1993 and 0.1
mg/kg (i.p.) in 1994. Thus, the reported behavioural effect ofMK-801 in rats was
observed at a little lower dose than in this experiment. The difference in the
experimental conditions, especially any differences in the stress level of the animals
during test trials, may modulate the potency of the drug's effect on the animal's
behaviour. In this experiment, the animals were handled by the experimenter and
received habituation trials beforehand to reduce stress of animals.
In any event, the extent of difference in potency ofMK-801 between the
present result and that found by others was less than 3 fold (There are no comparable
data for body rolling). In this as well as in other experiments, the effective dose of
MK-801 that induced ataxia, head weaving and locomotor stimulation was lower
than the reported therapeutic doses required to block ischaemic brain damage (MK-
801 reduced ischaemic brain damage at about 1 to 5 mg/kg i.p. in the rat middle
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cerebral artery occlusion model ( Dirnagle et al., 1990; Bielenberge and Beck, 1991;
Gill et al., 1992; Iijima et al., 1992; Frazzini et al., 1994).
The above dose is also lower than the dose (1 mg/kg i.p.) at which MK-801
blocks the induction of LTP in anaesthetised rats (Abraham and Mason 1989). In
other words, it is difficult to carry out a behavioural experiment at a dose at which
MK-801 blocks the brain damage or the induction of LTP because of the ataxic
effect.
The potency of FR115427 to induce behavioural effects was approximately 30
to 100 times weaker than the potency ofMK-801. This difference in potency seems
to be slightly greater than the difference in their binding affinity for the NMDA
receptor in rat brain membranes. As described in Chapter 1, Hodgkiss et al. (1993)
reported that FR115427 is 14-fold less potent than MK-801 as inhibitors of [3H]
MK-801 binding (the Ki values for FR115427 and MK-801 were 43.3 nM and 3.14
nM respectively in the presence of 10 |iM L-glutamate). Sherriffs et al. (1993)
reported that FR115427 was 10-fold less potent than MK-801 as inhibitors of [3H]
MK-801 binding (the Ki values for FR115427 and MK-801 were 35.4 nM and 3.57
nM respectively in the presence of 10 jlM L-glutamate).
The weaker in vivo behavioural effects of FR115427 relative to its affinity for
the NMDA receptor does not seem to be explained by lower absorption or
distribution of this compound in the brain after systemic administration because, in
an NMDA-induced convulsion test in mice conducted by Nakanishi et al. (1995),
FR115427 was found to be about 10 times less potent than MK-801 by three
different routes of administration (i.e.v., i.p. and p.o.) In the MCA occlusion
ischaemia model in rat, the therapeutically effective dose of FR115427 (10 mg/kg
i.p.) is also just about only 10 times higher than that of MK-801 (1 mg/kg
i.p.).(Katsuta et al., 1995). These differences in potency between FR and MK are
within the range of their difference in affinity for the receptor. A possible
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explanation of the weaker behavioural effects of FR115427 lies in a differential
requirement of L-glutamate or glycine in their binding to brain membrane because
the in vivo models in which FR shows only 10 times weaker potency than MK-801
are expected to be accompanied with an elevated level of agonists for NMDA
receptors (due to injection of NMDA or release of glutamate) in the brain.
According to the Sherriffs et al.(1993), the specific binding of [3H] FR115427 in the
absence of exogenous L-glutamate was too low for exact kinetics while [3H] MK-
801 binding was measurable in the absence of added exogenous L-glutamate due to
its higher affinity for the NMDA receptor ion channel. In another words, the
pharmacologically effective binding of FR may be more greatly affected by the
concentration of glutamate or another amino acid in the synaptic gap. As discussed
in Chapter 1, the extracellular level of glutamate is suggested to be dynamically
modulated in the brain and the binding of non-competitive NMDA antagonists could
be affected by the level of glutamate. For example, in vivo binding of [3H] MK-801
to the ischaemic cortex and striatum was found to be significantly enhanced in
circumstances in which the extra cellular glutamate level was likely to be elevated
(Wallace et ah, 1992). The binding affinity FR115427 may be much lower than
MK-801 if the extra cellular level of excitatory amino acids are very low or if amino
acid uptake activity is very high.
The relatively low potency of FR115427 in inducing ataxia may be an
advantage of this drcug as a pharmacological tool because the ataxic effect of non¬
competitive antagonist is the main problem in studying the effect of this type of drug
on learning.
As up to 10 mg/kg FR115427 did not induce serious troubles in the motor
ability of rats, this dose seems to be the maximum dose for water maze experiments
while only 0.1 mg/kg of MK-801 seems to be the maximum for that learning test.
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3.4.2 The effect of ataxia on the other behavioural indices
Before discussing the time course of the behavioural effects of MK-801 and
FR115427, the following section will comment on ataxia whose presence
complicates the analysis of the time course of the drug's effect. The ataxic effect
inhibits the locomotion of animal which is the prerequisite for the expression of head
weaving, body rolling and hyper locomotion. Therefore the analysis of the
behavioural effects ofMK-801 and FR115427 bears the paradoxical problem that
one drug effect inhibits another effect of its own. At the top doses of both drugs, the
above paradox severely distorted the time course of head weaving, body rolling and
locomotor activity. In these indices, an increase in the scores seems to indicate the
recovery from the ataxic effect rather than a real intensification of the drug's effect
because (1) the peak of the scores appeared in the declining phase of ataxic score; (2)
the peak of the scores of lower dose groups which suffered less ataxia appeared at
earlier periods; (3) the fact that the recovery of the scores of head weaving was faster
than the recovery of body rolling scores or locomotor activity in the top dose groups
is consistent with the observation that the recovery of small head movements
(necessary to express head weaving) was faster than the recovery of the activity of
the whole body in ataxic animals.
In the discussion of time course of head weaving, body rolling and locomotor
activity, the scores of lower dose groups seems more reliable than the scores of the
top doses although the change in the scores of lower doses did not always induce
statistically significant effects.
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3.4.3 The time course of the behavioural effects
The ataxic effect of FR115427 was exhibited very quickly. The score for
ataxia in the 32 mg/kg FR group reached its peak between 10 min and 30 min after
injection and then decreased gradually. FR 10 mg/kg group showed a consistent
time course of score. As the head movement of the animals recovered from ataxia
relatively faster than the whole body locomotion, the score of head weaving of 32
mg/kg FR group showed a similar time course to ataxia except the slight delay of
onset. The score of body rolling and locomotor activity of the highest dose group
was severely distorted by the ataxic effect. The score of the lower dose group
suggests a similar time course of onset and recovery to that of ataxia. That is, the
peak effect of the motor syndrome in the FR group was induced during the first 30
min after injection then the effect steadily reduced by the 90 min post drug period.
The behavioural effect of MK-801 was induced more slowly and sustained for
a longer period. A broad peak of score was observed between about 20 min and 60
min after the injection in the score for ataxia and head weaving at a dose of 1 mg/kg
and 0.32 mg/kg, and in locomotor activity at the 0.32 mg/kg dose. The score for




The potency of FR115427 to induce a motor syndrome is about 30 to 100-fold
weaker than that of MK-801. As the behavioural side effects of FR115427 seem to
be weaker than other physiological effects of this compound, FR 115427 can be
tested at a relatively higher dose in the water maze experiment. Because of the
ataxic condition induced by MK-801 and FR115427, the maximum doses that can be
tested seems to be 0.1 mg/kg for MK-801 and 10 mg/kg for FR115427. Since
FR115427 induced maximum scores for the behavioural syndrome at about 20 to 30
min after injection, one condition of the training and testing of animals in the water
maze is that it has to be carried out in this time window to examine the relationship
between the effect of FR115427 on behaviour and on learning performance.
However, this does not preclude the use of later post-injection time-periods if the
electrophysiological studies (Chapter 4) indicate that their examination would be
profitable. As the effect of MK-801 was induced slowly and sustained for a long
time, it is difficult to discuss the time dependence of the effect of MK-801.
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Chapter 4
Experiment 2: In vivo LTP study (1)
4.1 Introduction
Some investigations have found that MK-801 impairs the acquisition of
learning in the water maze but not the retention of the acquired performance, and
they have related the impairment to the inhibitory effect on LTP exhibited by
NMDA antagonists which, by analogy, block its induction but not expression
(Robinson et al., 1989, Heale and Harley 1990). However, they have not actually
tested the effect ofMK-801 on the induction of LTP in vivo. This seems to be partly
because they cannot test MK-801 in the water maze at the consistent dose range at
which MK-801 has a detectable effect on LTP because of the strong ataxic effect of
MK-801.
The behavioural test in Chapter 3 revealed that the ataxic effect of FR115427
was about 30 to 100 times weaker than that of MK-801. This finding suggests that
FR115427 can be a good substitute for MK-801 to investigate the effect of a non¬
competitive NMDA antagonist on spatial learning and LTP at the same dose range.
The purpose of the investigation in this chapter was:
(1) to find the conditions in which systemically administrated FR115427
blocks the induction of LTP in hippocampus;
(2) to examine whether the effect of FR115427 on LTP is exhibited across a
similar time course to that observed in the behavioural experiments in Chapter 3.
95
The time course of the drug's effect on LTP induction was examined by
modulating the interval between drug administration and the application of tetanus
stimulation. In this experiment, two different intervals (short and long) were
arranged to see whether the effect is an early onset type or late onset type.
The general experimental procedure was described in Chapter 2.
4.2 The effect of FR115427 after various intervals
4.2.1 Method
In order to find the suitable intervals between drug treatment and induction of
LTP for the following experiment, tetanus stimulation of perforant path fibres was
applied 20, 30, 90 and 150 min following i.p. injection of 10 mg/kg dose of
FR115427 (in 0.9 % saline). During electrophysiological recordings, 4 animals of
the 18 animals receiving 10 mg/kg FR injection died. The data from 14 surviving
animals were adopted for analysis (Data were sometimes collected from both
hemispheres of an individual rat).
The extent of potentiation of EPSP was assessed by the increase of EPSP slope
(Fig. 4-1). The increase of slope was expressed by the % increase in the mean slope
at 30 min after tetanus (actually the mean for 5 min between 30 and 35 min after







= the slope of population EPSP
a (raV/ms)
Fig. 4-1
Typical evoked population EPSPs in the dentate gyrus recorded just before and
1 min after tetanus stimulation. Recordings are from from a single rat injected
with saline.
Marked potentiation of the slope of the population epsp (b/a) was observed
after tetanus stimulation. (1) The stimulus artifact, (2) The negative-going
population spike and (3) The positive going epsp are shown
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4.2.2 Results
Fig. 4-2 shows the % increase of epsp slope induced by tetanus applied after
various interval following i.p. injection of 10 mg/kg FR 115427. Although ANOVA
on a percentage change did not indicate significant group effect [F(3,14) = 2.555 p =
0.097], strongest suppression of slope increase was observed 90 min after FR
injection and weakest effect was observed 30 min after FR injection.
4.2.3 Discussion
The comparison of the results between short intervals (20 or 30 min) and long
intervals (90 or 150 min) suggested the late onset effect of FR on LTP. This time
course of drug's effect seemed to be in contrast to the effect on behaviour shown in
Chapter 3. In order to confirm this time dependent manner of the effect on LTP, a
dose-response study was carried out with short interval and long interval. As the
short interval, 30 min was used for the following study because a 30 min interval
allows sufficient time to get a stable baseline of the EPSP slope (the amplitude of
EPSP sometimes fluctuated just after drug administration). In the later water maze
experiments, it is impossible to assess the drug's effect at an exact time point since
one day's training (6 trials) takes more than 10 min for each animal. If there were
not any essential differences between the result of 20 min interval and 30 min
interval LTP experiment, both experiments can be a reference for the water maze
experiment with 20 min interval between drug injection and training. Because the
strongest suppression of slope increase was observed at 90 min, this interval was




Fig. 4-2 Mean (+s.e.m.) % slope epsp after potentiation





Rats were anaesthetised with Urethane (1.5 g/kg i.p.) and placed in a
electrophysiological recording system as described in Chapter 2.
A single i.p. injection of saline (1 ml/kg), MK-801(0.1, 0.32, 1.0 mg/kg) or
FR115427 (1.0, 3.2, 10.0 mg/kg) was made for each animal after 10 min baseline of
recording. Tetanus stimulation was given at either 30 or 90 min intervals after drug
administration. The results with the 30 and 90 min intervals of the pilot experiment
(above) were combined with the results of the 10 mg/kg FR group.
Unfortunately, 5 animals out of 5 which received 1 mg/kg MK-801 died.
Therefore the experiment at this dose was not carried out further. One animal out of
5 that received 0.32 mg/kg MK-801 died. One animal out of 6 which received 3.2
mg/kg FR115427 died As described above, 4 out of 18 died in the 10 mg/kg FR
group. All animals which received 0.1 mg/kg MK-801 or 1 mg/kg FR115427
survived until the end of recording. Only the results from the surviving animals were
used for analysis. In the end, there were 12 different experimental groups in this
experiment (6 different drug treatment for each interval test).
Fig. 4-3 shows an example of EPSP slope recorded every 20 sec in a control
experiment (the values were normalized and averaged). To assess the effects of drug
on baseline, the average slope value between 25 min and 30 min (15 data points)
after drug injection ('pre-tetanus period' in Fig. 4-3) were made and compared to the
average value obtained just prior to drug injection period ('pre-drug period' in Fig.
4-3). To assess the elicited percentage change in EPSP by tetanus stimulation,
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Fig. 4-3 Time plot of epsp slope from saline 30 min group (n=5).
Values were averaged and normalized (pre-drug period = 100)
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after tetanus stimulation were made and compared with the average just before
tetanus stimulation ("pre-tetanus' period).
4.3.2 Results
(a) Drug's effect on baseline
The effect of drug dose on baseline was investigated in 30 min interval
experiments. The absolute value of slope EPSP recorded before the drug treatments
was in the range of 1.9 ~ 5.5 mV/ms. All groups showed a small increase in the
EPSP slope after drug treatment (Fig. 4-4). While an ANOVA of % change across 6
drug groups did not indicate significant group effect [F(5,21) = 1.676 p = 0.184],
one-way within-subjects ANOVA for individual groups, which was carried out to
compare the values before and after (25 ~ 30 min) drug treatment, revealed that MK-
801 induced a significant increase in slope value against pre-drug period at two
doses (MK 0.1 mg/kg group; [F(3,l)= 10.429 p < 0.05], 0.32 mg/kg group;[F(3,l)
= 48.375 p < 0.01]). No significant increase in slope value was detected in saline
and FR groups.
(b) Drug's effect on LTP
The potentiation of slope EPSP induced by tetanus stimulation was suppressed
by FR115427 in a dose and time dependent manner while the effect ofMK-801 was
equivocal at the tested doses (Fig. 4-5).
In order to analyse the time dependency of FR's effect independently, a two-
way between-subjects ANOVA was performed across only FR treated groups. This
analysis revealed a significant effect of interval [F( 1,22) = 11.312 p < 0.01] and
dose [F(2,22) = 11.206 p < 0.001]. The lack of any significant interaction term
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**
(5) (4) (4) (4) (5) (5) = (n)
Saline MKO.l MK 0.32 FR 1.0 FR 3.2 FR 10
Fig. 4-4 % change in baseline of EPSP slope ( mean ± s.e.m.)
25-30 min after drug injection
* : p < 0.05, ** : p < 0.01 before v.s. after drug
treatment (one-way within-subjects ANOVA)
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Effect of FR115427 and MK-801 on LTP induction
mean % change (±s.e.m.) in epsp slope induced by tetanus stimulation 30
min (shaded bars) or 90 min (filled bars) after injection (i.p.)
values are means for 5 min between 30 min and 35 min after tetenus.
*:p<0.05 **:p<0.01
significant difference from corresponding saline control group
(Dunnett multiple comparison test)
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(interval x drug dose) [F(l, 22) < 1], statistically confirms the tendency that 90 min
effect of FR was greater than 30 min effect at all doses. Tukey follow-up
comparisons among groups indicated the effect of 10 mg/kg (showing only 11.0%
LTP) was significantly more potent in suppressing LTP than that of 1 mg/kg (29%
LTP) (p < 0.01) and 3.2 mg/kg (25.2% LTP was induced) (p < 0.01) (This is the
comparison between groups including both 30 min and 90 min because of the
constitution of the two-way analysis : the % figures are the averages of 30 min and
90 min experiments). A comparison between the effect after 30 min interval and 90
min interval confirmed that the effect of FR 90 min after injection (16.2 %
potentiation) was significantly more potent than 30 min after injection (27.3%
potentiation) in suppressing LTP (Tukey p < 0.01).
Following the above two-way analysis indicating that the effect of FR was
time dependent, one-way between-subjects ANOVAs were carried out on the results
of the 30 min interval experiment and the 90 min interval experiments separately,
which allows comparison between control saline group and a drug group.
The ANOVA on the 30 min experimental groups revealed a significant effect
of group [F(5,21) = .719 p < 0.05)]. A Dunnett post hoc comparison indicated a
significant difference between control group (38.1% potentiation) and FR 10 mg/kg
group (16.6% potentiation) (p < 0.05). Therefore 10 mg/kg of FR significantly
reduced LTP by 56.4% (38.1-16.6 / 38.1 x 100 %).
The analysis on the data in 90 min interval experiments revealed a significant
effect of group [F(5,20) = 5.359 p < 0.01], A Dunnett multiple comparison test
indicated a significant difference between control group (35.5% potentiation) and FR
10 mg/kg group (5.4% potentiation) (p<0.01). Therefore 10 mg/kg of FR
significantly reduced LTP by 84.9% (Fig.4-5). Fig. 4-6 shows a plot of the averaged
EPSP slope indicating that induction of LTP was effectively blocked by 10 mg/kg of
FR115427 administered 90 min before tetanus.
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PR115427 10mg/kg 90m In
° f
0 10 20 30/90 100 110 120 130 140
f 60 min f
(min.)
, interval . ,drug (i.p.) tetanus
90 min interval
Fig. 4-6 Time plot of epsp slope from FR 10 mg/kg 90 min group (n=5).
Values were averaged and normalized (pre-drug period = 100)
20 min after the drug injection, 60 min interval was taken then
recording was restarted
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After the ANOVA across groups to analyse the drug dose effect and interval effect, a
separate analysis was carried out on the result of each group to examine the effect of
tetanus stimulation on EPSP slope. A one-way within-subjects ANOVA (slope
value just before tetanus vs. after tetanus) revealed that the tetanus stimulation
induced a significant increase in slope value in all groups except the FR 10 mg/kg 90
min group at the level of p < 0.05 or 0.01. As shown in Fig.4-5 and Fig. 4-6, tetanus
stimulation did not induce a significant change in slope value in the FR 10 mg/kg 90
min group [(F(4,l) = 4.239 p = 0.109], In another words, 10 mg/kg of FR115427




The toxic effects of FR115427 and MK-801 seemed to be synergistic with
urethane, because injection of FR or MK alone had never caused an animal's death
in any other experiment. Single i.p. injection of up to 1 mg/kg MK or 32 mg/kg FR
was not lethal in the Experiment 1 (the open field activity test). Similarly, multiple
injections (5 consecutive daily injections) of up to 0.32 mg/kg ofMK or 10 mg/kg of
FR in the Experiment 4 (the water maze experiment) did not cause death either.
Abraham and Mason.(1988) or Morimoto et al.(1991) did not report any death
caused by i.p. injection of 1 mg/kg or 2 mg/kg of MK-801 in urethane (1.2-1.5 g/kg
i.p.) anaesthetised rat. The difference is possibly due to the difference in strain of
animal; they used male Sprague-Dawley rats instead of Lister hooded rats.
After the injection of FR or MK, no particular pattern of change in the evoked
EPSP was observed and it was always stable until just before the death. The loss of
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the potential was sudden, about 30 to 60 min after drug injection. The mechanism of
this toxicity is not clear.
(b) Effect on the baseline EPSP slope
The 0.1 and 0.32 mg/kg doses ofMK-801 induced a small but significant
increase in slope of EPSPs within 30 min. This change is possibly not caused by a
change in body temperature because rectal temperature was monitored and
maintained at a stable level (± 0.1 °C) throughout the experiment (The body
temperature was initially in the range of 36.1 ~ 36.8°C and the initial temperature
was maintained throughout the experiment). Although a slight increase in slope
EPSP was also observed in some animals which received FR115427, this effect was
not statistically significant. In another published reports, the change in basal EPSP
caused by MK-801 was not significant. Abraham and Mason (1988) reported a
small but non-significant change in slope of the population EPSP in dentate gyrus 30
min after i.p. injection of 0.1 or 0.5 mg/kg of MK-801 (7.8% decrease or 0.7 %
increase respectively). Manfred et al. (1993) reported a small but not significant
decrease (less than 10%) in slope of the population EPSP in the dentate gyrus of
freely moving rats 30 min after i.p. injection of 0.2 mg/kg MK-801. The variance of
the results between the experiments suggested that the slight effect ofMK-801 was
not exhibited by the direct inhibition of neurotransmission in the hippocampus but
by some indirect physiological change such as blood pressure or energy supply,
which could be sensitive to minor modification of experimental conditions across
laboratories. MK-801 (0.3 mg/kg i.v.) induces a much stronger increase in local
cerebral glucose utilisation in limbic system than FR (3 mg/kg i.v.) (personal
communication with Sharkey, J.). This effect may partly explain the stronger effect
of MK-801 on EPSP slope in this experiment.
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In any event, MK-801 and FR115427 did not block or depress synaptic
transmission evoked by low frequency stimulation of the principal afferent fibres.
(c) Effect on LTP
The dose dependent and time dependent effect of FR115427 on LTP was
similar to the effect of MK-801 reported by Abraham and Mason (1988) who found
that LTP was only blocked when the tetanus was given 150 min after 1 mg/kg i.p.
administration. This effect is consistent with the idea that FR115427 acts as a non¬
competitive NMDA receptor antagonist in vivo. The potency of FR's effect on LTP
was about ten times weaker than that of MK-801 reported by Abraham and Mason.
This ratio is roughly consistent with the ratio in the affinity to the MK-801 binding
site (Sherriffs et al., 1993, Hodgkiss et al., 1993) and the therapeutic potency in the
MCA occlusion model (Katsuta et al., 1995). The relative potency of FR115427 in
inhibiting LTP was stronger than that in the induction of the motor syndrome (FR
was found to be 30 to 100 times weaker than MK-801 in Experiment 1). As
discussed in Chapter 3, the enhanced glutamate release during the tetanus
stimulation could increase the potency of FR115427. The relatively strong effect of
FR115427 on LTP in comparison with the motor side effects is an advantage of this
drug as a pharmacological tool.
Although the inhibitory effect of 1 mg/kg MK-801 on LTP could not be
replicated in the present experiment because of toxicity to anaesthetised Lister
hooded rats, Morimoto et al. (1991) confirmed that 1 and 2 mg/kg of MK-801
almost completely blocked LTP of the population EPSP induced 120 min after i.p
administration in anaesthetised SD rats. At the lower dose ofMK-801, neither
Abraham and Mason (0.5 or 0.1 mg/kg) nor the present experiments, could detect
any significant effect on EPSP potentiation.
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The mechanism of enhancement of the effectiveness of peripherally
administered FR115427 and MK-801 in suppressing LTP after long interval (90 to
150 min )is unclear. The "use-dependent" effectiveness of the non-competitive
NMDA antagonists (Church et al, 1987; Kemp et al., 1986) possibly explains this
long latency. According to this idea, the NMDA receptor may be spontaneously
activated in vivo during 90 or 150 min interval allowing FR115427 or MK-801
access to their binding site. In favour of this idea, Abraham and Kairiss (1988)
found AP5 sensitive (NMDA receptor mediated) spontaneous complex spike firing
by CA1 neurons in urethane-anaesthetised animals. However, it is difficult to
examine whether that slow development of LTP inhibition depends on the
spontaneous glutamate release in vivo (Abraham and Mason noted that development
was at least, independent of the stimulus test current). There is a possibility that
FR115427 or MK-801 slowly access their binding site by diffusing in the membrane
lipid other than through the ion channel of the receptor.
In any event, it is interesting that the time course of the effect of FR115427 on
hippocampal LTP (late onset) and on stereotyped behaviour (early onset) had a clear
contrast. Probably, this difference is explained by the difference of the brain region
where those effects are exhibited. FR115427 may act in a variety of kinetics modes
according to a level of extracellular glutamate or a firing rate of neurons or a
distribution of receptor subtypes or unknown factors in the various part of the brain.
The following water maze experiments make the most of the pharmacological
characteristics of FR115427: the clear contrast in the time course between the
behavioural effects and electrophysiological effects. In order to examine whether
any drug effect on learning is related to the effect on hippocampal LTP or another
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behavioural effect, water maze training was carried not only 20 -30 min after drug
administration, but also 90 - 100 min after injection. In order to examine whether
LTP represents the synaptic plasticity associated with spatial memory acquisition, up
to 10 mg/kg of FR115427 was tested in the water maze.
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Chapter 5
Experiment 3: Hippocampal Lesion Study
5.1 Introduction
Before proceeding to examine the effect of FR115427 on spatial learning,
animals with whole hippocampal lesions were tested in the water maze using an
almost identical procedure to that to be reported later using the drug (Chapter 6).
This lesion study examined whether spatial learning (place navigation) in the water
maze is sensitive to damage in the hippocampus. This point is important for the
following discussion about the relationship between the drug's effect on
hippocampal function (LTP) and its effect on spatial learning.
5.2 Methods
(a) Handling and pretraining trials
On the first week, 12 animals received 3 min handling for 3 days and 60 sec x
2 free swimming trials . The temperature of the milky water was adjusted to 25.0 ±
0.5 °C. The purpose of this handling and pretraining is to habituate the animals to
the experimenter's handling and to the water maze environment.
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(b) Lesion surgery
On the next week, 6 of the pretrained animals received bilateral complete
hippocampal lesion surgery and the other 6 animals received sham surgery. The
procedure of hippocampal lesion surgery described by Jarrard (1989) was modified
in this experiment. Hippocampal lesions (HL) were made by 12 injections of
ibotenic acid on each side of the hippocampus. Sham surgery involved inserting the
injection into the overlying cortex only. One or two lesions and another one or two
sham lesioning were carried out each day. It took 5 days to finish the surgery on all
12 animals. Animals were given a period of 16 to 21 days before commencing place
navigation training to obtain substantial cell death in hippocampus and recovery
from the acute effect of surgery.
(c) Place navigation training and transfer test
Three of the sham animals and 3 HL animals were trained to locate the
submerged platform fixed in the NE quadrant and the other 3 sham and 3 HL
animals were trained to locate the submerged platform fixed in the SW quadrant of
the pool. Each animal received 6 trials a day for 4 days (Day 1 ~ Day 4). The
escape latency on each trial was measured and recorded. If the rat failed to find the
platform within 60 sec, it was guided to it by the experimenter (on such occasions,
the escape latency was recorded as 60 sec). As the drugs to be used in the following
experiments are expected to induce hypothermia, the maximum swimming time (60
sec) was shorter than in other reported experiments.
On Day 5, the animals were tested in the transfer test to assess their memory of
the location of the submerged platform. In this test, the escape platform was
removed from the pool and the animals was made to swim for 60 sec. The time
spent in each quadrant of the pool was measured and analysed.
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The temperature of water was kept at 27.0 ± 0.5°C during the training on Day
1. On Day 2 and the following day, the water temperature was kept at 25.0 ± 0.5°C.
This modification of water temperature was made for the same reason as used to set
the maximum swimming time.
(d) Cue navigation training
Immediately following the transfer test, the animals received six trials of
additional training to learn to escape to a visible (cue) platform. This training was
carried out to assess the motor ability and motivation of the animals to escape to the
platform. Escape latency of each trial was measured and analysed.
None of the animals received any drug treatment during above training and
testing in this experiment.
(e) Histology
The following week, animals were injected (i.p.) with a lethal overdose of
Nembutal and transcardially perfused with saline followed by 10 % formalin. At
this point, 3 or 4 weeks had passed since the injection of ibotenic acid into the
hippocampus.
30 pm horizontal sections of brain were stained with fast cresyl violet and
examined microscopically to assess the neuronal loss.
(f) Coordination of time schedule with Experiment 4
In the above schedule, the procedure of training and testing in the water maze
was identical to that to be reported later using FR115427 (Experiment 4) except for
the interval between pretraining trials and the main acquisition training. In this
hippocampal lesion experiment (Experiment 3), there was a 2 ~ 3 week interval, in
contrast to a 3 day interval in Experiment 4. Coordination of this interval can be
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achieved by carrying out pretraining after lesion surgery. However, if the
pretraining was carried out after lesion surgery, the extent of habituation to the
training environment of HL animals may be different from that of sham animals.
This experiment took priority for unification of the condition between sham animals
and HL animals in the acquisition training.
5.3 Results
5.3.1 Histology
The examples of lesioned brain is shown in Fig. 5-1*. The result of the
assessment of cell loss in hippocampus is shown in Table 5-1. About 90 % of the
cells in hippocampus were removed by surgery. In most animals, the entorhinal
cortex was completely left intact and the subiculum was fairly intact. Although
some part of ventral hippocampus in some animals were spared, the network of
whole hippocampus seems to be effectively destroyed because the whole parts
throughout dentate gyrus to CA1 are not spared at any level of hippocampus.
(Although a fair proportion of CA3 or CA1 neuron are spared in the most ventral
level of hippocampus of No.3164, more than 50 % of granule cells in dentate gyrus
were damaged.) Therefore the data of all hippocampal lesioned (HL) animals are
included in the following analysis.
*
next page
Fig.5-1 Photographs of horizontal sections of the brain taken from the rat No. 3163
(sham), No. 3155 (hippocampal lesion) and No. 3164 (hippocampal lesion) 3 or 4
weeks after lesion surgery and stained with fast cresyl violt. The level of the
sections are, at 3.5, 4.0, 5.0 and 7.0 mm ventral to the bregma (according to the atlas








Table 5-1 Histological evaluation of hippocampal lesion (3 or 4 weeks after injection of ibotenic acid)
Rat No.31 52 LEFT RIGHT
horizontaIlevel(Bregma=0) DG CA3 CA1 Sub DG GA3 CA1 Sub
- 3 ~ - 3.5 mm 4-4-4-4- 4-4-4-4- 4-4-4-4- - 4-4-4- 4-4-4-4- 4-4-4-4- -
- 3.5 ~ - 4 mm dorsal 4-4-4- 4-4-4-4- 4-4-4- gggggggjg 4-4-4- 4-4-4-4- 4-4-
- 3.5 ~ - 4 mm ventral 4-4-4-4- 4-4-4-4- 4-4-4-4- - 4-4-4-4- 4-4-4-4- 4-4-4-4- -
- 4 ~- 6 mm 4-4-4-4- 4-4- 4-4- - 4-4-4-4- 4-4-4-4- 4-4-4-4- _
- 6 ~- 8 mm 4-4-4- 4-4- 4-4- - 4-4-4-4- 4-4- 4-4-4- _
Rat No.31 54
horizontallevel(Bregma=0) DG CA3 CA1 Sub DG CA3 CA1 Sub










- 3.5 ~ - 4 mm ventral ++ 4-4-4-4- 4-4-4-4- - 4-4-4-4- 4-4-4-4- 4-4-4- -
- 4 ~- 6mm 4-4- 4-4-4- 4-4-4- - 4-4-4- 4-4-4- 4-4-4-4- _
- 6 ~- 8 mm 4-4-4-4- 4-4- 4-4- - 4-4-4- 4-4- 4-4-4-4- .
Rat No.31 55
horizontallevel(Bregma=0) DG CA3 CA1 Sub DG CA3 CA1 Sub
- 3 ~ - 3.5 mm ++++ 4-4-4-4- 4-4-4-4- 4-4- 4-4-4-4- 4-4- 4-4-4- s
- 3.5 ~ - 4 mm ventral 4-4-4-4- 4-4-4-4- 4-4-4-4- . 4-4-4-4- 4-4-4-4- 4-4-4-4- -
- 4 ~- 6 mm 4-4- 4-4-4- 4-4-4- - 4-4- 1 4-4-4- 4-4-4- -
- 6 ~- 8 mm 4-4-4-4- 4-4- 4-4- 4-4- 4-4-4- 4-4- ++ -
Rat No.31 61
horizontallevel(Bregma=0) DG CA3 CA1 Sub DG CA3 CA1 Sub
- 3 ~ - 3.5 mm 4-4-4-4- 4-4-4- 4-4-4-4- 4-4-4- 4-4-4-4-
J 1 I L
4-4-4-4- "





- 4 ~- 6mm 4-4-4-4- 4-4- 4-4- - 4-4- 4-4-4-4- 4-4-4-4-
- 6 -- 8 mm 4-4-4-4- 4-4- S - 4-4-4- 4-4- 4-4- -
Rat No.31 64
horizontallevel(Bregma=0) DG CA3 CA1 Sub DG CA3 CA1 Sub
- 3 ~ - 3.5 mm 4-4-4-4- 4-4-4-4- 4-4-4-4- s 4-4-4-4- 4-4-4-4- 4-4-4-4- s
- 3.5 ~ - 4 mm dorsal 4-4-4- 4-4-4-4- 4-4-4-4- 4-4-4- 4-4-4-4- 4-4-4-4-
- 3.5 ~ - 4 mm ventral 4-4-4-t- 4-4-4-4- 4-4-4-4- s 4-4-4-4- 4-4-4-4- 4-4-4-4- s
- 4 ~- 6 mm 4-4-4-4- 4-4-4- 4-4- - 4-4-4-4- 4-4-4-4- 4-4-4- -
- 6 ~- 8 mm 4-4- S S - 4-4- S S -
Rat No.31 66
horizontallevel(Bregma=0) DG CA3 CA1 Sub DG CA3 CA1 Sub






4-4- 4-4-4-4- 4-4-4-4- 4-4-4-4- 4-4-
- 3.5 ~ - 4 mm ventral 4-4-4-4- 4-4-4-4- 4-4-4-4- S 4-4-4-4- 4-4-4-4- 4-4-4-4- S
- 4 ~- 6 mm 4-4-4-4- 4-4-4-4- 4-4-4-4- - 4-4-4-4- 4-4-4-4- 4-4-4-4- -
- 6 ~ - 8 mm 4-4-4-4- 4-4- 4-4- - 4-4-4-4- 4-4- 4-4- -
++++ : complete lesion (100-95 % removal of the neurons)
+++ : almost complete lesion (95 - 80 % removal of the neurons)
++ : partial lesion (80 - 20 % removal of the neurons)
s : slight damage ( 20 - 5 % removal of the neurons)
: intact (5 - 0 % removal of the neurons)
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5.3.2 Body weight
In order to avoid having a significant difference in body weight between the
sham group and the HL group during water maze training, assignment of animals
was designed as follow. In the assignment of 12 animals into two groups before
surgery, the heaviest 4 animals were assigned to HL group and the lightest 4 animals
were assigned to sham group. The mean body weight of the two groups was
significantly different from each other before surgery (p < 0.05 and the results of
statistical calculations are shown in Table 5-2 and 5-3). As the mean body weight of
HL group was slightly decreased 1 week following the last surgery (Fig. 5-2), there
was no statistical difference in body weight between two groups just before the
acquisition training (2 weeks following surgery).
5.3.3 Place navigation training (Day 1 - Day 4)
None of the animals had any difficulty or disturbance in their motor ability to
perform place navigation task, e.g. swimming around the pool or climbing onto the
platform.
The sham and HL groups showed a progressive decline in escape latency
across trials (Fig. 5-3) and with days (Fig. 5-4). Although the progress in acquisition
in the HL group was a little slower than that of sham group (see performance of HL
group on Day 2 in Fig. 5-4), the ANOVA of mean escape latency for trial (Table 5-
4) or for day (Table 5-5) revealed no significant difference between groups, in
addition, the latency of both groups reached a similar asymptotic level by the end of




Before 1 week after 2 weeks after
surgery last surgery surgery
*:p<0.05 vs Sham (t-Test)
Fig. 5 -2 Change in body weight of animals
Table 5-2 ANO\A of body weight
source of df sum of mean F P
variation squares suqare
Group 1 3287.111 3287.111 3.107 0.1085
Error 10 10581.222 1058.122
Day 2 2258.000 1129.000 59.982 0.0000
Group X Day 2 248.222 124.111 6.594 0.0063
Error 20 376.444 18.822
Table 5-3 T-Test for body weight
Sham group vs Hippocampal lesioned group
Dav of measurement Before sureerv 1 week after sureerv 2 weeks after sureerv
t value 2.6167 1.2944 1.4022
degree of freedom 10 10 10
two-tailed P value 0.0257 * 0.2246 0.1911
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Fig. 5-3 Mean (+ or - s.e.m.) escape latencies for each trials.




















Day 1 Day 2 Day 3 Day 4
Fig. 5 -4 Mean (± s.e.m.) escape latencies for each training day
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Table 5-4 Analysis of performance in place navigation training
ANOVA of the mean escape latencies for each trial
Group: 2 groups (sham group, hippocampal lesion group) Trial: 24 trials
source of degree of sum of mean F P
variation freedom squares suqare
Group 1 957.396 957.396 0.849 0.3784
Error 10 11271.857 1127.186
Trial 23 37279.732 1620.858 4.955 0.0000
Group x Trial 23 4641.048 201.785 0.617 0.9152
Error 230 75230.082 327.087
Table 5-5 Analysis of performance in place navigation training
ANOVA of the mean escape latencies for each day
Group: 2 groups (sham group, hippocampal lesion group) Day: 4 days
source of degree of sum of mean F P
variation freedom squares suqare
Group 1 159.505 159.505 0.849 0.3785
Error 10 1878.777 187.878
Day 3 4389.857 1463.286 19.361 0.0000
Group X Day 3 234.697 78.232 1.035 0.3912
Error 30 2267.368 75.579
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The swimming speed of both groups during place navigation training is
compared in Fig. 5-7 (This graph also shows the swimming speed on trials on Day 5
which will be commented on in later sections). An ANOVA of swimming speed
(Table 5-8) revealed a significant group effect (p < 0.01) and significant reduction of
speed across days (Day effect in Table 5-8 p < 0.05 ) but no significant group by
day interaction. T-test comparing the mean swimming speed for 4 days training
showed that a significantly higher speed of HL group than sham group (p < 0.01). If
the swimming speed is compared day by day, t-test revealed a significant difference
between groups on Day 1 (p < 0.01), Day 2 (p < 0.01) and Day 3 (p < 0.05) (see
Fig.5-7 and Table 5-8). As the escape latency was not statistically different, the HL
group swam a longer distance to find the platform on these days.
The swimming speed of HL group on Day 4 was not statistically different from
that of sham group. However, a close observation of animal behaviour found a
slight difference in their performance. A sham animal swam directly towards the
platform on one or two of the 6 trials on Day 4 (total 10 trials out of 36). In other
trials they swam towards the platform with a zig zag pattern or swam straight to the
vicinity of the platform and made a small search to find it. Examples of animal
performance during place navigation training is shown in Fig. 5-8. This behaviour
may indicate that they had to rely on both an inaccurate spatial memory of platform
location and a random searching skill. Their strategy on Day 4 was not developed in
comparison with that on Day 3. The HL animals swam directly to the platform in
only 6 trials out of total 36 trials on Day 4. They mostly used a circular search
strategy in which two dimensional spatial memory was not necessary. This
difference of performance between sham group and HL group in the final stage of







\ ° A-r J
chance level
A-l P A-r O
Lesioned
Fig. 5-5 Mean (±s.e.m.) time spent in each Quadrant during 60 sec transfer test.
(P: quadrant where the escape platformwas located during trainig,
A-l, A-r : quadrant ajacent to P, O: quadrant opposit to P )
* : p < 0.05 P vs O quadrant (Tukey multiple comparison test following ANOVA of
time spent in each quadrant, see Table 5-6 )
f : p < 0.05 hippocampal lesion vs sham (T-test of time spent in P quadrant t = 2.283 )
Cue training
Sham Lesioned
Fig. 5-6 Mean (± s.e.m.) escape latency in the cue trainig
Unpaired t test: t=0.0941 The tow tailed P value is 0.9269 The
difference between twp groups is not significant
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Table 5-6 Performance of Sham animals in transfer test
Repeated measures ANOVA of time spent in each of 4 quadrants
source of degree of sum of mean F P
variation freedom squares suqare
Quadrants (3) 928.77 309.59 19.157 0.0031**
Subjects 5 0.0071 0.0014
Error (15) 637.81 42.521
Repeated measures ANOVA of time spent in each of 3 quadrants
source of degree of sum of mean F P
variation freedom squares suqare
Quadrants 2 821.95 410.98 6.7809 0.0138*
Subjects 5 7.7244 1.5449
Error 10 606.08 60.608
Tukey Multiple comparison test following the above ANOVA
Comparison P value (4 quadrants) P value (3 quadrants)
P quadrant vs A-l p< 0.05* p < 0.05 *
P quadrant vs O p < 0.01 ** p < 0.05 *
P quadrant vs Ar p < 0.01 **
o quadrant vs A-l p > 0.05 p > 0.05
p > 0.05
A-l quadrant vs A-r p > 0.05
Table 5-7 Performance of Lesioned animals in transfer test
Repeated measures ANOVA of time spent in each 4 quadrant
source of degree of sum of mean F P
variation freedom squares suqare
Quadrants (3) 71.828 23.943 2.4270 0.1059
Subjects 5 0.0071 0.0014
Error (15) 147.97 9.865
Repeated measures ANOVA of time spent in each 3 quadrant
source of degree of sum of mean F P
variation freedom squares suqare
Quadrants 2 45.788 22.894 1.8740 0.2036
Subjects 5 6.4561 1.2912
Error 10 122.17 12.217
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Swimming speed
Day 1 Day 2 Day 3 Day 4
Place navigation training
Fig. 5-7 Mean (± s.e.m.) swimming speed during each training or testing.
Transfer Cue
Test training
*** : p < 0.0001 vs Sham
** : p < 0.01 vs Sham
* : p < 0.01 vs Sham (t-test)
Table 5-8 Analysis of swimming speed
ANOVA of the swimming speed dring place navigation training
source of degree of sum of mean F P
variation freedom squares suqare
Group 1 0.019 0.019 15.738 0.0027**
Error 10 0.012 0.001
Day 3 0.012 0.004 4.03 0.0160*
Group X Day 3 0.003 0.001 0.97 0.4198
Error 30 0.029 0.001
T-test Sham vs Hippocampal lesion
Dayl (p < 0.01) ; Day 2 (p < 0.01) ; Day 3 (p < 0.05) ; Day 4 (p = 0.59)
Unpaired t-test of swimming speed in Transfer test
Mean difference = 0.0783
t = 6.4559 with 10 degree of freedom
The two-tailed P < 0.0001***
Unpaired t-test of swimming speed in Cue training
Mean difference = 0.0083
t = 0.4235 with 10 degree of freedom
The two-tailed P = 0.6809
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performance of sham animal
on Day 4
The example that took long
time to find platform because




zig zag searching pattern
performance of HL animal
on Day 4
3154-23
performance of sham animal
on Day 4
Fig. 5~8 Examples of performance in the place navigation training
large circle: pool
medium circle: position of hidden platform
small circle: start point
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performance of sham animal performance of sham animal
proper bias to NE quadrant but
did not reach exact point
3164-25
performance of HL annual
3153-25
no swimming bias
but reached the exact point
immediately
Fig. 5-9 Examples of performance in the transfer test
large circle: pool
medium circle: position where the platform had been located during training
small circle: start point
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Although all rats usually stayed on the platform for 30 sec after climbing onto
it at the end of each trial, some rats dived into the water or jumped up and fell in
water before 30 sec had elapsed. In that case, the rats were brought back onto the
platform by the experimenter and made to stay on it for 30 sec to ensure they had
enough time to see the extra maze cue from the platform. In the training of sham
group, such incidents took place in 21 trials out of a total of 144 trials (total 6 trials x
4 days x 6 animals). In the training of HL group, such incidents took place in 12
trials out of 144 trials. Fisher's exact test revealed that there is not a significant
association between number of incidents and groups (p = 0.138).
5.3.4 Transfer Test
Examples of performance of both groups of animals in the transfer test is
shown in Fig. 5-9
The mean time spent in each quadrant of the pool during 60 sec test swimming
is shown in Fig. 5-5. While the sham rats stayed for longer time in the 'P quadrant'
in which the platform had been located during training trials than in any other
quadrants, HL rats did not show such swimming bias during 60 sec test period. In
order to assess the rat's memory of the platform location, the mean time spent in the
'P quadrant' was compared to the time spent in other quadrants. As total time spent
in all 4 quadrants was fixed at 60 sec (i.e. the data of all 4 quadrants are not
completely independent each other), mean time spent in 3 quadrants out of 4 was
analysed.
Repeated measures (one-way within subjects) ANOVA of sham group (Table
5-6) revealed a significant difference between quadrants [F = 6.78, p < 0.05],
Further analysis using Tukey multiple comparison test showed that the time spent in
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the P quadrant is significantly longer than the time spent in the opposite side
quadrant (O) or one of the adjacent quadrant (A-l) (p < 0.05, Table 5-6). On the
other hand, ANOVA ofHL group did not show any significant effect of quadrant (p
= 0.2036, Table 5-7).
Since the result of 3 quadrants analysis is variable according to the
combination of selected quadrants, analyses of 4 quadrants are also shown in Tables
5-6 and 5-7 for reference. The results of 4 quadrants analysis are shown to be
basically similar to those of 3 quadrants analysis.
Therefore, there is a striking contrast between the performance of the sham
group and that of the HL group. While sham group remembered the position of the
platform and searched significantly longer time in the P quadrant, HL group did not
show a swimming pattern to search in a particular quadrant.
In addition to the above within-subjects analysis, a significant difference of the
performance between sham group and HL group in the transfer test is also revealed
by the comparison between groups. T-test of the mean time spent in P quadrant
revealed that sham group stayed for significantly longer time (25.8 ±3.4 sec ) in P
quadrant than HL group (17.7 ± 0.9 sec) (t = 2.283 P < 0.05 Fig. 5-5). T-test of
swimming speed revealed that HL group significantly swam faster than sham group
(p< 0.0001) (Table 5-8).
5.3.5 Cue navigation training (Day 5)
The mean escape latency in the cue training is shown in Fig. 5-6. T-test
revealed no significant difference between sham and HL group. The mean




If there were any intra- or extra-maze objects that guided animals to or drove
animals away from a particular location in the pool, they could inhibit acquisition of
spatial location. In order to check the uniformity of the maze environment, the
performance of the rats trained with the platform in different locations was
compared.
Three of sham animals and three of HL animals were trained with the platform
located in the NE quadrant during place navigation training (NE group). The other
three sham animals and three HL animals were trained with the platform located in
the SW quadrant (SW group).
The escape latency in the place navigation training and cue navigation training
is compared in Fig.5-10 (A). An ANOVA of escape latency in place navigation
training shows no significant group effect [F(l, 10) = 0.077 p = 0.78], a significant
day effect [F(3,30) = 20.43 p < 0.0001] and no significant interaction between group
and day [F(3,30) = 0.78 p = 0.510]. T-test of escape latency in cue navigation
training shows the difference between two groups is not significant [t = 0.227 p =
0.82],
Swimming speed was also compared (Fig.5-10 (B)). An ANOVA of
swimming speed during place navigation training revealed no significant group
effect [F(l, 10) =1.47 p = 0.25], a significant day effect [F(3,30) = 4.357 p < 0.05]
and no significant group by day interaction [F(3,30) = 1.86 p = 0.16], T-tests of
swimming speed in the transfer test and in the cue navigation training did not
indicate significant difference between groups (t = 0.946 p = 0.366 or t= 1.163 p =






NE group vs SW group











Fig. 5-10 Comparison of performance between NE group and SW group.
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5.4 Discussion
The results of the transfer test demonstrated that the hippocampal lesioned
animals did not acquire the memory of the platform after 4 days place navigation
training while sham animals acquired. This impairment of learning in HL animals is
considered to be due to the lack of ability for memory acquisition, rather than to a
delayed acquisition process because the escape latency of both groups reached an
asymptote on Day 4 and further improvement or progress could hardly be expected.
The learning deficit of HL animals in the present experiment revealed by the
transfer test is consistent with the deficit of hippocampal lesion animals reported by
Morris et al. (1982) and AP5 treated animals reported by Morris (1989), and Davis et
al. (1992). All these results suggested that the place navigation learning in the water
maze task is sensitive to the damage in hippocampal function.
However, the above cited experiments showed learning deficit of hippocampal
lesion or AP5 animals not only by the poor swimming bias in the transfer test but
also by,
(1) a significantly longer escape latency in the early stage of place navigation
training
(2) a higher asymptote level of escape latency in the last stage of training.
In the present results, on the other hand,
(1') HL group showed a little but not significantly longer escape latency than
sham group.
(2') The escape latency of HL group and sham group reached a similar
asymptotic level by the end of training.
The present experiment set the time limit for each trial at 60 sec while in the
other reported experiments it was set at 120 sec. In the 120 sec experiment, the
performance of poor learners increases the mean escape latency much greater than in
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the 60 sec experiment. In order to check the effect of the shorter maximum time on
the results, the raw data was transformed by changing all escape latencies of 60 sec
to 120 sec and recalculated. For example, the mean (± s.e.m.) escape latency of
sham group on Day 2: 22.61(±4.31) sec was changed to 27.61(±7.35) sec while that
of HL group: 33.73(±4.73) sec was changed to 53.73(±12.37) sec. However,
ANOVA of transformed escape latency still showed no significant group effect [F(l,
10) = 0.78 p = 0.397] nor a significant group by day interaction [F(3, 30) = 1.78 p =
0.172], (Group x trial ANOVA also showed no group effect). Thus, the shorter
maximum latency docs not seem to mask the poor performance of HL group.
Although the analysis of escape latency did not detect the difference between
groups, the analysis of swimming speed revealed a significant difference between
sham and HL group. The HL group swam significantly faster than sham group on
Days 1, 2 and 3. It means that the HL group found the platform after a search with
longer distance than the sham group. Therefore, performance of HL animals in the
present experiment was poorer than that of sham group at an early stage of training.
From a standpoint of escape efficiency, the difference between (1) and (1') may not
be fundamental. However, on Day 4 (the last day of training) the performance of
sham and HL animals reached the same level and there is no measurable difference
even using the above measure (2'). On the other hand, a clear contrast was revealed
between the performance of sham and HL animals in the transfer test which showed
that the sham animals obviously acquired some information about the platform
position. Therefore it is explained that the spatial memory of sham animals was not
precise enough to find the platform quicker than the HL animals searching the pool
randomly. In addition, it seems that the sham animals did not feel the necessity to
improve their performance further on Day 4. While the control animals in the other
published study are reported to take a direct path to the platform and the mean
escape latency is about 10 sec on the last day of training, the sham rats in the present
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experiment did not always take direct paths and took about 20 sec to find the
platform in the pool of the same size. That 20 sec latency is also found to be too
long for direct escape behaviour by the fact that the escape latency was only about 5
second in the cue navigation training in Experiment 3. This evidence shows that the
result (2') is caused by the poor performance of sham animals rather than the
exceptionally better performance of HL animals.
The possible cause for the poor performance of the sham group is the
modification of the water temperature and the maximum swimming time for each
trial in the Experiment 3. These modification were made in the attempt to reduce
stress on the first day on which sometimes makes rats refuse to take normal and
effective escape behaviour (e.g. swim round and round keeping close to the side wall
and never try to seek escape in the central area). However, the reduction in stress
level in training is also considered to have an adverse effect on the motivation to
make a precise quick escape. As reported by McNaughtom and Morris (1987b) or
McNamara and Skelton (1991), treatment with anxiolytic drugs or an increase of
water temperature impairs spatial learning in the water maze probably by
suppressing motivation to escape from water. In order to cope with this problem,
the modification was mainly targeted only to the procedure on the first day of place
navigation training in the Experiment 3. The water temperature was raised only on
Day 1 (2°C higher than the standard experiments). The rescue of rats after 60 sec
limit was mainly carried out on Day 1 because the rat escaped within 60 sec on most
of the trials of following days (e.g. sham rats failed to escape within 60 sec on only 3
trials out of 36 on Day 2). It is amazing this slight modification on Day 1 had effect
on the final performance.
Although the spatial memory acquired by sham group may not be precise
enough to show clearly more effective escape than that of HL group in the final day
of training, the acquisition of that memory itself and its dependence on the
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hippocampal function was demonstrated by the clear contrast in the acquisition of
swimming bias in the transfer test between sham group and HL group.
Therefore, this learning model is still considered to be useful to evaluate drug's
effect on the animal's ability of spatial memory acquisition which is dependent on
hippocampal function. We should keep in mind that the higher efficiency of finding
the escape platform (shorter escape latency) does not necessarily represent the
acquisition of spatial memory of platform location in this experimental condition.
The spatial memory is only represented by the searching bias in the transfer test.
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Chapter 6
Experiment 4: Water Maze study (1)
Experiment 5: Water Maze study (2)
Experiment 6: In vivo LTP study (2)
This chapter discusses two water maze experiments and a supplementary LTP
experiment. Experiment 4 is an investigation of the dose and time dependence of the
effect of FR115427 and MK-801 on spatial learning. Experiment 5 involves a
modified pre-training procedure and changed water temperature. Experiment 6 was
conducted in the same animals that were tested in the water maze to examine the effect
of repetitive injection of FR115427.
6.1 Experiment 4
6.1.1 Introduction
The preceding investigations of the effect of FR115427 on open field activity
and LTP showed that the MK-801 like motor syndrome and inhibitory effect on LTP
were exhibited according to different time courses. The former was a quick onset
effect and the latter a late onset effect.
The main purpose of the studies of this chapter are to investigate: (1) whether
FR115427 has any effect on spatial learning; and (2) establish whether it is the early
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onset type or the late onset type because the time course is expected to be a key to
understanding the mechanism of any learning effect of the drug. Accordingly, some
groups were given a short interval (20 min) between drug administration and training
in the water maze, others a long interval (90 min), both being carried out in parallel
and the results compared. In addition to saline control groups, MK-801 groups were
also tested as a reference to compare the results with that of the other reported water
maze experiments using MK-801 discussed in Chapter 1.
6.1.2 Methods
(a) Assignment of drug dosage
MK-801 was tested at two doses 0.1 and 0.032 mg/kg. The top dose, 0.1
mg/kg, is the maximum dose at which no significant ataxic effect was observed in
Experiment 1 (Chapter 3) and significant impairments of learning in the water maze
have previously been obtained (Chapter 1 Table 1-1). The second dose is lower than
that at which impairments of learning was reported. FR115427 was tested at 4 doses
10, 3.2, 1.0 and 0.32 mg/kg. The 10 mg/kg is the maximum dose at which
significant ataxic effect was not detected in the Experiment 1. At this dose, FR115427
blocked LTP in Experiment 3. The lower doses 3.2, 1.0 and 0.32 mg/kg are
approximately equivalent to 0.1, or 0.032 mg/kg ofMK-801 as an NMDA receptor
antagonist. Thus, there were 7 different drug groups including the saline group.
Using both the short and long intervals between injection and training making a total
of 14 different groups in the experiment.
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(b) Assignment of animals
This experiment was run in replicates each consisting of 7 or 8 animals. Each
animal was randomly assigned to one of 14 different experimental groups as shown in
Table 6-1. As 6 animals were finally allocated to each group, a total of 84 animals
were used in Experiment 4.
(c) The procedure for training and testing
Each replicate in Experiment 4 exactly followed the schedule shown in Fig.2-3
(Chapter 2) All rats received handling and pretraining trials (2 trials)in the first week.
In the 2nd week, animals had place navigation training for 4 days (Day 1 ~ Day 4, 6
trials per day). The position of the submerged platform was fixed at one location for
each animal. As shown in Table 6-1, 38 out of 84 animals were trained to locate the
platform in the NE quadrant and the rest of the animals were trained to locate the
platform in SW quadrant. About 24 hours after the last training (on Day 5), the
animals received a single transfer test followed by cue navigation training (6 trials).
Drugs were administered 20 min or 90 min before the commencement of training or
test of each day. The water temperature was kept at 25.0 ± 0.5°C except on Day 1 on
which the temperature was kept at 27.0 ± 0.5 °C.
(d) Trials that rats refused to escape onto the platform
Some animals, especially some in the high drug dose groups, were so anxious
or nervous that they showed no intention of escaping onto the submerged platform and
stayed close to the side walls of the pool during training even on Day 4. In the worse
case, the rats did not stay voluntarily on the platform when the experimenter placed
them on the platform after 60 sec time limit of each trial. They jumped up to the side
wall or dived into the water and swam away from the platform. In such cases, the rats
were picked up again and returned to the platform and, if necessary, restrained there
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Table 6-1 Assignment of Animals in each replicate of Experiment 4
The same procedure of training and testing was repeated 11 times.







20 min 90 min
Saline MKO. MK FR FR FR FR
032 0.1 0.32 1.0 3.2 10
Saline MKO. MK FR FR FR FR
032 0.1 0.32 1.0 3.2 10
1 1,1 2 1 1 1 1 sw
2 1 1 1 1 1 2 sw
3 1 1 11 2 1 1 NE
4 1 1 11 1 1 11 NE
5 11 11 2 1 1 SW
6 111 1 11 11 sw
7 111 1 1 1 1 NE
8 1 1 1 11111 NE
9 1 111 11 1 1 SW
10 1 11 1 1 1 1 sw
11 1 1 1 1 11 1 NE
Total No
of animals
6 6 6 6 6 6 6 6 6 6 6 6 6 6
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by hand for 30 sec to secure sufficient time for them to see the spatial relationship
between the platform and the extra maze cues.
Training trials on which an animal did not stay voluntarily on the platform for 30
sec were recorded as 'refused trials'. The rats which showed normal escape
behaviour also sometimes dived into the water before 30 sec had elapsed and looked
for another possible escape. Such trials were also counted as 'refused trials' although
they actually did not refuse to escape to the platform. Fisher's exact test was applied
to compare the numbers of refused trial between two groups. As each group (N = 6)
had 144 trials (6 trials x 4 days x N), the numbers of each incident were expressed as
a proportion of the total 288 trials (144 x 2 groups) in the 2 x 2 test table.
6.1.3 Results of Experiment 4
20 min interval groups
(a) Place navigation training
Fig. 6-1 (page 150) shows the mean (± s.e.m.) escape latencies for each group
over 4 days training. In order to avoid making the figure complicated, the results of
MK-801 groups and FR115427 groups are shown in separate graphs. The results of
the saline group is shown in both graphs of the figure as a reference to compare. All
groups except FR 10 mg/kg group showed a progressive decline in escape latency
across days. The performance of FR 10 mg/kg became worse on Day 2 and could not
catch up with the level of the other groups by Day 4. One-way between and one-way
within-subjects ANOVA of escape latencies revealed a significant main effect of group
[F(6,35) = 4.15 p < 0.01] and day [F(3,105) = 64.545 p< 0.001]. The significant
interaction term (group x day) [F(18,105) = 2.01 p < 0.05] allows analysis of
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performance on each day. ANOVA of escape latency on Day 2 and on Day 3 revealed
significant group effects [F(6, 35) = 5.52 p < 0.001, F(6, 35) = 6.99 p<0.0001
respectively]. The following Dunnett multiple comparison test revealed that only the
performance of FR 10 mg/kg was significantly different from that of saline group on
Day 2 (p < 0.01) and on Day 3 (p < 0.01). While the escape latency of MK-801 was
slightly longer than that of the saline group throughout the 4 days training, the
difference was not statistically significant.
The animals receiving FR 10 mg/kg showed a strong aversion to the water.
They frequently vocalized and refused to stay on the submerged platform at the end of
trials. As shown in Fig.6-6 (A) (page 155), the count of 'refused' trials reached a
total of 61. Fisher's exact test (2x2) revealed that this number of incidents was
significantly greater than the number of incidents observed in the saline group (p <
0.0001). Other groups did not show significantly higher incidents than the saline
group.
No notable disturbance of swimming was observed in any group. Swimming
speed during training is shown in Fig.6-5 (page 154). Although the swimming speed
ofMK 0.1 mg/kg group was slightly lower and the speed of FR 1 mg/kg group was
slightly higher than other groups, one-way between and one-way within-subjects
ANOVA on swimming speed during place navigation training showed no significant
group differences [F(6,35) = 1.73 p = 0.14], The main effect of day was significant
[F(3,105) = 12.14 p < 0.001], and the interaction term (group x day) was not
significant [F(18,105) = 0.970 p = 0.50], This results reflects the tendency of all
groups to decrease swimming speed in the latter phase of training (on Day 3 or Day 4)
as they become more careful in their approach to the platform.
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(b) Transfer test
Fig. 6-3 (A) (page 152) shows mean (+ s.e.m.) time spent in each quadrant
during 60 sec transfer test. All groups, except the FR 10 mg/kg group showed a
proper bias of swimming to the 'P quadrant' in which the escape platform had been
located during training. As previously described in Chapter 5, repeated measures
(one-way between subjects) ANOVA of time spent in 3 (P, A1 and O) out of 4
quadrants was applied to the performance of each group to examine whether the above
bias is statistically significant. The degrees of freedom of quadrant, subjects and
residual error measure was 2, 5 and 10 respectively in each analysis. The ANOVA of
all groups except FR 10 mg/kg group revealed a significant quadrant effect (p < 0.001
~ p < 0.05 see Fig. 6-3 (A))(page 152). Tukey multiple comparison test confirmed
that the time spent in P quadrant was significantly longer than that in the O quadrant or
A1 quadrant ( p < 0.001 ~ 0.05) in all groups except FR 10 mg/kg group. The results
of ANOVA in FR 10 mg/kg (20 min interval) group was that F = 1.07 p = 0.38.
This group failed to acquire the memory of platform location after 4 days training.
The swimming speed of each group during transfer test is shown in Fig. 6-5(A)
(page 154). ANOVA of swimming speed of 20 min groups did not detect any
significant group differences [F(6,35) = 0.86 p=0.53].
(c) Cue navigation training
The mean (+ s.e.m.) escape latencies during 6 trials of cue navigation training
are shown in Fig. 6-4 (A) (page 153). The escape latency of saline group was a little
longer than the other groups because some of the saline animals still searched for the
hidden platform during cue navigation trials. The difference between groups was not
statistically significant according to the ANOVA (the main group effect;
[F(6,35)= 1.167 p=0.172]). There were no 'refused' trials in this cue training.
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Mean (± s.e.m.) swimming speed of each group during this training is given in
the Fig.6-5(A) (page 154). Analysis of swimming speed did not indicate a significant
group effect either [F(6,35) = 0.76 p = 0.61].
90 min interval groups
(d) Place navigation training
The mean (± s.e.m.) escape latencies are shown in Fig.6-2 (page 151).
Although progressive decline of escape latency was observed in all groups, MK 0.1
mg/kg and FR 10 mg/kg group showed notably longer escape latencies. A one-way
between and one-way within subjects ANOVA indicated a significant main effect of
group [F(6,35) = 2.38 p = 0.049]. Because this significance was marginal, Tukey
pairwise comparisons did not show any significant difference between any
combination of groups. Only a Duncan's analysis detected significant differences (p<
0.05) between the saline group and the MK-801 0.1 mg/kg group, and between the
saline and the FR 10 mg/kg group. The above ANOVA also detected a significant
effect of day [F(3,105) = 44.97 p < 0.0001]. The interaction term (group x day) was
not significant [F(18,105) = 0.74 p = 0.76] these effects reflected the uniform
tendency of decreased latency by day in all the groups.
Some of the rats in MK 0.1 mg/kg and FR 10 mg/kg groups showed anxious
behaviour like vocalization, swimming at the perimeter of the side walls and refusal to
stay on the submerged platform. The incident of 'refused' trial observed in these
groups was significantly higher than saline group (both p <0.0001 Fisher's exact test)
(Fig. 6-6 B) (page 155). However, the number of incidents in FR 10 mg/kg 90 min
interval group was significantly smaller than that of FR 10 mg/kg 20 min interval
group (p < 0.05). This smaller number of incidents in the 90 min group agreed with
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the better performance of this group than the 20 min group in training trials. In
contrast to the FR groups, the number of 'refused' trials was larger in the MK 0.1
mg/kg 90 min than that in the 20 min group. Fisher's exact test between MK 0.1
mg/kg 90 min and 20 min group revealed a significant difference (p <0.0001).
A one-way between and within subjects ANOVA on swimming speed (Fig.6-5-
B) (page 154) indicated a significant main effect of group [F(6,35) = 2.41 p < 0.05]
and a significant main effect of day [F(3,105) = 6.06 p < 0.001]. The interaction
between group and day was not significant [F( 18,105) = 0.87 p = 0.61]. Subsequent
post hoc Tukey or other comparison tests did not show any significant difference
between saline group and other groups. The group effect was mainly due to the
difference between the fast swimming FR 1 mg/kg group and slow swimming MK
0.1 mg/kg group.
(e) Transfer test
Fig. 6-3 (B) (page 152) summarises the performance of 7 groups during the
transfer test. Although some groups showed a poor performance during place
navigation training, all groups showed a proper searching bias to the platform
quadrant. A significant quadrant effect was detected in all groups by repeated
measures (one-way between subjects) ANOVAs of time spent in 3 (P, A1 and O)
quadrants (p<0.05 ~ 0.001 see Fig. 6-3 B) (page 152). Tukey post hoc test among
quadrants confirmed that the time spent in Training quadrant was significantly longer
than the time spent in O quadrant or A1 quadrant (p<0.05 ~ p < 0.001).
Analysis of the swimming speed in the transfer test revealed a significant group
effect [F(6,35) = 3.558 p < 0.01] (Fig. 6-5 B) (page 154). However, following
Dunnett multiple comparison test did not detect any significant difference between
saline group and other groups. Tukey multiple comparisons among all combinations
of groups revealed the significant group effect was due to a difference between fast
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swimming FR 1 mg/kg group and slow swimming MK-801 0.1 mg/kg or FR 10
mg/kg group (p<0.05).
(f) Cue navigation training
Analysis of escape latency during cue navigation training indicated no significant
group effect [F(6,35) = 0.63 p = 0.71] (Fig.6-4 B) (page 153).
There were no significant difference in swimming speed among groups
[F(6,35)=1.416 p=0.236] (see Fig.6-5B) and no 'refused' trials were observed
during this cue training.
6.1.4 Discussion of Experiment 4
The main points in the results of Experiment 4 are:
(1) The FR115427 10 mg/kg group in the 20 min interval experiment failed to
learn the platform location which should be expressed by a significant swimming bias
to the platform quadrant in the transfer test.
(2) The FR115427 10 mg/kg group in the 90 min interval experiment did learn
the platform location which was expressed as a significant swimming bias to the
platform quadrant in the transfer test.
(3) The MK-801 0.1 mg/kg group learn the platform location in both the 20 min
and the 90 min interval experiments.
(a) FR 10 mg/kg group in 20 min interval experiment.
FRIOmg/kg, 20min group had place navigation training in a post-injection time
interval at which LTP was partially inhibited but not completely blocked. Therefore,
the severe learning deficit of this group could be a starting point of the argument that
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the effect of non-competitive NMDA receptor antagonist on learning is nothing to do
with the effect on LTP in the hippocampus. As the hippocampal lesion represents a
complete loss of hippocampal plasticity, the learning deficit of the hippocampal lesion
(HL) animals in Experiment 3 is compared to the performance of FRIOmg/kg, 20min
group in the first part of this discussion.
Although both the FRIOmg/kg, 20min group and the HL group failed to acquire
a significant swimming bias to P quadrant in the transfer test, some different points
were observed between the performances of FRIOmg/kg, 20min animals and HL
animals. While the inefficiency of escape performance of HL animals (which
completely lost hippocampal function) was only marginally detected by a slight
increase in swimming path, the performance of FRIOmg/kg, 20min was significantly
and apparently deteriorated in comparison with that of the control group. The
noticeable point of the performance of the FRIOmg/kg, 20min group is that the escape
latency was increased on Day 2 rather than decreased compared to on Day 1. These
observation suggests that the drug not only negatively restrained the learning process
but also positively deteriorated the learning performance. Furthermore, unlike in the
HL group, there was a significant increase in the number of 'refuse' trial in the
FRIOmg/kg, 20min group. FRIOmg/kg, 20min rats seemed to be strongly stressed
and lost a regard of the submerged platform as a secure enough place to escape.
A loss of motivation to escape to the platform should be detected by a poor
performance in training with the 'cue' platform which requires a similar behaviour but
not the spatial memory. However, if the loss ofmotivation was caused by a rejection
of the submerged platform itself as an safe refuge, the cue platform may not be a good
control for test motivation because it protrudes above the water and enables the rats to
get out from it completely, hi addition, the cue navigation training is carried out after
4 days training by which time the rats possibly had learned to overcome their fear of
the water. Thus the normal performance in the cue navigation training does not
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guarantee the normal motivation level of animals during place navigation training. A
training schedule started with cue raining and/or use of visible-submerged platform
would seem to be required. In short, a difference of the regard for the escape platform
between FR animals and HL animals is suggested by their escape behaviour.
The other difference between HL animals and FR animals was that HL animals
received the transfer test after their performance in acquisition training reached an
asymptote level whilst FR animals had still showed an improvement in their
performance on the last day of training. There is a possibility that the learning of FR
animals are just delayed but not blocked. Although a test with an extension of the
training period seems to be an effective method to examine that point, there is a
possibility that too much training can transform the nature of the learning in the water
maze. Morris et al., (1990b) reported that the spatial learning deficit of the
hippocampal lesion animals was eventually abolished after overtraining (rats received
76 trials training over 11 days) in the water maze. As discussed in Chapter 1, the
animal with damage in the hippocampal system can identify and memorise a particular
location in the pool after special training. (According to my idea, such learning can be
achieved by utilizing the extramaze cues as a 'taxon' cue rather than by acquiring a
'spatial map'.) As it is difficult to define what extent of training is over training, and
what level of performance is the asymptote performance, we have to decide whether
the learning is "impaired" or "not impaired" in the defined period. Although it is
difficult to discuss whether the learning is "blocked" or "delayed", there is a
possibility that the learning in the FRIOmg/kg, 20min animals was delayed.
To sum up, the impaired performance of FRIOmg/kg, 20min group in the water
maze seemed to be different from that of HL animals and such effect was observed in
the equivalent condition in which FR115427 did not block LTP completely. The
learning impairment in the FRIOmg/kg, 20min group is possibly nothing to do with
the inhibition of hippocampal plasticity.
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(b) FR 10 mg/kg group in 90 min interval experiment.
The FRIOmg/kg, 90min group was given place navigation training at a time at
which the induction of LTP in hippocampus was blocked according to the results of
Experiment 2. This group was considered to be comparable to the AP5 group in the
experiment reported by Morris (1989). It was shown that the acquisition of significant
swimming bias as well as induction of hippocampal LTP was inhibited in the AP5
group.
The result was totally different from that of the AP5 experiment. The
performance of FRIOmg/kg, 90min group in the place navigation training and transfer
test was not statistically different from its saline control while AP5 animals were
significantly poorer in the respect of escape latency during training as well as the
respect of swimming bias during transfer test. Unexpectedly, the performance of the
AP5 group was more similar to that of FRIOmg/kg, 20min group. The point we
should take into account is that the AP5 experiment tested LTP in the same animals
that were used in the water maze. Unlike this, Experiment 2 used a naive and separate
group of animals. Experiment 6 was carried out to cope with this point.
In the respect of the timecourse of the drug's effect, the result that the FRIOmg/kg,
90min group showed a better performance than the FRIOmg/kg, 20min group draws
attention. This result suggests the effect of FR115427 on water maze performance is
not relevant to its effect on LTP in which the 90 min effect was significantly stronger
than the 30 min effect. The timecourse of the effect on learning performance agrees
with the timecourse of stereotyped behaviour in the Experiment 1. In addition, the
FRIOmg/kg, 90min group showed significantly fewer incidents of refused trial than
the FRIOmg/kg, 20min group. These results suggests that the effect of FR on the
spatial learning and on the expressoin of stressed behaviour is more relevant to the
effect on spontaneous behaviour than the effect on the hippocampal plasticity.
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(c) The performance ofMK-801 groups.
It is confirmed that MK-801 does not block the acquisition of spatial memory,
represented by the significant bias of swimming in the transfer test, at a dose at which
MK-801 does not have any effect on LTP. This results is consistent with the result
reported by Halliwell and Morris (1987) and McLamb et al.(1990) (see Table 1-1).
In the present study, even an increased escape latency caused by MK-801 was
not clearly detected. It suggests that the drug's effect on the rate of learning
acquisition may be variable according to the experimental condition such as the method
of training or water temperature. Tliis point is addressed in the following experiment.
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Mean (± s.e.m.) escape latency on each of 4 days training in Experiment 4 (20 min)
** : p < 0.01 vs saline group (Dunnett multiple comparison test)
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6-2 Mean (± s.e.m.) escape latency on each of 4 days training in Experiment 4 (90 min)
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Saline MK 0.032 MK 0.1 FR0.32 FR 1.0 FR 3.2 FRIO
Group *** ; p <0.001, * : p < 0.05 significant
quadrant effect
(repeated measures ANOVA)
(B) Experiment 4 (90 min)
Transfer Test
chance level
Saline MK 0.032 MK 0.1 FR 0.32 FR 1.0 FR 3.2 FRIO
Group
*** : p < 0.001 , ** p < 0.01 , * : p < 0.05
significant quadrant effect
(repeated measures ANOVA)
Fig. 6-3 Mean (+s.e .m.) time spent in each quadrant during the 60 sec
transfer test on Day 5
152




I I l l I l
saline MK0.032 MK0.1 FR0.32 FR1.0 FR3.2 FRIO
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saline MK0.032 MK0.1 FR 0.32 FR1.0 FR3.2 FRIO
Fig. 6-4 Mean (+s.e.m.) escape latency for 6 trials of cue navigation training on Day 5.
153
(A) Experiment 4 (20 min)
Swimming Speed













Dayl Day2 Day3 Day4
Transfer Cue
Place navigation training test training
Day 5
Fig. 6-5 Mean (+s.e.m.) swimming speed during Place navigation training (mean for
each day), Transfer test and cue navigation training
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(A) Experiment 4, Experiment 5 ( 20 min)
Aversive behaviour in the
Place navigation training
80
saline MK0.032 MK0.1 FR0.32 FR 1.0 FR 3.2 FRIO
(B) Experiment 4, Experiment 5 (90 min)
Aversive behaviour in the
Place navigation training
saline MK0.032 MK0.1 FR0.32 FR 1.0 FR 3.2 FR10
***: p<0.0001, **:p<0.01, *:p<0.05 vs saline
*AA:p<0.0001 vsExpl (Fisher's exact test)
Fig. 6-6 Total number of 'refused' trials during place navigation training (Each group
had 144 trials in 4 days trainng ). The used' trial is a trial on which animals refused to escape
onto the submerged platform
6.2 Experiment 5
6.2.1 Introduction
Experiment 5 is a smaller version of Experiment 4 with modification in the
experimental procedure.
The purpose of Experiment 5 is to confirm that the impairment of performance
induced by FR115427 and MK-801 is dependent on the experimental conditions
especially those considered to affect the stress level of animals.
As the FRIOmg/kg, 20min animals in Experiment 4 seemed to be too stressed to
perform the learning task normally according to their behaviour at the 'refused' trial, it
is expected that the reduction of the stress levels in the training (e.g. raising the water
temperature, modulation of the procedure of habituation trials ) would ameliorate the
performance of those groups. However, the relatively poor performance of the
control group in Experiment 3 suggest that further reduction of stress level in the
present training schedule possibly inhibits the normal learning acquisition. Therefore,
an alternative strategy was taken. If the effect of FR115427 on learning is related to
stress, a further increase of stress in the experimental condition should deteriorate the
performance of drug group.
In order to increase the stress level, the habituation trials were not run, and
modulation of the water temperature on Day 1 was removed. As an animal under the
influence of drug suddenly experiences cold water, the shock on the first trial is
supposed to be much more emphasized than that on the first trial in Experiment 4.
The drug dose used for this experiment was 3.2 mg/kg of FR115427 which had
no significant effect on LTP or on learning performance in Experiment 4. The effect at
this dose was tested in both 20 min and 90 min interval experiment to test if 20 min
effect is stronger than 90 min effect. The effect of MK-801 0.1 mg/kg was also tested
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to check whether the effect of MK-801 is also enhanced under these conditions. The
interval between injection of MK 0.1 mg/kg and training was fixed to 20 min to
compare the result of this experiment with the results of the other reported
experiments.
6.2.2 Brief procedure of Experiment 5
The animals received handling 3 times but had no pre-training trials in the first
week. The following week, the same training trials and test were carried out as in
Experiment 4. The water temperature was fixed at 25.0 ± 0.5 °C throughout the
experiment.
6.2.3 Results of Experiment 5
(a) Observation of animal behaviour
As was expected, the number of the refused trial in the place navigation training
was increased as compared with Experiment 4 (Fig. 6-6) (page 155). While FR 3.2
mg/kg 20 min interval group showed only 1 refused trial out of 144 trials in
Experiment 4, the corresponding group (FR 3.2-20 min) showed 20 refused trials out
of 144 in Experiment 5. The Fisher's exact test revealed this increase in Experiment 5
is highly significant (p < 0.0001). The number of refused trial of FR 3.2 mg/kg 20
min interval group is also significantly larger than the incidents of control group (4
trials out of 144) in Experiment 5 (p < 0.01). The number of incidents in the FR 3.2
mg/kg 90 min interval group in Experiment 5 was not statistically different from that
of Experiment 4(11 trials in Experiment 4 and 13 trials in Experiment 5). A
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remarkable increase of refused trial (56 trials) was observed in the MK 0.1 mg/kg
group in Experiment 5. The difference between the MK 0.1 mg/kg group in
Experiment 4 and the corresponding group in Experiment 5 was highly significant (p
< 0.0001) and difference between MK 0.1 mg/kg group and control group in the
Experiment 5 was also significant (p < 0.0001)
No refused trial was observed in the cue navigation training.
20 min interval experiments
(b) Place navigation training
Fig 6-7 (A) (page 162) shows the mean escape latency (± s.e.m.) over 4 days
training. Poor performance of FR 3.2 mg/kg and MK 0.1 mg/kg group on Day 2 and
Day 3 is noticeable. An over all one-way between and one-way within-subjects
ANOVA shows no significant group effect [F(2,15)=3.217 p=0.0688] and a
significant day effect [F(3, 45) = 33.28 p < 0.0001]. A significant interaction term
(group x day) [F(6, 45) = 2.415 p < 0.05] allows the analysis on each day. ANOVA
of escape latency on Day 2 [F(2, 15) = 4.90 p < 0.05] and on Day 3 [F(2, 15) = 4.17
p < 0.05] revealed a significant group effect. Post hoc Dunnett multiple comparison
test showed that the escape latency of MK 0.1 mg/kg group on Day 2 and escape
latency of FR 3.2 mg/kg group on Day 3 is significantly longer than that of saline
group (p < 0.05 each).
(c) Transfer test
Fig. 6-8 (A) (page 163) shows mean (± s.e.m) time spent in each quadrant
during 60 sec transfer test. The saline group failed to show a significant swimming
bias to the P quadrant ( ANOVA of time spent in 3 quadrants: [F(7, 10)=2.1904
p=0.1626]). This is caused by a very strange behaviour of one of the saline animals
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(record No. 3316). Although it was trained with platform in SW, it showed strong
swimming bias to NE (Opposite) quadrant (i.e. 0.1 sec in P, 4.5 sec in Ar, 33.8 sec
in O and 21.7 sec in A1 quadrant). As it showed normal escape behaviour during
training trials, this performance was accidental and mysterious. If the data of this
animal is excluded from the analysis, mean swimming time is 31.8 sec in P., 9.5 sec
in Ar., 10.2 sec in O. and 8.5 sec in Al. quadrant respectively. An ANOVA of time
spent in 3 quadrants shows significant swimming bias [F(6,8) =15.71 p < 0.01].
This result is very similar to that of 90 min saline group.
The 3 quadrants ANOVA of the FR 3.2 mg/kg group [F(7, 10) = 2.14 p =
0.1678] and of the MK 0.1 mg/kg group [F(7,10) = 3.46 p=0.072] showed no
significant swimming bias. Therefore both drug groups failed to acquire the spatial
memory.
(d) Cue navigation training
Fig. 6-9 (A) (page 164) shows the performance of each group in the cue
navigation training. An ANOVA ofmean escape latencies did not show any
significant group effect [F(2, 15) = 0.104 p = 0.902]
90 min interval experiments
(e) Place navigation training.
Fig 6-7 (B) (page 162) shows the mean escape latency (± s.e.m.) over 4 days
training. Both groups showed progressive improvement of performance across day.
The performance of the FR 3.2 mg/kg group was not statistically different from that of
the saline group. A one-way between and one-way within-subjects ANOVA showed
that the group effect was not significant [F(l, 10) = 0.78 p = 0.399]. The main effect
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of day was significant [F(3, 30) = 39.45 p < 0.0001]. The interaction term (group x
day) was not significant [F(3, 30) = 0.90 p = 0.454],
(f) Transfer test
Fig. 6-8 (B) (page 163) shows mean (± s.e.m) time spent in each quadrant
during 60 sec transfer test. Both group acquired significant swimming bias to the P
quadrant as follow: The 3 quadrant ANOVA in saline group, [F(7, 10) = 19.71 p <
0.001]; The 3 quadrant ANOVA in FR 3.2 mg/kg group, [F(7, 10) = 52.95 p <
0.0001],
(g) Cue navigation training
Fig. 6-9 (B) (page 164) shows the performance of each group in the cue
navigation training. A t-test shows that the difference between groups is not
significant (t = 0.356 degree of freedom is 10 p = 0.7294)
(h) Analysis of swimming speed
The swimming speed of each group during place navigation training, transfer
test and cue navigation training is summarised in Fig. 6-10 (page 165). Analysis was
carried out on all 5 groups. ANOVA of swimming speed in place navigation training
showed no significant group effect [F(4, 25) = 2.33 p = 0.836], a significant day
effect [F(3, 75) = 5.58 p < 0.01] and no significant interaction between group and
day [F( 12, 75)= 0.76 p = 0.686]. An ANOVA of swimming speed in transfer test
showed no significant difference among groups [F(4, 24) = 1.03 p = 0.411] (one
swimming speed data of an animal in FR 3.2 mg/kg 90 min group was excluded in
this analysis because of a computer problem during the test). An ANOVA of
swimming speed in cue training showed no significant group effect either [F(4, 25) =
0.599 p = 0.667].
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6.2.3 Discussion
The performance of FR 3.2 mg/kg 20 min group and MK 0.1 mg/kg 20 min
(MK0.1Ex5-I20) group in the place navigation training was significantly deteriorated
by reducing water temperature on Day 1 and abolishing the habituation pre-training.
However, these modifications did not have a significant effect on the saline or the FR
3.2 mg/kg 90 min group. The enhancement of drug's effect on the learning by the
procedural modification seemed to be parallel to the induction of stressed behaviour.
The procedural modification increased the number of refused trials in the FR 3.2
mg/kg, 20 min and in the MK0.1mg/kg, 20 min groups but not in the saline or the FR
3.2 mg/kg, 90 min groups. It is suggested that the effect of FR115427 on
performance in the water maze is an early onset effect which may be related to the
stress in the animals, and unrelated to its late onset effect on LTP. It is not clear
whether the effect of MK-801 is early or late onset. However, the nature of its effect
on learning was similar to that of FR115427. The performance of the MK0.1mg/kg,
20 min group is comparable to the performance of the MK-801 0.05 mg/kg group
reported by Robinson et al. (1989) because significant increase of escape latency
(escape path length) and poor biased swimming in the transfer test was observed. The
learning effect of FR 115427 and MK-801 was not explained by sensory motor
impairment because no significant effect was detected in the performance in cue
navigation training or swimming speed. To sum up, the effect of these non¬
competitive NMDA receptor antagonist does not seemed to be closely related to the
hippocampal plasticity because those effect are overcome by modulation of stress level
in the experimental procedure.
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Day 1 Day 2 Day 3 Day 4
* : p < 0.05 vs saline group (Dunnett multiple comparison test)



















Day 1 Day 2 Day 3 Day 4
Fig. 6-7 Mean(±s.e.m.w) escape latency on each of 4 days training in Experiment 2









*** : p < 0.001 significant quadrant effect
(repeated measures ANOVA)
Fig.6-8 Mean (+s.e.m.) time spent in each quadrant during the 60 sec























saline MK0.1 FR3.2 saline FR 3.2
Fig. 6-9
Mean (+s.e.m.) escape latency for 6 trials of cue navigation training on Day 5
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Fig. 6-10 Mean (±s.e.m.) swimming speed during Place navigation
training(mean for each day), Transfer test and cue navigation training
165
6.3 Experiment 6 (LTP experiment)
6.3.1 Methods
On Day 6 of the Experiment 4 or 5, some of the rats which received 3.2 mg/kg
or 10 mg/kg of FR115427 during 5 day's training and testing were submitted to
Experiment 6. The surgical procedure and electrophysiological method of stimulation
and recording are the same as in Experiment 2 (Chapter 3). The animals had received
5 days repetitive treatments of 3.2 mg/kg during the water maze training and received
the same 3.2 mg/kg dose of FR in this experiment. The rats that had received 10
mg/kg per day during the training also had the same 10 mg/kg injection in this
experiment. The 6th i.p. injection of 3.2 or 10 mg/kg FR115427 was given 30 or 90
min before tetanus stimulation of perforant path.
6.3.2 Results of Experiment 6
(a) Effect of FR on baseline after repetitive injection
As described in Chapter 3, initial EPSP slope of 15 wave forms at the period
just before drug injection and the period 25 ~ 30 min after drug injection were
averaged and analysed to assess the 6th injection of 3.2 or 10 mg/kg FR115427 on
baseline. An one-way within ANOVA revealed no significant change in baseline after
6th injection of 3.2 [F(l ,4) = 6.27 p = 0.067] or 10 mg/kg FR [F( 1,4) = 0.95 p =
0.384],
166
(b) Effect of FR on LTP after repetitive injection
Tetanus stimulation was administered 30 min or 90 min following 6th injection
of FR 3.2 or 10 mg/kg (i.p.). Averages of the initial EPSP slope from 15 wave forms
just before and 30 min after tetanus stimulation were made.
Tetanus stimulation 30 min and 90 min after 6th injection of FR 3.2 mg/kg
induced a 34.4 ± 5.5 % (n=5) and 25.9 ± 3.2 % (n=5) increase in EPSP slope
respectively. Fig. 6-11 (page 169) compares the effect of single injection and 6th
injection. These results were not statistically different from the results after a single
injection of 3.2 mg/kg FR in Experiment 2.
Tetanus stimulation 30 min after 6th injection of 10 mg/kg FR induced 15.9 ±
1.5 % (n=5) increase in EPSP slope (Fig. 6-11, Fig.6- 12(A)).This change was also
not statistically different from the result of the single injection in the Experiment 2.
However, tetanus stimulation 90 min after 6th injection of 10 mg/kg FR induced
15.0 ± 5.6 % (n=5) increase in EPSP slope (Fig. 6-11,6-12(B)) while tetanus 90 min
after a single injection of 10 mg/kg induced only 5.4 ± 3.1% increase in the
Experiment 2. Although the difference between the % change after 6 th injection and
after single injection was not significant (t-test, p = 0.1210), the tetanus 90 min after
a single injection did not induce a significant slope increase in comparison with the
pre-tetanus base line (p <0.05) while the tetanus 90 min after a 6 th injection induced a
significant potentiation of EPSP slope . In short, in the 90 min interval test, single
injection of 10 mg/kg FR blocked induction of LTP but a 6 th injection of 10 mg/kg
FR did not block the induction of significant slope increase.
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6.3.3 Discussion
At the dose of 3.2 mg/kg FR115427, no difference was observed between the
effect of a single injection and a 6 th injection of the drug on LTP.
At the dose of 10 mg/kg, a remarkable difference was observed between the
effect of single injection and injection after 5 consecutive treatment. The enhancement
of inhibitory effect of the drug on LTP in the 90 min interval test disappeared (see Fig.
6-13 "90 min interval specific tolerance" page 171). This reduction of the drug's
effect after repetitive treatment seems to be different from the general desensitisation
because the desensitisation was only observed in the 90 min interval effect (if the
general desensitisation was induced, the result should be as shown in Fig. 6-13
-"imaginary results"). The mechanism of this unique tolerance is interesting but is
unknown. Ligand binding studies suggest that the binding of FR115427 to the
NMDA receptor involves more than a simple binding process (Sherriffs et al., 1993).
This may be related to the necessity of a longer interval to exhibit the full inhibitory
effect on LTP and induction of unusual tolerance. Probably some special events, such
as generation of an effective channel block conformation between receptor and ligand,
may be induced during the 90 min interval after the initial injection and such a change
is blocked after repetitive injection of the drug.
As 10 mg/kg FR 90 min prior to the tetanus did not block the induction of LTP
after repetitive injection, it is doubtful that the FR 10 mg/kg 90 min interval group in
Experiment 4 was carried out in the condition in which LTP was completely blocked.
As the efficacy of FR115427 in suppressing LTP was not potentiated after









* :p<0.05 ** :p<0.01 p< 0.001
significant effect of tetanus (ANOVA)
Fig.6-11
The effect of repetitive injection of FR115427 on LTP induction
values are means for 5 min between 30 min and 35 min after tetanus.
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Fis. 6-12
Plots of averaged and normalized EPSP slope value
Plots were made between 10 min before and 40 min after tetanus stimulation
In(A), tetanus stimulation was applied 30 min after drug injection (i.p.).
In(B), tetanus stimulation was applied 90 min after drug injection (i.p.).
Close dots show the result after single injection of drug.






























































The aim of this thesis has been to examine whether the effect of FR115427 on
spatial learning and on LTP show similar dose and time dependency. If they are
similar, results strongly support the hypothesis that LTP is a form of neural plasticity
underlying spatial memory. If they are not similar, results suggest that NMDA
receptor mediated process which is different from LTP plays an important role during
learning performance, standing alongside the LTP hypothesis. The results which
were obtained in the present experiments supported the latter suggestion. These
experiments also confirmed that the induction ofmotor syndrome is another example
of behavioural effects of the NMDA receptor antagonists which can be distinguished
from the effect on LTP. At first, this general discussion summarises the experimental
results show the effect of FR115427 on behaviour and learning to be different from its
effect on LTP, then an analysis of the process the NMDA receptors are involved in
during learning in the water maze.
7.1 Summary of results
This thesis consists of 6 experiments (Experiment 1 ~ 6). The animals utilised
in Experiment 6 were the animals already tested in Experiment 4 and Experiment 5
while Experiments 1-5 utilised naive animals. All drug treatments were done by i.p.
injection.
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7.1.1 Experiment 1: Open field activity study
FR115427 and MK-801 induced a characteristic motor syndrome: ataxia, head
weaving, body rolling and hyperlocomotion. The minimum effective doses of
FR115427 were 32 mg/kg for induction of ataxia or body rolling and 10 mg/kg for the
induction of head weaving or hyperlocomotion. This potency was 30 ~ 100 times
weaker than that ofMK-801. Scores of Ataxia and head waving reached a peak
within 30 min after injection of FR. The time course of hyperlocomotion and body
rolling seemed to be exhibiting a similar time course to the dose at which ataxia was
not very severe. The behavioural effects ofMK-801 appeared slower than that of
FR115427.
7.1.2 Experiment 2: in vivo LTP experiment
FR115427 suppressed the LTP (sustained increase of slope EPSP induced by
tetanus stimulation of perforant path) in the dentate gyrus of anaesthetised rats dose
dependently. An analysis of the effect of FR115427 on LTP at different doses and at
different post injection periods showed that the drug's effect is significantly more
potent after a 90 min than a 30 min interval following injection. The induction of LTP
was completely blocked 90 min after injection of 10 mg/kg dose of FR115427 but not
after 30 min. MK-801 exhibited no significant effect at the dose of 0.32 mg/kg or 0.1
mg/kg. All anaesthetised animals died after injection of 1 mg/kg dose of MK-801 in
the present experiment using Lister hooded rats. It is reported that 1 mg/kg MK-801
completely blocked LTP induced 150 min or 120 min after injection but not 30 min
after injection in anaesthetised SD rats (Abraham and Mason, 1989; Morimoto et al.,
1991). Both the observed effect of FR115427 and the reported effect ofMK-801 on
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LTP were enhanced after the longer interval. This time course effect of FR115427 is
totally different from the behavioural effect. This potency of FR115427 is about 10
times weaker than the reported potency ofMK-801.
7.1.3 Experiment 3: the water maze experiment with hippocampal lesion animals (in
mild stress version)
The conventional procedure of the water maze was modified in this experiment
using habituation trials before the main training with a hidden platform and warmer
water on the first day of the main training. These procedural modifications were
conducted to alleviate the stress of Day 1 training. This experiment's aim was to
examine whether the spatial learning under conditions of mild stress depends on the
same hippocampal functions as learning under the conventional condition.
After 4 days training (1 day training in the warmer water: 27 °C, followed by 3
days training in the normal water: 25 °C), sham animals succeeded but hippocampal
lesion animals failed to acquire the spatial memory as exhibited by the bias seen in the
swimming pattern in the transfer test. These results showed that spatial learning in the
modified procedure was still sensitive to the hippocampai damage. The performance
of hippocampal lesion animals in cue navigation training suggested that their learning
deficit was not due to side effects of the lesion surgery on their sensory motor system.
7.1.4 Experiment 4: water maze experiment (mild stress)
In Experiment 4, the same procedural modification (habituation trials and
modulation of water temperature) were introduced.
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The 10 mg/kg dose of FR115427 interfered with the acquisition of spatial
memory if a 20 min interval was taken between drug injection and commencement of
training, but had no significant effect if a 90 min interval was taken (training took
about 10 min each day). At the dose of 3.2 mg/kg or lower doses, FR115427 had no
effect, with either the 20 or 90 min interval. MK-801 had no significant effect at 0.1
mg/kg or lower doses. Both drugs did not induce significant effect on performance in
the cue navigation training.
While FR more strongly suppressed LTP after longer interval (90 min, 150 min)
than after the shorter interval (20 min, 30 min), learning after the short interval (20 ~
30 min) was severely impaired but no impairment was observed after the longer
interval (90 ~ 100 min).
The above results suggested that the time course of the learning effect is different
from that of the inhibitory effect on LTP.
7.1.5 Experiment 5: water maze experiment (normal stress)
In the Experiment 5, the habituation trials and modulation of water temperature
were removed. The 3.2 mg/kg dose of FR impaired the acquisition of spatial memory
in the 20 min interval training, but did not impair memory acquisition in the 90 min
interval training. The 0.1 mg/kg dose of MK-801 impaired the acquisition of spatial
memory in the 20 min interval training.
This experiment suggested that FR's effect on learning and LTP were different
in the dose response as well as in the time course. The 3.2 mg/kg dose of FR did not
significantly suppress LTP in Experiment 2 but it did impair learning in this
experiment. MK-801 also impaired the spatial learning at a dose (0.1 mg/kg) that did
not block LTP.
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Another interesting finding was that the potency of those drugs on learning
seemed to depend on the level of stress to which the animals were exposed on the first
day of training. The deterioration of the learning performance in the FR group and
MK group in Experiment 5 seemed to be proportional to the significant increase of
'refused' trials in this experiment. Neither FR norMK impaired performance in the
cue navigation training. FR115427 and MK-801 were found to exhibit similar effects
on learning.
7.1.6 Experiment 6: LTP experiment after water maze experiments
Following the water maze experiments, the effect of FR115427 on LTP after the
daily repetitive injection was examined. While single injection of 10 mg/kg FR115427
blocked LTP induced 90 min after injection, a 6th injection of 10 mg/kg FR after 5
consecutive injections did not completely block LTP induced 90 min after injection.
The drug's efficacy of suppressing LTP induced 30 min after injection was not
changed by repetitive injection. An apparent desensitisation effect specific to the 90
min interval (using FR115427) seemed to occur after repeated treatment. No
noticeable change was detected in the drug's effect after repetitive injection of the 3.2
mg/kg dose. The possibility that the accumulation of drug potentiated the drug's effect
was excluded.
On the other hand, it was found that even the highest drug dose group in
Experiment 4 was not always in the equivalent condition in which LTP was
completely blocked. As an attempt to examine learning performance of defective
animals in hippocampal LTP failed, the above results do not deny the LTP hypothesis.
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7.2 The nature of the effect of non-competitive NMDA receptor
antagonists on learning
In Experiment 4 and 5, three groups showed a significant deficit in learning
performance. They are as follows: the FR 10 mg/kg 20 min interval group in
Experiment 4, FR 3.2 mg/kg 20 min interval group in Experiment 5 and MK 0.1
mg/kg 20 min interval group in Experiment 5. For convenience, these groups shall be
termed FR10Ex4, FR3.2Ex5 and MK0.1Ex5 respectively. One remarkable point is
that equivalent groups in Experiment 4 to groups FR3.2Ex5 and MK0.1Ex5, which
are FR3.2Ex4 and MK0.1Ex4 in the 20 min interval experiment, showed no
impairment in their learning performance. That is to say, the procedural manipulation
in the Experiment 4 canceled the drug's effect on learning observed in the FR3.2Ex5
and MK0.1Ex5 group. This point seems to be the key to understand the nature of the
learning effect of FR 115427 and MK-801.
7.2.1 Memory consolidation/retention process and memory retrieval process
The procedural modification of the Experiment 4 was introduced in the very
early stage of learning (before training and during training on Day 1). On the other
hand, the process for consolidation and retention of the acquired memory during
training (spatial information of the hidden platform) and the process for the retrieval of
that memory may not be active until tne end of training on Day 1 or later. Therefore, it
is suggested that the learning effect of FR orMK is not caused by the impairment of
the memory consolidation, retention or the memory retrieval process. As forMK-
801, some groups confirmed this point by modulating the timing of drug injection.
177
Robinson et al. (1989) showed that administration of MK-801 immediately after place
navigation training of each day, did not interfere learning (exhibition of a significant
swimming bias in the transfer test) at the dose (0.1 mg/kg). McLamb et al. (1990)
obtained the similar results. These provide groundwork for the argument that MK-
801 does not interfere the memory retention/consolidation process.
Robinson et al. (1989) and Heale and Harley (1990) revealed that MK-801 does
not block the retrieval process ofmemory along to behavioural expression ofmemory
using the 'place recall' test (see Chapter 1). In that test, animals treated with the
vehicle were trained in advance and MK-801 was injected only before the transfer test.
Since MK-801 did not disrupt the expression of the acquired memory, it had no effect
on memory retrieval.
7.2.2 Learning acquisition process
The only remaining process of learning which can be impaired by FR115427 or
MK-801 is the acquisition process of learning. However, the main process of
learning acquisition, an acquisition of substantial 'information' about platform
location, should take place throughout the training period. If this process is impaired
by a drug, it becomes difficult to reverse the impairment, ever using circumstantial
modifications at the only beginning of the training. In order to explain the cancellation
of the drug's effect by the modification at the initial stage, one has to presume some
early stage of the learning acquisition process which is crucial to the following
process.
The poor learning groups; FR10Ex4, FR3.2Ex5 and MK0.1Ex5 seemed to have
poor motivation to escape to the platform because they showed high incidence of
'refused' trial in the early stage of training. They seemed to have troubles in initiation
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of substantial learning. This observation suggests the existence of process which is
essential to initiate the learning. Whishaw et al. (1995) called the establishment of
learning constitution "finding the solution". Hence, the acquisition of learning
processes can be subdivided into 2 stages; (i) 'finding the solution' process and (ii)
'learning the task' process.
For example, this idea of subdivided acquisition process is explained as follows.
In order to acquire the normal escape performance in the water maze, (i) a rat has to
understand that memorising the position of submerged platform is beneficial to them at
first, (ii) then it has to organise and memorise the 'information' which is necessary to
specify the platform's location. Only if the submerged platform is satisfactory for a rat
to escape, (i) process may be accomplished. However, the submerged platform may
not be necessarily a satisfactory refuge for a rat which is strongly aversive to water as
it does not enable rats to get out of the water completely. Strong aversion may force a
rat to continue to search a better foothold or hidden path leading to a complete escape.
Conversely, if swimming in the water is not an aversive event, they may not try to
reduce the escape latency by memorising the position of platform. They may prefer to
take an easygoing random search strategy. The 'finding the solution' process can be
understood as an acquisition process of the proper attitude to the escape platform and it
seems to be influenced by psychological states of animals.
Going back to the initial point of argument of this section, if there is an
inhibition of learning process which can be abolished by circumstantial modifications
in the early stage of learning, the only possible inhibition may be an inhibition of
learning process (i) but not (ii). FR115427 and MK-801 seem to prevent animals
from learning that the submerged platform is worth to escape or to memorise its
location.
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7.2.3 Learning effect of nitric oxide synthase inhibitor.
A report by Bannerman et al. (1994a, 1994b) which studied the effect of L-nitro-
arginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, on LTP and spatial
learning gives a good clue about a role of NMDA receptors in learning process.
Inhibitors of nitric oxide synthase are expected to share some of the physiological
actions with NMDA receptor antagonists because those inhibitors not only block
induction of LTP (Bohme et al., 1991; O'Dell et al., 1991; Schuman and Madison,
1991; Haley et al., 1992) but also attenuate some stimulatory effects mediated by
NMDA receptor such as, formation of cyclic GMP in rat cerebellar slices (Bredt and
Snyder, 1989; East and Garthwaite, 1990) or in hippocampal slices (East and
Garthwaite, 1991) or in cerebellum of free moving rats (Luo et al., 1994), release of
noradrenaline and aspartate from rat hippocampal slices (Jones et al., 1995) and
excitotoxic damage in rat cerebral cortical culture (Dawson et al., 1991).
Similar to the results of present experiments, Bannerman et al. showed that L-
NAME produced an impairment in spatial learning in the water maze at a relevant dose
at which it did not block in vivo LTP. More interestingly, they found that once rats
have experienced a water maze task in the normal condition, L-NAME did not impair
the learning in a second water maze located in a novel spatial environment. In another
words, L-NAME did not block spatial learning in rats which were already familiar to
aspects of the water maze but had not acquired any of the spatial information about the
new maze. In the first water maze, rats seemed to acquired something essential but
different from the substantial information to solve the second maze. This acquisition
may be the acquisition of process (i). This process may be an acquisition of a proper
regard to the platform as a satisfactory refuge for rats or a proper choice of place
navigation strategy in solving the maze. L-NAME, FR115427 and MK-801 blocked
acquisition of process (i) but could not reverse or cancel the acquired process (ii).
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7.3 Anxiety and water maze
In the present Experiments, FR115427 and MK-801 increased the incidents of
'refused' trial which seemed to be an expression of aversion to water. As the
reduction of water temperature increased the incidents of 'refused' trials and the
increase in the FR3.2Ex5 and MK0.1Ex5 group paralleled their poor performance; too
strong stress in the water seemed to prevent rats from regarding the position of
platform as a worth place to memorise.
Matching to the above point of view, too weak stress is also considered to
prevent rats from regarding the position of platform as a worth place to memorise
because rats have weak necessity to reduce the escape latency by memorising the
position of platform. Consistent to this view, anxiolytics were reported to impair
water maze learning. Chlordiazepoxide (McNaughton and Morris, 1987), morphine
(McNamara and Skelton, 1991a), buspirone (McNaughton and Morris, 1992),
diazepam (McNamara and Skelton, 1991b; 1992a) and CL218,872 (McNamara and
Skelton, 1992b) impair learning in the water maze. Despite the different structure and
different side effects, they all have anxiolytic effects in the behavioural tests.
Interestingly, McNamara and Skelton (1991a) reported that not only naloxon reverse
the acquisition impairment caused by morphine, reducing the water temperature also
reversed the effects ofmorphine. Reducing the water temperature canceled the effects
of anxiolytics. This result shows a fine contrast to the results of present experiments,
in which increasing water temperature canceled the effect of FR115427 or MK-801
that induced stressed behaviour in the water maze. Therefore the anxiogenic aspect in
the effect of FR115427 and MK-801 is suggested to be important in the induction of
learning effect in the water maze.
However, anxiolytic-like properties of competitive and noncompetitive NMDA
receptor antagonists have been generally demonstrated in rodent models, including
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social interaction, elevated plus-maze (Dunn et al., 1989), separation-induced
ultrasonic vocalisation (Kehne et al., 1991), and conflict paradigms (Bennett and
Amric, 1986; Cineschmidt et al., 1982c). Although the NMDA receptor agonists
induce dopamine agonist-like behaviour as discussed in Chapter 1, the anxiogenic
aspects of the effects of NMDA receptor antagonists do not seem to be well
investigated.
7.4 Conclusion
The non-competitive NMDA receptor antagonist FR115427 impaired spatial
learning in the water maze. The dose response and time course analysis suggested that
this learning effect was not caused by a blocking effect on hippocampal LTP. The
time course of the learning effect of FR115427 was similar to that of the induction of
motor syndrome. As no direct effect on sensory motor system was observed in the
poor learning performance following FR115427 treatment, the learning effect seemed
to be related to the psychological effect of the drug underlying the induction of
abnormal behaviour. A reduction of stress level during the water maze learning
alleviate the learning impairment as well as the abnormal aversive behaviour induced
by FR115427. Therefore, the anxiogenic-like effects of FR115427 is suggested to
impair some psychologically important process of the learning in the water maze.
More investigations need to be conducted on the psychological aspects of the effects of
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